SULFOXYIMINO-SUBSTITUTED BENZOYL DERIVATIVE AND HERBICIDE

Information

  • Patent Application
  • 20110144345
  • Publication Number
    20110144345
  • Date Filed
    August 03, 2009
    15 years ago
  • Date Published
    June 16, 2011
    13 years ago
Abstract
The benzoyl derivative of the present invention is represented by formula (I)
Description
TECHNICAL FIELD

The present invention relates to a benzoyl derivative or salt thereof having sulfoxyimino group, and a herbicide including one or two or more types of the compounds as active ingredient.


Priority is claimed on Japanese Patent Application No. 2008-202445, filed Aug. 5, 2008, the content of which is incorporated herein by reference.


BACKGROUND ART

Many herbicides are being used for weed control, which has required intensive labor in the past when growing field and garden crops. However, the development of drugs which are reliably effective at a lesser dose and which are also possible to use safely is desired due to the occurrence of chemical damage to crops, environmental persistence of the drugs, and environmental pollution caused by the drugs.


Several patent documents disclose that benzoic acid derivatives which are similar to the compound of the present invention have herbicidal activity.


For example, Patent document 1 discloses that a benzoic acid derivative represented by the following formula is effective as an active ingredient of herbicide. In addition, Patent document 1 also discloses that the compounds described in this patent document are useful for an active ingredient of herbicide.




embedded image


(In the formula, Y′ represents methyl group or the like, Z represents hydrogen atom or the like, X′ represents a halogen atom or the like, R, R′ and R″ each independently represents an alkyl group or the like.)


However, the compound of the present invention is not described in this patent document.


In addition, Patent document 2 discloses that a benzoic acid derivative represented by the following formula is effective as an active ingredient of herbicide.




embedded image


(In the formula, R1′ to R5′ each independently represents hydrogen atom or the like, Q′ represents the groups represented by the following formulas (Q′-1) to (Q′-3).




embedded image


Although the compound represented by the general formula described in this patent document includes the compound of the present invention, there is only the compound having methylsulfonyl group (SO2Me) at 4-position of benzoyl group is practically synthesized in this patent document, and this patent document does not describe a specific example of the compound of the present invention.


PRIOR ART LITERATURE
Patent Literature



  • Patent document 1: publication of WO98/42678

  • Patent document 2: publication of WO04/52849








DISCLOSURE OF INVENTION
Problems to be Solved by the Invention

The objective of the present invention is to provide a compound for herbicide which is reliably effective when used in a low dose and is highly safe.


Means for Solving the Problems

As a result of intensive research, the present inventors discovered that the compound represented by formula (I) is particularly useful for an active ingredient of herbicide, and completed the present invention.


Namely, the present invention relates to the following.


(1) A benzoyl derivative represented by formula (I)




embedded image


(In the formula, E represents hydrogen atom, an alkyl group, an alkenyl group, an alkynyl group, an aryl group, an alkoxy group, a cycloalkoxy group, an alkoxycarbonyl group, an alkyl thio group, cyano group, an acyl group, a heterocyclic group, NRa2 group (in the formula, each Ra independently represents hydrogen atom or a hydrocarbon group), Ra2NC(O) group (in the formula, Ra is as defined above), NRcC(O)Ra (in the formula, Ra is as defined above, Rc represents hydrogen atom or an alkyl group), NRcCO2Ra (in the formula, Ra and Rc are as defined above), or CRc═NORd (in the formula, Rc is as defined above, Rd represents hydrogen atom or an alkyl group), when E represents NRa2 group or Ra2NC(O) group, two Ra may bond together to form a 3- to 6-membered ring,


R1 represents a halogen atom, hydroxyl group, mercapto group, NRa2 group (in the formula, Ra is as defined above), nitro group or an organic group,


p represents an integer of 0 to 3, when p is 2 or more, the numerous R1 may be the same or different from each other,


R2 and R3 each independently represents an alkyl group, a cycloalkyl group, an alkenyl group, an alkynyl group, an aryl group or a heterocyclic group,


and R2 and R3 may bond together to form a 3- to 8-membered hetero ring which may have 1 to 4 nitrogen atoms, oxygen atoms or sulfur atoms other than the sulfur atom in sulfoxyimino group,


Q represents a group selected from the groups represented by the following formulas Q1 to Q8:




embedded image


(In the formula, * represents binding site,


G represents oxygen atom, —S—, —S(O)—, —S(O)2— or —NRb— (in the formula, Rb represents hydrogen atom or an organic group),


R4 represents hydrogen atom, an alkyl group, a cycloalkyl group or NRa2 group (in the formula, Ra is as defined above),


R5 represents hydrogen atom, an alkyl group, an alkenyl group, an alknyl group, an aryl group, a heteroaryl group, an alkoxycarbonyl group, an alkyl thiocarbonyl group, an acyl group, Ra2NC(O) group (in the formula, Ra is as defined above), an alkylsulfonyl group, an arylsulfonyl group or NRa2SO2 group (in the formula, Ra is as defined above),


R6 represents cyano group, an acyl group, an alkoxycarbonyl group, —C(R71)═NR7 group (in the formula, R71 represents hydrogen atom, an alkyl group, an aryl group or a heteroaryl group, R7 represents hydrogen atom, an alkyl group or an alkoxy group) or a tetrazolyl group,


R8 and R9 each independently represents hydrogen group or an alkyl group,


R10 and R11 each independently represents hydrogen atom, an alkyl group or a cycloalkyl group,


X represents —C(R12)(R13)— or —N(R12)— (in the formula, R12 and R13 each independently represents hydrogen atom or an alkyl group),


Y represents oxo group, an alkyl group, an alkoxy group, an acyl group or an alkoxycarbonyl group,


m represents an integer of 0 to 4,


when m is 2 or more, the numerous Y may be the same or different from each other, Y may bond with each other to form a ring regardless of the substitutents listed above, Y and R12 of X may bond together to form a ring regardless of the substitutents listed above)) or salt thereof.


(2) The benzoyl derivative or salt thereof according to (1), wherein the benzoyl derivative is represented by formula (1-b):




embedded image


(In the formula, E, R1 to R3, and Q are as defined above).


(3) The benzoyl derivative or salt thereof according to (1) or (2), wherein in the formulas, R1 represents a halogen atom, an alkyl group or —N═S(═O)R2R3 (in the formula, R2 and R3 are as defined above).


(4) The benzoyl derivative or salt thereof according to any one of (1) to (3), wherein in the formulas, E represents an alkoxy group or an alkoxycarbonyl group.


(5) A herbicide comprising at least one type of benzoyl derivative or salt thereof according to any one of (1) to (4) as an active ingredient.


Effects of the Invention

The composition of the present invention, which includes as an active ingredient one or two or more types of benzoyl derivatives having sulfoxyimino group or salts thereof is useful for herbicide which is reliably effective when used in a low dose and is highly safe.


BEST MODE FOR CARRYING OUT THE INVENTION

Hereinafter, the present invention will be described in detail.


1) Benzoyl Derivative or Salt Thereof Having Sulfoxyimino Group

The first aspect of the present invention is a benzoyl derivative having sulfoxyimino group represented by formula (I):




embedded image


(In the formula, E represents hydrogen atom, an alkyl group, an alkenyl group, an alkynyl group, an aryl group, an alkoxy group, a cycloalkoxy group, an alkoxycarbonyl group, an alkyl thio group, cyano group, an acyl group, a heterocyclic group, NRa2 group (in the formula, each Ra independently represents hydrogen atom or a hydrocarbon group), Ra2NC(O) group (in the formula, Ra is as defined above), NRcC(O)Ra (in the formula, Ra is as defined above, Rc represents hydrogen atom or an alkyl group), NRcCO2Ra (in the formula, Ra and Rc are as defined above), or CRc═NORd (in the formula, Rc is as defined above, Rd represents hydrogen atom or an alkyl group), when E represents NRa2 group or Ra2NC(O) group, two Ra may bond together to form a 3- to 6-membered ring,


R1 represents a halogen atom, hydroxyl group, mercapto group, NRa2 group (in the formula, Ra is as defined above), nitro group or an organic group,


p represents an integer of 0 to 3, when p is 2 or more, the numerous R1 may be the same or different from each other,


R2 and R3 each independently represents an alkyl group, a cycloalkyl group, an alkenyl group, an alkynyl group, an aryl group or a heterocyclic group,


R2 and R3 may bond together to form a 3- to 8-membered hetero ring which may have 1 to 4 nitrogen atoms, oxygen atoms or sulfur atoms other than the sulfur atom in sulfoxyimino group,


Q represents a group selected from the groups represented by the following formulas Q1 to Q8:




embedded image


(In the formula, * represents binding site,


G represents oxygen atom, —S—, —S(O)—, —S(O)2— or —NRb— (in the formula, Rb represents hydrogen atom or an organic group),


R4 represents hydrogen atom, an alkyl group, a cycloalkyl group or NRa2 group (in the formula, Ra is as defined above),


R5 represents hydrogen atom, an alkyl group, an alkenyl group, an alknyl group, an aryl group, a heteroaryl group, an alkoxycarbonyl group, an alkyl thiocarbonyl group, an acyl group, Ra2NC(O) group (in the formula, Ra is as defined above), an alkylsulfonyl group, an arylsulfonyl group or NRa2SO2 group (in the formula, Ra is as defined above),


R6 represents cyano group, an acyl group, an alkoxycarbonyl group, —C(R71)═NR7 group (in the formula, Rn represents hydrogen atom, an alkyl group, an aryl group or a heteroaryl group, R7 represents hydrogen atom, an alkyl group or an alkoxy group) or a tetrazolyl group,


R8 and R9 each independently represents hydrogen group or an alkyl group,


R10 and R11 each independently represents hydrogen atom, an alkyl group or a cycloalkyl group,


X represents —C(R12)(R13)— or —N(R12)— (in the formula, R12 and R13 each independently represents hydrogen atom or an alkyl group),


Y represents oxo group, an alkyl group, an alkoxy group, an acyl group or an alkoxycarbonyl group,


m represents an integer of 0 to 4,


when m is 2 or more, the numerous Y may be the same or different from each other, Y may bond with each other to form a ring regardless of the substitutents listed above, Y and R12 of X may bond together to form a ring regardless of the substitutents listed above)) (hereinafter referred to as “the compound of the present invention”) or salt thereof. The compound of the present invention or salt thereof includes hydrate, various solvates, crystalline polymorphism and the like.


The groups like will be described in detail below. Each group may include one or more types, or one or more substituents within a chemically acceptable range. In addition; the number of carbon atoms described below does not include the number of carbon atoms in the substituents when the group is substituented.


(E)

In the present invention, E represents hydrogen atom, an alkyl group, an alkenyl group, an aryl group, an alkoxy group, a cycloalkoxy group, an alkoxycarbonyl group, an alkyl thio group, cyano group, an acyl group, a heterocyclic group, NRa2 group (in the formula, each Ra independently represents hydrogen atom or a hydrocarbon group), Ra2NC(O) group (in the formula, Ra is as defined above), NRcC(O)Ra (in the formula, Ra is as defined above, Rc represents hydrogen atom or an alkyl group), NRcCO2Ra (in the formula, Ra and Rc are as defined above), or CRc═NORd (in the formula, Rc is as defined above, Rd represents hydrogen atom or an alkyl group), when E represents NRa2 group or Ra2NC(O) group, two Ra may bond together to form a 3- to 6-membered ring,


“Alkyl group” indicates a linear or branched alkyl group. Examples of “alkyl group” include methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, i-butyl group, s-butyl group, t-butyl group, n-pentyl group, n-hexyl group and the like. Among these examples, a C1-6 alkyl group is preferable.


Within a chemically acceptable range, “alkyl group” may have one or more types of, or one or more substituents selected from the substituents described in TABLE 1. The substituents are preferably hydroxy group, thiole group, cyano group, isocyano group, nitro group, isocyanato group, isothiocyanato group, cyanato group, thiocyanato group, carboxyl group, amino group, a cycloalkyl group, a cycloalkenyl group, an aryl group, an unsaturated 5-membered heterocyclic group, an unsaturated 6-membered heterocyclic group, a saturated heterocyclic group, a monoalkyl amino group, a monoaryl amino group, a dialkyl amino group, a diaryl amino group, an alkyl sulfonyl amino group, an aryl sulfonyl amino group, a heteroaryl sulfonyl amino group, an alkyl carbonyl amino group, an alkoxycarbonyl amino group, a bis(alkyl sulfonyl)amino group, an alkoxy group, a haloalkoxy group, an alkenyloxy group, an alkynyloxy group, an aryloxy group, an alkoxycarbonyloxy group, an aryl alkyloxy group, a heteroring oxy group, an alkyl thiocarbonyl group, an alkoxycarbonyl group, a substituted or unsubstituted aminocarbonyl group, a substituted or unsubstituted hydrazino group, a substituted or unsubstituted hydrazinocarbonyl group, an alkyl thio group, an alkenyl thio group, an alkynyl thio group, an aryl thio group, a heteroaryl thio group, an aryl alkyl thio group, an alkyl sulfonyl group, an alkenyl sulfonyl group, an alkynyl sulfonyl group, an aryl sulfonyl group, a heteroaryl sulfonyl group, an aryl alkyl sulfonyl group, an acyl group, and an acyloxy group, and particularly preferably an alkoxy group.


Examples of “alkenyl group” include ethenyl group, 1-propenyl group, 2-propenyl group, 1-butenyl group, 2-butenyl group, 3-butenyl group, 1-methyl-2-propenyl group, 2-methyl-2-propenyl group, 1-pentenyl group, 2-pentenyl group, 3-pentenyl group, 4-pentenyl group, 1-methyl-2-butenyl group, 2-methyl-2-butenyl group, 1-hexenyl group, 2-hexenyl group, 3-hexenyl group, 4-hexenyl group and 5-hexenyl group and the like. Among these examples, an alkenyl group having 2 to 6 carbon atoms is preferable. Within a chemically acceptable range, “alkenyl group” may have one or more types of substituents, or one or more substituents selected from the substituents described in TABLE 1.


Examples of “alkynyl group” include ethynyl group, 1-propynyl group, 2-propynyl group, 1-butynyl group, 2-butynyl group, 3-butyryl group, 1-methyl-2-propynyl group, 2-methyl-3-butynyl group, 1-pentynyl group, 2-pentynyl group, 3-pentynyl group, 4-pentynyl group, 1-methyl-2-butynyl group, 2-methyl-3-pentynyl group, 1-hexynyl group, 1,1-dimethyl-2-butynyl group and the like. Among these examples an alkynyl group having 2 to 6 carbon atoms is preferable. Within a chemically acceptable range, “alkynyl group” may have one or more types of substituents selected from the substituents described in TABLE 1.


“Aryl group” indicates a monocyclic or polycyclic aryl group. The polycyclic aryl group includes a fully-unsaturated group as well as a partially-unsaturated group. Examples of “aryl group” include phenyl group, 1-naphthyl group, 2-naphthyl group, azulenyl group, indenyl group, indanyl group, tetralinyl group and the like. Among these examples an aryl group having 6 to 14 carbon atoms is preferable. Within a chemically acceptable range, “aryl group” may have one or more types of substituents, or one or more substituents selected from the substituents described in TABLE 1.


Examples of “alkoxy group” include methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, i-butoxy group, s-butoxy group, t-butoxy group, n-pentyloxy group, n-hexyloxy group and the like. Among these examples an alkoxy group having 1 to 6 carbon atoms is preferable.


Within a chemically acceptable range, “alkoxy group” may have one or more types of substituents, or one or more substituents selected from the substituents described in TABLE 1. The substituents are preferably hydroxy group, thiole group, a halogen atom, cyano group, isocyano group, nitro group, isocyanato group, isothiocyanato group, cyanato group, thiocyanato group, carboxyl group, amino group, a cycloalkyl group, an alkenyl group, a cycloalkenyl group, an alkynyl group, a haloalkyl group, an aryl group, an unsaturated 5-membered heterocyclic group, an unsaturated 6-membered heterocyclic group, a saturated heterocyclic group, a monoalkyl amino group, a monoaryl amino group, a dialkyl amino group, a diaryl amino group, an alkyl sulfonyl amino group, an aryl sulfonyl amino group, a heteroaryl sulfonyl amino group, an alkyl carbonyl amino group, an alkoxycarbonyl amino group, a bis(alkyl sulfonyl)amino group, an alkoxy group, a haloalkoxy group, an alkenyloxy group, an alkynyloxy group, an aryloxy group, an alkoxycarbonyloxy group, an aryl alkyloxy group, a heteroring oxy group, an alkyl thiocarbonyl group, an alkoxycarbonyl group, a substituted or unsubstituted aminocarbonyl group, a substituted or unsubstituted hydrazino group, a substituted or unsubstituted hydrazinocarbonyl group, an alkyl thio group, an alkenyl thio group, an alkynyl thio group, an aryl thio group, a heteroaryl thio group, an aryl alkyl thio group, an alkyl sulfonyl group, an alkenyl sulfonyl group, an alkynyl sulfonyl group, an aryl sulfonyl group, a heteroaryl sulfonyl group, an aryl alkyl sulfonyl group, an acyl group, and an acyloxy group.


“Cycloalkoxy group” indicates a group in which oxygen atom bond to an alkyl group having a monocyclic moiety or a polycyclic moiety. Examples of “cycloalkoxy group” include cyclopropyloxy group, cyclopentyloxy group, cyclohexyloxy group, cyclopropyl methyloxy group, cyclopentyl methyloxy group and the like. “Cycloalkoxy group” is preferably a C3-C8 cycloalkoxy group. Within a chemically acceptable range, “cycloalkoxy group” may have one or more types of substituents, or one or more substituents selected from the substituents described in TABLE 1.


Examples of “alkoxycarbonyl group” include methoxycarbonyl group, ethoxycarbonyl group, n-propoxycarbonyl group, i-propoxycarbonyl group, n-butoxycarbonyl group, i-butoxycarbonyl group, s-butoxycarbonyl group, t-butoxycarbonyl group, n-pentyloxycarbonyl group, n-hexyloxycarbonyl group and the like. Among these examples, an alkoxycarbonyl group having 2 to 6 carbon atoms are preferable. Within a chemically acceptable range, “alkoxycarbonyl group” may have one or more types of substituents, or one or more substituents selected from the substituents described in TABLE 1.


Examples of “alkyl thio group” include methyl thio group, ethyl thio group, n-propyl thio group, i-propyl thio group, n-butyl thio group, i-butyl thio group, s-butyl thio group, t-butyl thio group and the like. Among these examples, an alkyl thio group having 1 to 6 carbon atoms is preferable.


Within a chemically acceptable range, “alkyl thio group” may have one or more types of substituents, or one or more substituents selected from the substituents described in TABLE 1. The substituents are preferably hydroxy group, thiole group, a halogen atom, cyano group, isocyano group, nitro group, isocyanato group, isothiocyanato group, cyanato group, thiocyanato group, carboxyl group, amino group, a cycloalkyl group, a cycloalkenyl group, an aryl group, an unsaturated 5-membered heterocyclic group, an unsaturated 6-membered heterocyclic group, a saturated heterocyclic group, a monoalkyl amino group, a monoaryl amino group, a dialkyl amino group, a diaryl amino group, an alkyl sulfonyl amino group, an aryl sulfonyl amino group, a heteroaryl sulfonyl amino group, an alkyl carbonyl amino group, an alkoxycarbonyl amino group, a bis(alkyl sulfonyl)amino group, an alkoxy group, a haloalkoxy group, an alkenyloxy group, a haloalkenyl group, an alkynyloxy group, an aryloxy group, an alkoxycarbonyloxy group, an aryl alkyloxy group, a heteroring oxy group, an alkyl thiocarbonyl group, an alkoxycarbonyl group, a substituted or unsubstituted aminocarbonyl group, a substituted or unsubstituted hydrazino group, a substituted or unsubstituted hydrazinocarbonyl group, an alkyl thio group, an alkenyl thio group, an alkynyl thio group, an aryl thio group, a heteroaryl thio group, an aryl alkyl thio group, an alkyl sulfonyl group, an alkenyl sulfonyl group, an alkynyl sulfonyl group, an aryl sulfonyl group, a heteroaryl sulfonyl group, an aryl alkyl sulfonyl group, an acyl group, an acyloxy group.


“Acyl group” indicates a group in which carbonyl group bond to hydrogen atom, an alkyl group, an alkenyl group, an alkynyl group, an aryl group, a hetero aryl group or the like. Examples of “acyl group” include formyl group;


an alkyl carbonyl group (preferably having 2 to 6 carbon atoms) such as acetyl group, propionyl group, butyroyl group, pentanoyl group, hexanoyl group, heptanoyl group, octanoyl group, nonanoyl group, decanoyl group, 3-methyl nonanoyl group, 8-methyl nonanoyl group, 3-ethyl octanoyl group, 3,7-dimethyl octanoyl group, undecanoyl group, dodecanoyl group, tridecanoyl group, tetradecanoyl group, pentadecanoyl group, hexadecanoyl group, 1-methyl pentadecanoyl group, 14-methyl pentadecanoyl group, 13,13-dimethyl tetradecanoyl group, heptadecanoyl group, 15-methyl hexadecanoyl group, octadecanoyl group, 1-methyl heptadecanoyl group, nonadecanoyl group, eicosanoyl group, heneicosanoyl group or the like;


an alkenyl carbonyl group (preferably having 3 to 6 carbon atoms) such as acryloyl group, allyl carbonyl group or the like;


an alkynyl carbonyl group (preferably having 3 to 6 carbon atoms) such as ethynyl carbonyl group, 2-propynyl carbonyl group or the like;


a cycloalkyl carbonyl group (preferably having 4 to 7 carbon atoms) such as cyclopropyl carbonyl group, cyclopentyl carbonyl group or the like;


an aryl carbonyl group (preferably having 7 to 15 carbon atoms) such as benzoyl group, napthyl carbonyl group, biphenyl carbonyl group, anthranicarbonyl group or the like; a hetero aryl carbonyl group (preferably having 7 to 15 carbon atoms) such as 2-pyridyl carbonyl group, 2-thienyl carbonyl group or the like. Within a chemically acceptable range, “acyl group” may have one or more types of substitutents, or one or more substituents selected from the substituents described in TABLE 1.


“Heterocyclic group” indicates a 5- to 7-membered heteroaromatic ring, a 5- to 7-membered saturated heterocyclic ring or a 5- to 7-membered unsaturated heterocyclic ring, which have 1 to 4 hetero atoms selected from nitrogen atom, oxygen atom and sulfur atom other than carbon atom, or indicates a condensed heterocyclic ring in which benzene ring and these heterocyclic rings are condensed. Examples of “heterocyclic group” include 2-furyl group, 3-furyl group, 2-thienyl group, 3-thienyl group, 2-oxazolyl group, 2-oxazolinyl group, 3-isoxazolyl group, 4-isoxazolyl group, 5-isoxazolyl group, 3-isoxazolinyl group, 2-thiazolyl group, 2-thiazolinyl group, 3-isothiazolyl group, 3-isothiazolinyl group, 2-pyranyl group, 4-tetrahydropyranyl group, 1-azetidinyl group, 2-azetidinyl group, 3-azetidinyl group, 2-pyrrolyl group, 2-pyrrolidinyl group, 2-imidazolyl group, 3-pyrazolyl group, 2-imidazolinyl group, 2-pyridyl group, 3-pyridyl group, 4-pyridyl group, 2-piperidyl group, piperidino group, 2-morpholinyl group, morpholino group, 2-piperazinyl group, 2-pyrimidinyl group, 3-pyridazinyl group, 2-pyrazinyl group and the like. Within a chemically acceptable range, “heterocyclic group” may have one or more types of substituents, or one or more substituents selected from the substituents described in TABLE 1.


Ra of “NRa2 group” represents hydrogen atom or a hydrocarbon group.


In the examples of Ra, “hydrocarbon group” represents an alkyl group, a cycloalkyl group, an alkenyl group, a cycloalkenyl group, an alkynyl group, an aryl group, an aryl alkyl group or the like.


In addition, two Ra may bond with each other to form a 3- to 6-membered ring.


Here, examples of “alkyl group”, “alkenyl group”, “alkynyl group”, and “aryl group” are as defined above.


“Cycloalkyl group” indicates an alkyl group having a monocyclic or a polycyclic moiety. Examples of “cycloalkyl group” include cyclopropyl group, cyclobutyl group, cyclopentyl group, cyclohexyl group, cyclopropyl methyl group, cyclohexyl methyl group and the like. Among these examples, a cycloalkyl group having 3 to 8 carbon atoms is preferable.


“Cycloalkenyl group” indicates an alkenyl group having a cyclic moiety. Examples of “cycloalkenyl group” include cyclopropenyl group, 2-cyclobutenyl group, 3-cyclopentenyl group, 4-cyclohexenyl group, 3-cyclopentenyl methyl group, 4-cyclohexenyl methyl group and the like. Among these examples, a cycloalkenyl group having 3 to 8 carbon atoms is preferable.


Examples of “arylalkyl group” include benzyl group, phenethyl group, 3-phenyl-n-propyl group, 1-phenyl-n-hexyl group, naphthalene-1-yl methyl group, naphthalene-2-yl ethyl group, 1-naphthalene-2-yl-n-propyl group, indene-1-yl methyl group and the like. Among these examples, a (C6 to 10) aryl (C1 to 6) alkyl group is preferable.


Examples of “Nra2 group” include amino group, dimethyl amino group, methyl ethyl amino group, vinyl amino group, allyl amino group, phenyl amino group, benzyl amino group, pyrrolidine-2-yl group and the like.


Within a chemically acceptable range, “NRa2 group” may have one or more types of substituents, or one or more substituents selected from the substituents described in TABLE 1.


Ra2NC(O) group is a group in which the above described NRa2 group and carbonyl group are bonded. Two Ra may bond with each other to form a 3- to 6-membered ring.


Examples of “Ra2NC(O) group” include aminocarbonyl group, dimethyl aminocarbonyl group, methyl ethyl aminocarbonyl group, vinyl aminocarbonyl group, allyl aminocarbonyl group, phenyl aminocarbonyl group, benzyl aminocarbonyl group and the like.


Within a chemically acceptable range, “Ra2NC(O) group” may have one or more types of substituents, or one or more substituents selected from the substituents described in TABLE 1.


Ra of “NRcC(O)Ra group” is as defined above and Rc of “NRcC(O)Ra group” represents hydrogen group or an alkyl group. Examples of an alkyl group of Rc are the same as the examples of an alkyl group of the above described E.


Examples of “NRcC(O)Ra group” include acetyl amino group, propionyl amino group, benzoyl amino group, N-methyl acetyl amino group, N-i-propyl cyclohexyl carbonyl amino group and the like.


Within a chemically acceptable range, “NRcC(O)Ra group” may have one or more types of substituents, or one or more substituents selected from the substituents described in TABLE 1.


Ra and Rc of “NRcCO2Ra group” are as defined above.


Examples of “NRcCO2Ra group” include methoxycarbonyl amino group, phenoxycarbonyl amino group, N-methyl-methoxycarbonyl amino group and the like.


Within a chemically acceptable range, “NRcCO2Ra group” may have one or more types of substituents, or one or more substituents selected from the substituents described in TABLE 1.


Rc of “CRc═NORd group” is as defined above, and Rd of “CRc═NORd group” represents hydrogen atom or an alkyl group. Examples of an alkyl group of Rd are the same as the examples of an alkyl group of the above described E.


Examples of “CRc═NORd group” include CH═NOH, CH═NOMe, CMe=NOEt and the like.


Within a chemically acceptable range, CRc═NORd group may have one or more types of substituents, or one or more substituents selected from the substituents described in TABLE 1.


E is preferably an alkoxy group or an alkoxycarbonyl group.










TABLE 1





Type of substituent
Example







Hydroxyl group



Thiol group


Halogen atom
Fluorine atom, chlorine atom, bromine atom, iodine



atom


Cyano group


Isocyano group


Nitro group


Isocyanato group


Isothiocyanato group


Cyanato group


Thiocyanato group


Carboxyl group


Amino group


Alkyl group
Methyl group, ethyl group, n-propyl group, i-propyl



group, n-butyl group, s-butyl group, i-butyl group,



t-butyl group, n-pentyl group, n-hexyl group, n-decyl



group, n-dodecyl group or the like,



preferably C1-6 alkyl group


Cycloalkyl group
Cyclopropyl group, cyclobutyl group, cyclopentyl



group, cyclohexyl group, cyclobutyl group or the like



preferably C3-8 cycloalkyl group


Alkenyl group
Vinyl group, 1-propenyl group, 2-propenyl group,



1-butenyl group, 2-butenyl group, 3-butenyl group,



1-methyl-2-propenyl group, 2-methyl-2-propenyl



group, 1-pentenyl group, 2-pentenyl group, 3-pentenyl



group, 4-pentenyl group, 1-methyl-2-butenyl group,



2-methyl-2-butenyl group, 1-hexenyl group,



2-hexenyl group, 3-hexenyl group, 4-hexenyl group,



5-hexenyl group, 1-decenyl group or the like,



preferably C2-6 alkenyl group


Cycloalkenyl group
Cyclopropenyl group, 2-cyclopentenyl group,



3-cyclohexenyl group, 4-cyclooctenyl group or the like,



preferably C3-8 cycloalkenyl group


Alkynyl group
Ethynyl group, 1-propynyl group, 2-propynyl group,



1-butynyl group, 2-butynyl group, 3-butynyl group,



1-methyl-2-propynyl group, 2-methyl-3-butynyl group,



1-pentynyl group, 2-pentynyl group, 3-pentynyl group,



4-pentynyl group, 1-methyl-2-butynyl group, 2-methyl-3



pentynyl group, 1-hexynyl group,



1,1-dimethyl-2-butynyl group, 1-decynyl group or the



like,



preferably C2-6 alkynyl group


Haloalkyl group
Chloromethyl group, fluoromethyl group, bromomethyl



group, dichloromethyl group, difluoromethyl group,



dibromomethyl group, trichloromethyl group,



trifluoromethyl group, bromodifluoromethyl group,



1,1,1-trifluoroethyl group, 1-chloroethyl group,



2-chloroethyl group, 1-bromoethyl group,



pentafluoroethyl group or the like,



preferably halo C1-6 alkyl group


Aryl group
Phenyl group, 1-naphthyl group, 2-naphthyl group,



1-indanyl group, 2-indanyl group, 1-indenyl group,



2-indenyl group or the like,



preferably C6-10 aryl group


Unsaturated 5-membered
furan-2-yl group, furan-3-yl group, thiophene-2-yl


heterocyclic group
group, thiophene-3-yl group, pyrrole-2-yl group,



pyrrole-3-yl group, oxazole-2-yl group, oxazole-4-yl



group, oxazole-5-yl group, thiazole-2-yl group,



thiazole-4-yl group, thiazole-5-yl group,



isoxazol(e)-3-yl group, isoxazol(e)-4-yl group,



isoxazol(e)-5-yl group, isothiazol(e)-3-yl group,



isothiazol(e)-4-yl group, isothiazol(e)-5-yl group,



imidazol(e)-2-yl group, imidazol(e)-4-yl group,



imidazol(e)-5-yl group, pyrazol(e)-3-yl group,



pyrazol(e)-4-yl group, pyrazole-5-yl group,



1,3,4-oxadiazole-2-yl group, 1,3,4-thiadiazole-2-yl



group, 1,2,3-triazole-4-yl group, 1,2,4-triazole-3-yl



group, 1,2,4-triazole-5-yl group or the like


Unsaturated 6-membered
pyridine-2-yl group, pyridine-3-yl group,


Heterocyclic group
pyridine-4-yl group, pyridazine-3-yl group,



pyridazine-4-yl group, pyrazine-2-yl group,



pyrimidine-2-yl group, pyrimidine-4-yl group,



pyrimidine-5-yl group, 1,3,5-triazine-2-yl group,



1,2,4-triazine-3-yl group or the like


Saturated heterocyclic group
tetrahydrofuran-2-yl group, tetrahydropyran-4-yl



group, piperidine-3-yl group, pyrrolidine-2-yl group,



morpholino group, piperidino group, N-methyl



piperazinyl group or the like


Monoalkyl amino group
Methyl amino group, ethyl amino group or the like


Monoaryl amino group
1-naphthyl amino group, anilino group or the like


Dialkyl amino group
Dimethyl amino group, diethyl amino group or the



like


Diaryl amino group
Diphenyl amino group, diindanyl amino group or the



like


Alkyl sulfonyl amino group
Methyl sulfonyl amino group, ethyl sulfonyl amino



group, n-propyl sulfonyl amino group, isopropyl



sulfonyl amino group, n-butyl sulfonyl amino group,



t-butyl sulfonyl amino group or the like


Aryl sulfonyl amino group
Phenyl sulfonyl amino group, indanyl sulfonyl



amino group or the like


Heteroaryl sulfonyl amino group
Pyridine-3-yl sulfonyl amino group, furan-2-yl



sulfonyl amino group or the like


Alkyl carbonyl amino group
Methyl carbonyl amino group, ethyl carbonyl amino



group, n-propyl carbonyl amino group, isopropyl



carbonyl amino group or the like


Alkoxycarbonyl amino group
Methoxycarbonyl amino group, ethoxycarbonyl



amino group, n-propoxycarbonyl amino group,



isopropoxycarbonyl amino group or the like


Bis(alkyl sulfonyl)amino group
Bis(methyl sulfonyl)amino group, bis(ethyl



sulfonyl)amino group, (ethyl sulfonyl)(methyl



sulfonyl)amino group, bis(n-propyl sulfonyl)amino



group, bis(isopropyl sulfonyl)amino group,



bis(n-butyl sulfonyl)amino group, bis(t-butyl



sulfonyl)amino group or the like


N-unsubstituted or N-substituted
N-methyl iminomethyl group, 1-N-phenyl


iminoalkyl group
iminoethyl group, N-hydroxyiminomethyl group,



N-methoxyiminomethyl group or the like,



preferably N-unsubstituted or N-substituted imino



C1-6 alkyl group


Aryl alkyl group
Benzyl group, phenethyl group or the like,



preferably C6-10 aryl C1-6 alkyl group


Unsaturated 6-membered
Pyridine-2-yl methyl group, pyridine-3-yl methyl


heterocyclic alkyl group
group, 6-chloro-pyridine-3-yl methyl group,



pyrimidine-2-yl methyl group or the like,



preferably unsaturated 6-membered heterocyclic



C1-6 alkyl group


Unsaturated 5-membered
Furan-2-yl-methyl group, thiophene-3-yl methyl


heterocyclic alkyl group
group, 1-methyl-pyrazol(e)-3-yl methyl group or



the like,



preferably unsaturated 5-membered heterocyclic



C1-6 alkoxy group


Saturated heterocyclic alkyl group
Tetrahydrofuran-2-yl-methyl group, piperazine-3-yl



methyl group, N-methyl-pyrrolidine-3-yl methyl



group, morpholinomethyl group or the like


Alkoxy group
Methoxy group, ethoxy group, n-propoxy group,



isopropoxy group, n-butoxy group, s-butoxy group,



isobutoxy group, t-butoxy group or the like,



preferably C1-6 alkoxy group


Haloalkoxy group
Chloromethoxy group, trifluoromethoxy group,



2,2,2-trifluoroethoxy group, 3-bromo-n-propoxy



group, perfluoro-t-butoxy group or the like



preferably C1-6 haloalkoxy group


Alkenyloxy group
Vinyloxy group, allyloxy group or the like,



preferably C2-6 alkenyloxy group


Haloalkenyl group
2,3-dichloroallyl group, 2-chloro-2-propenyl group,



2-chloromethyl-2-propenyl group,



4-bromo-2-butenyl group or the like,



preferably C2-6 haloalkenyl group


Alkynyloxy group
Ethynyloxy group, propargyloxy group or the like,



preferably C2-6 alkynyloxy group


Haloalkynyloxy group
5-bromo-2-pentynyloxy group,



6-iodo-2-hexynyloxy group, 5,5,5-trifluoro-



2-pentynyloxy group, 3-chloropropargyloxy group



or the like,



preferably C2-6 haloalkynyloxy group


Aryloxy group
Phenoxy group, 1-naphthoxy group or the like,



preferably C6-10 aryloxy group


Alkoxycarbonyloxy group
Methoxycarbonyloxy group, ethoxycarbonyloxy



group, i-propoxycarbonyloxy group,



t-butoxycarbonyloxy group or the like,



preferably C1-6 alkoxycarbonyloxy group


Aryl alkyloxy group
Benzyloxy group, phenethyloxy group or the like,



preferably C6-10 aryl C1-6 alkyloxy group


Heterocyclic oxy group
Pyridine-2-yloxy group, 3-oxazoline-2-yloxy



group, pyrrolidine-2-yloxy group or the like


Alkyl thiocarbonyl group
Methyl thiocarbonyl group, ethyl thiocarbonyl



group, n-propyl thiocarbonyl group, isopropyl



thiocarbonyl group, n-butyl thiocarbonyl group,



isobutyl thiocarbonyl group, s-butyl thiocarbonyl



group, t-butyl thiocarbonyl group or the like,



preferably C1-6 alkyl thiocarbonyl group


Alkoxy carbonyl group
Methoxycarbonyl group, ethoxycarbonyl group,



n-propoxycarbonyl group, isopropoxycarbonyl



group, n-butoxycarbonyl group, t-butoxycarbonyl



group or the like,



preferably C1-6 alkoxycarbonyl group


Unsubstituted or substituted amino
Aminocarbonyl group, dimethyl aminocarbonyl


carbonyl group
group, phenyl aminocarbonyl group or the like


Unsubstituted or substituted
Hydrazino group, N′-phenyl hydrazino group,


hydrazino group
N′-methoxycarbonyl hydrazino group, N′-acetyl



hydrazino group, N′-methyl hydrazino group or the



like


Unsubstituted or substituted
Hydrozinocarbonyl group, N′-methyl


hydrazino carbonyl group
hydrozinocarbonyl group, N′-phenyl



hydrazinocarbonyl group or the like


Alkyl thio group
Methyl thio group, ethyl thio group, t-butyl thio



group or the like,



preferably C1-6 alkyl thio group


Alkenyl thio group
Vinyl thio group, allyl thio group or the like,



preferably C2-6 alkeynyl thio group


Alkynyl thio group
Ethynyl thio group, propargyl thio group or the like,



preferably C2-6 alkynyl thio group


Aryl thio group
Phenyl thio group, 4-chlorophenyl thio group or the



like,



preferably C6-10 aryl thio group


Heteroaryl thio group
Pyridine-2-yl thio group, pyridazine-3-yl thio group



or the like,


Aryl alkyl thio group
Benzyl thio group, phenethyl thio group or the like,



prererably C6-10 aryl C1-6 alkyl thio group


Alkyl sulfonyl group
Methyl sulfonyl group, ethyl sulfonyl group, t-butyl



sulfonyl group or the like,



preferably C1-6 alkyl sulfonyl group


Alkenyl sulfonyl group
Vinyl sulfonyl group, allyl sulfonyl group or the



like,



preferably C2-6 alkenyl sulfonyl group


Alkynyl sulfonyl group
Ethynyl sulfonyl group, propargyl sulfonyl group or



the like,



preferably C2-6 alkynyl sulfonyl group


Aryl sulfonyl group
Phenyl sulfonyl group, naphthyl sulfonyl group or



the like,



preferably C6-10 aryl sulfonyl group


Heteroaryl sulfonyl group
prydine-2-yl sufonyl group, prydine-3-yl sulfonyl



group or the like


Aryl alkyl sulfonyl group
benzyl sulfonyl group, phenethyl sulfonyl group or



the like,



preferably C6-10 aryl C1-6 alkyl sulfonyl group


Acyl group
formyl group, acetyl group, propionyl, acryloyl



group, cinnamoyl group, benzoyl group,



pyridine-2-yl carbonyl group, cyclohexyl carbonyl



group or the like,



preferably C1-10 acyl group


Acyloxy group
formyloxy group, acetyloxy group, propionyloxy



group, cinnamoyloxy group, benzoyloxy group,



pyridine-2-yl carbonyloxy group, cyclohexyl



carbonyloxy group or the like,



preferably C1-10 acyloxy group









(R1)

In the present invention, R1 represents a halogen atom, hydroxyl group, mercapto group, NRa2 group (in the formula, Ra is as defined above), nitro group, or an organic group.


Examples of “halogen atom” include fluorine atom, chlorine atom, bromine atom, iodine atom and the like.


Ra of “NRa2 group” is as defined as Ra of the above described E. Examples of NRa2 include amino group, methyl amino group, dimethyl amino group, methyl ethyl amino group, vinyl amino group, allyl amino group, phenyl amino group, diphenyl amino group, benzyl amino group and the like.


“Organic group” indicates a general functional group having carbon atoms.


Examples of “organic group” include cyano group, an alkyl group, an alkenyl group, an alkynyl group, an alkoxy group, a cycloalkyl group, a cycloalkenyl group, an aryl group, an aryloxy group, an acyl group, an alkoxycarbonyl group, an alkyl thiocarbonyl group, an alkyl thio group, an alkyl sulfinyl group, an alkyl sulfonyl group, an aryl thio group, an aryl sulfinyl group, an aryl sulfonyl group, a substituted sulfoxyimino group and the like. Any of the examples of “organic group” may be substituted except nitro group.


The groups of the examples of “organic group” are defined as follows.


Examples of “alkyl group”, “alkenyl group”, “alkynyl group”, “alkoxy group”, “cycloalkyl group”, “cycloalkenyl group”, “aryl group”, “alkoxycarbonyl group”, “alkyl thio group”, and “acyl group” may be the same as the examples of the above described E and Ra.


Examples of “aryloxy group” include phenoxy group, 1-naphthyloxy group, 2-naphthyloxy group, azulenyloxy group, indenyloxy group, indanyloxy group, tetrolynyloxy group and the like. Among these examples, an aryloxy group having 6 to 14 carbon atoms is preferable. Within a chemically acceptable range, “aryloxy group” may have at least one or more types of substitutents, or one or more substituents selected from the substituents described in TABLE 1.


Examples of “alkyl thiocarbonyl group” include methyl thiocarbonyl group, ethyl thiocarbonyl group, n-propyl thiocarbonyl group, i-propyl thiocarbonyl group, n-butyl thiocarbonyl group, i-butyl thiocarbonyl group, s-butyl thiocarbonyl group, t-butyl thiocarbonyl group, n-pentyl thiocarbonyl group, n-hexyl thiocarbonyl group and the like. Among these examples, an alkyl thiocarbonyl group having 2 to 6 carbon atoms is preferable. Within a chemically acceptable range, “alkyl thiocarbonyl group” may have one or more types of substituents, or one or more substituents selected from the substituents described in TABLE 1.


Examples of “alkyl sulfinyl group” include methyl sulfinyl group, ethyl sulfinyl group, n-propyl sulfinyl group, i-propyl sulfinyl group, n-butyl sulfinyl group, 1-butyl sulfinyl group, s-butyl sulfinyl group, t-butyl sulfinyl group and the like. Among these examples, an alkyl sulfinyl group having 1 to 6 carbon atoms is preferable. Within a chemically acceptable range, “alkyl sulfinyl group” may have one or more types of substituents, or one or more substituents selected from the substituents described in TABLE 1.


Examples of “alkyl sulfonyl group” include methyl sulfonyl group, ethyl sulfonyl group, n-propyl sulfonyl group, i-propyl sulfonyl group, n-butyl sulfonyl group, i-butyl sulfonyl group, s-butyl sulfonyl group, t-butyl sulfonyl group and the like. Among these examples, an alkyl sulfonyl group having 1 to 6 carbon atoms is preferable. Within a chemically acceptable range, “alkyl sulfonyl group” may have one or more types of substituents, or one or more substituents selected from the substituents described in TABLE 1.


Examples of “aryl thio group” include phenyl thio group, 1-naphthyl thio group, 2-naphthyl thio group and the like. Among these examples, an aryl thio group having 6 to 14 carbon atoms is preferable. Within a chemically acceptable range, “aryl thio group” may have one or more types of substituents, or one or more substituents selected from the substituents described in TABLE 1.


Examples of “aryl sulfinyl group” include phenyl sulfinyl group, 1-naphthyl sulfinyl group, 2-naphthyl sulfinyl group and the like. Among these examples, an aryl sulfinyl group having 6 to 14 carbon atoms is preferable. Within a chemically acceptable range, “aryl sulfinyl group” may have one or more types of substituents, or one or more substituents selected from the substituents described in TABLE 1.


Examples of “aryl sulfonyl group” include phenyl sulfonyl group, 1-naphthyl sulfonyl group, 2-naphthyl sulfonyl group and the like. Among these examples, an aryl sulfonyl group having 6 to 14 carbon atoms is preferable. Within a chemically acceptable range, “aryl sulfonyl group” may have one or more types of substituents, or one or more substituents selected from the substituents described in TABLE 1.


“Substituted sulfoxyimino group” may be represented by formula —N═S(═O)(R′)(R″).


In this formula, R′ and R″ each independently represents the groups same as the examples of R2 and R3 that are described hereinafter. “Substituted sulfoxyimino group” is preferably represented by formula —N═S(═O)R2R3.


In addition, R′ and R″ may bond together to form a ring.


Examples of “substituted sulfoxyimino group” include followings.




embedded image


Among these examples, R1 is preferably at least one selected from the group consisting of halogen atom, substituted or unsubstituted alkyl group and —N═S(═O)(R′)(R″), and more preferably a halogen atom or a haloalkyl group having 1 to 6 carbon atoms.


(R2, R3)

R2 and R3 each independently represents an alkyl group, a cycloalkyl group, an alkenyl group, a alkynyl group, an aryl group, or a heterocyclic group.


Examples of “alkyl group”, “cycloalkyl group”, “alkenyl group”, “alkynyl group” and “aryl group” are the same as the examples of R1. Within a chemically acceptable range, these groups may have one or more types of substitutents, or one or more substituents selected from the substituents described in TABLE 1.


“Heterocyclic group” indicates a 5- to 7-membered heteroaromatic ring, a 5- to 7-membered saturated heterocyclic ring or a 5- to 7-membered unsaturated heterocyclic ring, which have 1 to 4 hetero atoms selected from nitrogen atom, oxygen atom and sulfur atom other than carbon atom, or indicates a condensed heterocyclic ring in which benzene ring ad these heterocyclic rings are condensed. Examples of “heterocyclic group” included 2-furyl group, 3-furyl group, 2-thienyl group, 3-thienyl group, 2-oxazolyl group, 2-oxazolinyl group, 3-isoxazolyl group, 4-isoxazolyl group, 5-isoxazolyl group, 3-isoxazolinyl group, 2-thiazolyl group, 2-thiazolinyl group, 3-isothiazolyl group, 3-isothiazolinyl group, 2-pyranyl group, 4-tetrahydropyranyl group, 1-azetidinyl group, 2-azetidinyl group, 3-azetidinyl group, 2-pyrrolyl group, 2-pyrrolidinyl group, 2-imidazolyl group, 3-pyrazolyl group, 2-imidazolinyl group, 2-pyridyl group, 3-pyridyl group, 4-pyridyl group, 2-piperidyl group, piperidino group, 2-morpholinyl group, morpholino group, 2-piperazinyl group, 2-pyrimidinyl group, 3-pyridazinyl group, 2-pyrazinyl group and the like. Within a chemically acceptable range, “heterocylic group” may have one or more types of substituents, or one or more substitutents selected from the substitutents described in TABLE 1.


In addition, R2 and R3 may bond together to than a 3- to 8-membered, substituted or unsubstituted heterocyclic group which may include 1 to 4 nitrogen atoms, oxygen atoms or sulfur atoms other than the sulfur atom in sulfoxyimino group. In this case, R2 and R3 form a ring regardless of the functional groups of R2 and R3 described above.


Examples of heterocyclic ring include thiophene ring, tetrahydrothiophene ring, thiopyran ring, tetrahydrothiopyran ring, 4-oxathiane ring, thiomorpholine ring, 1,4-dithiane ring, tetrahydrothiopyran-4-one ring and the like. Within a chemically acceptable range, these rings may have one or more types of substituents, or one or more substituents selected from the substituents described in TABLE 1.


(Q)

Q represents a group selected from the following groups Q1 to Q8.




embedded image


In the above formulas (Q1 to Q8), * represents binding site,


G represents oxygen atom, —S—, —S(O)—, —S(O)2— or —NRb—,


Rb in formula “—NRb—” represents hydrogen atom or an organic group. Examples of “organic group” are the same as the examples of organic group of R1 described above. Within a chemically acceptable range, “organic group” may have one or more types of substituents, or one or more substituents selected from the substituents described in TABLE 1.


Examples of “—NRb—” include —NH—, —N(CH3)—, —N(C2H5)—, —N(OCH3)— and the like.


(R4)

R4 represents hydrogen atom, an alkyl group, a cycloalkyl group or NRa2 group.


“Alkyl group”, “cycloalkyl group” and “NRa2 group” of R4 are the same as the examples of E and R1 described above.


(R5)

R5 represents hydrogen atom, an alkyl group, an alkenyl group, an alkynyl group, an aryl group, a heteroaryl group, an alkoxycarbonyl group, alkyl thiocarbonyl group, acyl group, Ra2NC(O) group, an alkylsulfonyl group, an arylsulfonyl group or NRa2SO2 group.


“Alkyl Group”, “Alkenyl Group”, “Alkynyl Group”, “Aryl Group”, “Alkoxycarbonyl group”, “alkyl thiocarbonyl group”, “acyl group”, “Ra2NC(O) group”, “alkylsulfonyl group” and “arylsulfonyl group” of R5 are the same as the examples of E or R1 described above. Within a chemically acceptable range, these groups may have one or more types of substituents, or one or more substituents selected from the substituents described in TABLE 1.


“Heteroaryl group” includes a 5- to 7-membered monocyclic or polycyclic heteroaromatic ring having 1 to 4 hetero atoms selected from nitrogen atom, oxygen atom and sulfur atom other than carbon atom, and a condensed ring in which benzene ring and a 5- to 7-membered heterocyclic ring having 1 to 4 hetero atoms selected from nitrogen atom, oxygen atom and sulfur atom are condensed. Examples of heteroaryl group include pyridinyl, imidazolyl, pyrimidinyl, pyrazolyl, triazolyl, pyrazinyl, tetrazolyl, furyl, thienyl, isoxazolyl, thiazolyl, oxazolyl, isothiazolyl, pyrrolyl, quinolinyl, isoquinolinyl, indolyl, benzimidazolyl, benzofuranyl, cinnolinyl, indazolyl, indolizinyl, phthalazinyl, pyridazinyl, triazinyl, isoindolyl, pteridinyl, purinyl, oxadiazolyl, triazolyl, thiadiazolyl, thiadiazolyl, furazanyl, benzofurazanyl, benzothiophenyl, benzothiazolyl, benzoxazolyl, quinazolinyl, quinoxalinyl, naphthyridinyl, furopyridinyl and the like.


Within a chemically acceptable range, “heteroaryl group” may have one or more types of substituents, or one or more substituents selected from the substituents described in TABLE 1.


Ra of “NRa2SO2 group” is as defined above. Examples of “NRa2SO2” include aminosulfonyl group, methyl aminosulfonyl group, ethyl aminosulfonyl group, allyl aminosulfonyl group, benzyl aminosulfonyl group, phenyl aminosulfonyl group, dimethyl aminosulfonyl group, phenyl methyl aminosulfonyl group and the like. Within a chemically acceptable range, “NRa2SO2 group” may have one or more types of substituents, or one or more substituents selected from the substituents described in TABLE 1.


(R6)

R6 represents cyano group, an acyl group, an alkoxycarbonyl group, C(R71)═NR7, or tetrazolyl group.


Examples of “Acyl Group” and “Alkoxycarbonyl Group” are the Same as the examples of E and R1 described above. In addition, within a chemically acceptable range, these groups may have one or more types of substituents, or one or more substituents selected from the substituents described in TABLE 1.


In formula C(R71)═NR7, R71 represents hydrogen atom, an alkyl group, an aryl group, or a heteroaryl group.


Examples of “alkyl group”, “aryl group” and “heteroaryl group” are the same as the examples of E or R5 described above. Within a chemically acceptable range, these groups may have one or more types of substituents, or one or more substituents selected from the substituents described in TABLE 1.


In addition, in formula C(R71)═NR7, R7 represents hydrogen atom, an alkyl group or an alkoxy group. Examples of “alkyl group” and “alkoxy group” are the same as the examples of E described above. Within a chemically acceptable range, these groups may have one or more types of substituents, or one or more substituents selected from the substituents described in TABLE 1.


(R8, R9)

R8 and R9 each independently represents hydrogen atom or an alkyl group.


Examples of “Alkyl Group” are the Same as the Examples of Alkyl Group of E described above. Within a chemically acceptable range, “alkyl group” may have one or more types of substituents, or one or more substituents selected from the substituents described in TABLE 1.


(R10, R11)

R10 and R11 each independently represents hydrogen atom, an alkyl group or a cycloalkyl group.


Examples of “alkyl group” and “cycloalkyl group” are the same as the examples of E or R1 described above. Within a chemically acceptable range, these groups may have one or more types of substituents, or one or more substituents selected from the substituents described in TABLE 1.


(X)

X represents —C(R12)(R13)— or —N(R12)—.


R12 and R13 each independently represents hydrogen group or an alkyl group.


Examples of “alkyl group” may be the same as the examples of alkyl group of E described above. Within a chemically acceptable range, “alkyl group” may have one or more types of substituents, or one or more substituents selected from the substituents described in TABLE 1.


(Y)

Y represents oxo group (═O), an alkyl group, an alkoxy group, an acyl group or an alkoxycarbonyl group.


Examples of “alkyl group”, “alkoxy group”, “acyl group” and “alkoxycarbonyl group” may be the same as the examples of E described above. Within a chemically acceptable range, these groups may have one or more types of substituents, or one or more substituents selected from the substituents described in TABLE 1.


m represents an integer of 0 to 4.


When m is 2 or more, the numerous Y may be the same or different from each other, and Y may bond with each other to form a ring regardless of the above described substituents. In addition, Y and R12 of X may bond together to form a ring regardless of the above described substituents.


As shown in below, the examples of the above described ring include a 3- to 8-membered spiro ring represented by the following formula (Q2-1), a 3- to 8-membered condensed ring represented the following formula (Q2-2) and a 3- to 8-membered bridge ring represented by the following formula (Q2-3) or the like, which form a C1-6 alkylene chain having 0 to 3 nitrogen atoms, oxygen atoms or sulfur atoms. In addition, the examples of the ring which formed by bonding Y and Y may be shown by formulas (Q2-4) to (Q2-8), and the examples of the ring which formed by bonding Y and R12 may be shown by formulas (Q2-9), (Q2-10).




embedded image


embedded image


(In the formula, G, R5, X are as defined above, Z represents a C1-6 alkylene chain having 0 to 3 nitrogen atoms, oxygen atoms and/or sulfur atoms).


From the point of view of having an excellent herbicide activity, the benzoyl derivative of the present invention is preferably a compound represented by the following formula (I-a)




embedded image


(In the formula, E, R1 to R3, p, and Q are as defined above), more preferably a compound represented by the following formula (I-b)




embedded image


(In the formula, E, R1 to R3, and Q are as defined above).


In addition, the benzoyl derivative and salt thereof of the present invention is more preferably a compound represented by formula (I-b), wherein R1 represents a halogen atom, a substituted or unsubstituted alkyl group or a group represented by formula —N═S(═O)R2R3 (in the formula, R2, R3 are as defined above).


Examples of the salt of the compound (I) of the present invention include a salt of alkali metal such as lithium, sodium, potassium or the like; a salt of alkali earth metal such as calcium, magnesium, or the like; a salt of transition metal such as iron, copper or the like; a salt of organic base such as ammonia, triethylamine, tributylamine, pyridine, hydrazine or the like.


Compound (I) of the present invention may have stereoisomer or tautomer based on asymmetric carbon or double bond. All of these isomers and mixture thereof are included in the technical scope of the present invention.


Optical isomer is possible for the compound of the present invention and the compound also may have numerous tautomers. All of these isomers are included in the scope of the present invention.


The structure of the compound of the present invention may be determined by NMR spectrum, IR spectrum, MS spectrum or the like.


Examples of the Compound of the Present Invention

The representative examples of the compound of the present invention are shown in the following tables. However, the compound of the present invention is not limited by these compounds.


In addition, the abbreviations described in the tables have the meanings as defined below.


Me: methyl, Et: ethyl, Pr: propyl, Ph: phenyl, n: normal, i: iso,


c: cyclo, Tosyl: p-toluensulfonyl.









TABLE 2







Example of Compound (1)




embedded image
























Position








No.
E
(R1)p
of A
R2
R3
R4
R5
R7
G



















1
H
2-Cl
3
Me
Me
H
H
Me
O


2
H
2-Cl
3
Et
Et
H
CF3
Et
O


3
H
2-Cl
3
n-Pr
n-Pr
H
H
i-Pr
O


4
H
2-Cl
3
Me
c-Pr
Me
Me
Me
O


5
CN
2-Cl
3
Me
CF3
H
Ph
CF3
S


6
Me
2-Cl
3
Me
CH3═CHCH2
H
PhCH2
H
O


7
Me
2-Cl
3
Me
CH≡CCH2
H
Tosyl
H
O


8
Me
2-Me2N
3
Me
Ph
H
MeC(O)
MeO
O


9
Me
2-NH2
3
Me
2-Thienyl
c-Pr
PhC(O)
EtO
O


10
MeS
5-Cl, 6-F
3
Me
2-Furyl
H
CH2═CH
H
S(O)


11
CF3
2-Cl
3
Me
2-Pyridyl
H
CH≡C
Me
O


12
CF3
2-Cl
3
Me
4-Piperidyl
H
2-Pyridyl
Et
O















13
CF3
2-Cl
3
—CH2CH2CH2
H
H
i-Pr
O


14
CF3
2-Cl
3
—CH2CH(Me)CH2
NH2
MeSO2
CF3
O


15
CF3
2-Cl
3
—CH2CH2CH2CH2
H
PhSO2
Me
S(O)2


16
MeO
2-Cl
3
—CH2CH2CH2CH2CH2
H
N(Me)2SO2
H
O


17
MeO
2-Cl
3
—CH2CH2—O—CH2CH2
H
H
H
O


18
MeO
2-Cl
3
—CH2CH2—C(O)—CH2CH2
H
CF3
MeO
O


19
MeO
2-Cl
3
—CH2CH2CH(OEt)—CH2CH2
N(Me)2
H
EtO
O


20
MeO
2-Cl
3
—CH2CH2—N(Me)—CH2CH2
H
Me
H
NH
















21
Ph
2-Cl
3
Me
Me
H
Ph
Me
O


22
Ph
2-Cl
3
Et
Et
H
PhCH2
CF3
O


23
Ph
2-Cl
3
n-Pr
n-Pr
H
Tosyl
i-Pr
O


24
Ph
2-Cl
3
Me
c-Pr
Me
MeC(O)
Me
O


25
Ph
2-Cl
3
Me
CF3
H
PhC(O)
Me
N(Me)


26
NH2
2-Cl
3
Me
CH2═CHCH2
H
CH2═CH
H
O


27
NH2
2-Me
3
Me
CH≡CCH2
H
CH≡C
H
O


28
NH2
2-Me
3
Me
Ph
H
2-Pyridyl
MeO
O


29
NH2
2-Me
3
Me
2-Thienyl
c-Pr
H
EtO
O


30
NH2
2-Me
3
Me
2-Furyl
H
MeSO2
H
S


31
N(Me)2
2-Cl
3
Me
2-Pyridyl
H
PhSO2
Me
O


32
N(Me)2
2-Me
3
Me
4-Piperidyl
H
N(Me)2SO2
Et
O















33
N(Me)2
2-Me
3
—CH2CH2CH2
H
H
i-Pr
O


34
N(Me)2
2-Me
3
—CH2CH(Me)CH2
NH2
CF3
Me
O


35
N(Me)2
2-Me
3
—CH2CH2CH2CH2
H
H
Me
S(O)


36
HN(Me)C(O)
2-Cl
3
—CH2CH2CH2CH2CH2
H
Me
H
O


37
HN(Me)C(O)
2-CF3
3
—CH2CH2—O—CH2CH2
H
Ph
H
O


38
HN(Me)C(O)
2-CF3
3
—CH2CH2—C(O)—CH2CH2
H
PhCH2
MeO
O


39
HN(Me)C(O)
2-CF3
3
—CH2CH2CH(OEt)CH2CH2
N(Me)2
Tosyl
EtO
O


40
HN(Me)C(O)
2-CF3
3
—CH2CH2—N(Me)—CH2CH2
H
MeSC(O)
H
S(O)2
















41
MeOC(O)
2-Cl
3
Me
Me
H
PhC(O)
Me
O


42
MeOC(O)
2-CF3
3
Et
Et
H
CH2═CH
CF3
O


43
MeOC(O)
2-CF3
3
Me
n-Pr
H
CH≡C
i-Pr
O


44
MeOC(O)
2-CF3
3
Me
c-Pr
CF3
2-Pyridyl
Me
O


45
MeOC(O)
2-CF3
3
Me
CF3
H
H
Me
NH


46
c-Pentyloxy
2-Cl
3
Me
CH2═CHCH2
H
MeSO2
H
O


47
c-Pentyloxy
2-OH
3
Me
CH≡CCH2
H
PhSO2
H
O


48
c-Pentyloxy
2-OH
3
Me
Ph
H
N(Me)2SO2
MeO
O


49
c-Pentyloxy
2-OH
3
Me
2-Thienyl
c-Pr
H
EtO
O


50
c-Pentyloxy
2-OH
3
Me
2-Furyl
H
CF3
H
N(Me)


51
PhC(O)
2-Cl
5
Me
Me
H
H
Me
O


52
2-Pyridyl
2-MeO
5
Et
Et
H
CF3
Et
O


53
H
2-MeO
5
n-Pr
n-Pr
H
EtOC(O)
i-Pr
O


54
H
2-MeO
5
Me
c-Pr
Me
Me
CF3
O


55
H
2-MeO
5
Me
CF3
H
Ph
Me
S


56
Me
2-Cl
5
Me
CH2═CHCH2
H
PhCH2
H
O


57
Me
2-CF3O
5
Me
CH≡CCH2
H
Tosyl
H
O


58
Me
2-CF3O
5
Me
Ph
H
MeC(O)
MeO
O


59
Me
2-CF3O
5
Me
2-Thienyl
c-Pr
PhC(O)
EtO
O


60
Me
2-CF3O
5
Me
2-Furyl
H
CH2═CH
H
S(O)


61
CF3
2-Cl
5
Me
2-Pyridyl
H
CH≡C
Me
O


62
CF3
2-CF3O
5
Me
4-Piperidyl
H
2-Pyridyl
Et
O















63
CF3
2-CF3O
5
—CH2CH2CH2
H
H
i-Pr



64
CF3
2-CF3O
5
—CH2CH(Me)CH2
NH2
MeSO2
Me
O


65
CF3
2-CF3O
5
—CH2CH2CH2CH2
H
PhSO2
Me
S(O)2


66
MeO
2-Cl
5
—CH2CH2CH2CH2CH2
H
N(Me)2SO2
H
O


67
MeO
2-SH
5
—CH2CH2—O—CH2CH2
H
H
H
O


68
MeO
2-SH
5
—CH2CH2—C(O)—CH2CH2
H
CF3
MeO
O


69
MeO
2-SH
5
—CH2CH2CH(OEt)CH2CH2
N(Me)2
H
EtO
O


70
MeO
2-SH
5
—CH2CH2—N(Me)—CH2CH2
H
Me
H
NH
















71
Ph
2-Cl
6
Me
Me
H
Ph
Me
O


72
Ph
2-MeS
6
Et
Et
H
PhCH2
CF3
O


73
Ph
2-MeS
6
n-Pr
n-Pr
H
Tosyl
i-Pr
O


44
Ph
2-MeS
6
Me
c-Pr
CF3
MeC(O)
Me
O


75
Ph
2-MeS
6
Me
CF3
H
PhC(O)
Me
N(Me)


76
NH2
2-Cl
6
Me
CH2═CHCH2
H
CH2═CH
H
O


77
NH2
2-MeS(O)2
6
Me
CH≡CCH2
H
CH≡C
H
O


78
NH2
2-MeS(O)2
6
Me
Ph
H
2-Pyridyl
MeO
O


79
NH2
2-MeS(O)2
6
Me
2-Thienyl
c-Pr
H
EtO
O


80
NH2
2-MeS(O)2
6
Me
2-Furyl
H
MeSO2
H
S


81
N(Me)2
2-Cl
6
Me
2-Pyridyl
H
PhSO2
Me
O


82
N(Me)2
2-NO2
6
Me
4-Piperidyl
H
N(Me)2SO2
Et
O















83
N(Me)2
2-NO2
6
—CH2CH2CH2
H
H
i-Pr
O


84
N(Me)2
2-NO2
6
—CH2CH(Me)CH2
NH2
CF3
Me
O


85
N(Me)2
2-NO2
6
—CH2CH2CH2CH2
H
H
Me
S(O)


86
HN(Me)C(O)
2-Cl
6
—CH2CH2CH2CH2CH2
H
Me
H
O


87
HN(Me)C(O)
2,5-diMe
6
—CH2CH2—O—CH2CH2
H
Ph
H
O


88
HN(Me)C(O)
2,5-diMe
6
—CH2CH2—C(O)—CH2CH2
H
PhCH2
MeO
O


89
HN(Me)C(O)
2,5-diMe
6
—CH2CH2CH(OEt)CH2CH2
N(Me)2
Tosyl
EtO
O


90
HN(Me)C(O)
2,5-diMe
6
—CH2CH2—N(Me)—CH2CH2
H
MeC(O)
H
S(O)2
















91
MeOC(O)
2-Cl
3
Me
Me
H
PhC(O)
Me
O


92
MeOC(O)
2,5-diCl
3
Et
Et
H
CH2═CH
CF3
O


93
MeOC(O)
2,5-diCl
3
n-Pr
n-Pr
H
CH≡C
i-Pr
O


94
MeOC(O)
2,5-diCl
3
Me
c-Pr
Me
2-Pyridyl
Me
O


95
MeOC(O)
2,5-diCl
3
Me
CF3
H
H
Me
NH


96
c-Pentyloxy
2-Cl
3
Me
CH2═CHCH2
H
MeSO2
H
O


97
c-Pentyloxy

3
Me
CH≡CCH2
H
PhSO2
H
O


98
c-Pentyloxy

3
Me
Ph
H
N(Me)2SO2
MeO
O


99
c-Pentyloxy

3
Me
2-Thienyl
c-Pr
H
EtO
O


100
c-Pentyloxy

3
Me
2-Furyl
H
CF3
H
N(Me)
















TABLE 3









embedded image









embedded image







Exanple of Compound (2)



















Position








No.
E
(R1)p
of A
R2
R3
X
R5
(Y)m
G



















1
H
2-Cl
3
Me
Me
CH2
H

O


2
H
2-Cl
3
Et
Et
CH2
CF3

O


3
H
2-Cl
3
n-Pr
n-Pr
CH2
H

O


4
H
2-Cl
3
Me
c-Pr
CH2
Me

O


5
H
2-Cl
3
Me
CF3
CH2
Ph
5′-Me
S


6
iPrS
2-Cl
3
Me
CH2═CHCH2
CH(Me)
PhCH2

O


7
PhC(O)
2-Cl
3
Me
CH≡CCH2
C(Me)2
Tosyl

O


8
3-Furyl
2-Cl
3
Me
Ph
NH
MeC(O)

O


9
Me
2-Cl
3
Me
2-Thienyl
N(Me)
PhC(O)

O


10
Me
2-Cl
3
Me
2-Furyl
CH2
CH═CH

S(O)


11
CF3
2-Cl
3
Me
2-Pyridyl
CH2
CH≡C
5′-oxo
O


12
CF3
2-Cl
3
Me
4-Piperidyl
CH2
2-Pyridyl
5′-CF3
O















13
CF3
2-Cl
3
—CH2CH2CH2
CH2
CH2
5′-MeO
O


14
CF3
2-Cl
3
—CH2CH(Me)CH2
CH2
CH2
5′,5′-diMe
O


15
CF3
2-Cl
3
—CH2CH2CH2CH2
CH2
PhSO2
5′-MeC(O)
S(O)2


16
MeO
2-Cl
3
—CH2CH2CH2CH2CH2
CH(Me)
Me2NCO
5′-PhC(O)
O


17
MeO
2-Cl
3
—CH2CH2—O—CH2CH2
C(Me)2
H
5′-MeOC(O)
O


18
MeO
2-Cl
3
—CH2CH2—C(O)—CH2CH2
NH
CF3
4′-oxo
O


19
MeO
2-Cl
3
—CH2CH2CH(OEt)CH2CH2
N(Me)
H
4′-Me
O


20
MeO
2-Cl
3
—CH2CH2—N(Me)—CH2CH2
CH2
Me
4′-MeO
NH
















21
Ph
2-Cl
3
Me
Me
CH2
EtSC(O)
4′,4′-diMe
O


22
Ph
2-Cl
3
Et
Et
CH2
tBu
4′-MeC(O)
O


23
Ph
2-Cl
3
n-Pr
n-Pr
CH2
PhC(O)
4′-PhC(O)
O


24
Ph
2-Cl
3
Me
c-Pr
CH2
MeOC(O)
4′-MeOC(O)
O


25
Ph
2-Cl
3
Me
CF3
CH2
PhC(O)

N(Me)


26
NH2
2-Cl
3
Me
CH2═CHCH2
CH(Me)
CH2═CH

O


27
NH2
2-NH2
3
Me
CH≡CCH2
C(Me)2
CH≡C

O


28
NH2
2-Me
3
Me
Ph
NH
2-Pyridyl

O


29
NH2
2-Me
3
Me
2-Thienyl
N(Me)
MeSC(O)
5-Me
O


30
NH2
2-Me
3
Me
2-Furyl
CH2
MeSO2

S


31
N(Me)2
2-Cl
3
Me
2-Pyridyl
CH2
PhSO2

O


32
N(Me)2
2-Me
3
Me
4-Piperidyl
CH2
N(Me)2SO2

O















33
N(Me)2
2-Me
3
—CH2CH2CH2
CH2
H

O


34
N(Me)2
2-Me
3
—CH2CH(Me)CH2
CH2
CF3

O


35
N(Me)2
2-Me
3
—CH2CH2CH2CH2
CH2
H
5′-oxo
S(O)


36
HN (Me) C(O)
2-Cl
3
—CH2CH2CH2CH2CH2
CH(Me)
Me
5′-CF3
O


37
HN (Me) C(O)
2-CF3
3
—CH2CH2—O—CH2CH2
C(Me)2
Ph
5′-MeO
O


38
HN (Me) C(O)
2-CF3
3
—CH2CH2—C(O)—CH2CH2
NH
PhCH2
5′,5′-diMe
O


39
HN (Me) C(O)
2-CF3
3
—CH2CH2CH(OEt)CH2CH2
N(Me)
Tosyl
5′-MeC(O)
O


40
HN(Me) C(O)
2-CF3
3
—CH2CH2—N(Me)—CH2CH2
CH2
MeC(O)
5′-PhC(O)
S(O)2
















41
MeOC(O)
2-Cl
3
Me
Me
CH2
PhC(O)
5′-MeOC(O)
O


42
MeOC(O)
2-CF3
3
Et
Et
CH2
CH═CH
4′-oxo'
O


43
MeOC(O)
2-CF3
3
n-Pr
n-Pr
CH2
CH≡C
4′-Me
O


44
MeOC(O)
2-CF3
3
Me
c-Pr
CH2
2-Pyridyl
4′-MeO
O


45
MeOC(O)
2-CF3
3
Me
CF3
CH2
H
4′,4′-diMe
NH


46
c-Pentyloxy
2-Cl
3
Me
CH2═CHCH2
CH(Me)
MeSO2
4′-MeC(O)
O


47
c-Pentyloxy
2-OH
3
Me
CH≡CCH2
C(Me)2
PhSO2
4′-PhC(O)
O


48
c-Pentyloxy
2-OH
3
Me
Ph
NH
N(Me)2SO2
4′-MeOC(O)
O


49
c-Pentyloxy
2-OH
3
Me
2-Thienyl
N(Me)
H

O


50
c-Pentyloxy
2-OH
3
Me
2-Furyl
CH2
CF3

N(Me)


51
H
2-Cl
5
Me
Me
CH2
H

O


52
H
2-MeO
5
Et
Et
CH2
CF3

O


53
H
2-MeO
5
n-Pr
n-Pr
CH2
H
5′-Me
O


54
H
2-MeO
5
Me
c-Pr
CH2
Me

O


55
H
2-MeO
5
Me
CF3
CH2
Ph

S


56
Me
2-Cl
5
Me
CH2═CHCH2
CH(Me)
PhCH2

O


57
Me
2-CF3O
5
Me
CH≡CCH2
C(Me)2
Tosyl
5′-oxo
O


58
Me
2-CF3O
5
Me
Ph
NH
MeC(O)
5′-CF3
O


59
Me
2-CF3O
5
Me
2-Thienyl
N(Me)
PhC(O)
5′-MeO
O


60
Me
2-CF3O
5
Me
2-Furyl
CH2
CH═CH
5′,5′-diMe
S(O)


61
CF3
2-Cl
5
Me
2-Pyridyl
CH2
CH≡C
5′-MeC(O)
O


62
CF3
2-CF3O
5
Me
4-Piperidyl
CH2
2-Pyridyl
5′-PhC(O)
O















63
CF3
2-CF3O
5
—CH2CH2CH2
CH2
H
5′-MeOC(O)
O


64
CF3
2-CF3O
5
—CH2CH(Me)CH2
CH2
MeSO2
4′-oxo′
O


65
CF3
2-CF3O
5
—CH2CH2CH2CH2
CH2
PhSO2
4′-Me
S(O)2


66
MeO
2-Cl
5
—CH2CH2CH2CH2CH2
CH(Me)
N(Me)2SO2
4′-MeO
O


67
MeO
2-SH
5
—CH2CH2—O—CH2CH2
C(Me)2
H
4′,4′-diMe
O


68
MeO
2-SH
5
—CH2CH2—C(O)—CH2CH2
NH
CF3
4′-MeC(O)
O


69
MeO
2-SH
5
—CH2CH2CH(OEt)CH2CH2
N(Me)
H
4′-PhC(O)
O


70
MeO
2-SH
5
—CH2CH2—N(Me)—CH2CH2
CH2
Me
4′-MeOC(O)
NH
















71
Ph
2-Cl
6
Me
Me
CH2
Ph

O


72
Ph
2-MeS
6
Et
Et
CH2
PhCH2

O


73
Ph
2-MeS
6
n-Pr
n-Pr
CH2
Tosyl

O


74
Ph
2-MeS
6
Me
c-Pr
CH2
MeC(O)

O


75
Ph
2-MeS
6
Me
CF3
CH2
PhC(O)

N(Me)


76
NH2
2-Cl
6
Me
CH2═CHCH2
CH(Me)
CH═CH
5′-Me
O


77
NH2
2-MeS(O)2
6
Me
CH≡CCH2
C(Me)2
CH≡C

O


78
NH2
2-MeS(O)2
6
Me
Ph
NH
2-Pyridyl

O


79
NH2
2-MeS(O)2
6
Me
2-Thienyl
N(Me)
H

O


80
NH2
2-MeS(O)2
6
Me
2-Furyl
CH2
MeSO2

S


81
N(Me)2
2-Cl
6
Me
2-Pyridyl
CH2
PhSO2
5′-oxo
O


82
N(Me)2
2-NO2
6
Me
4-Piperidyl
CH2
N(Me)2SO2
5′-CF3
O















83
N(Me)2
2-NO2
6
—CH2CH2CH2
CH2
H
5′-MeO
O


84
N(Me)2
2-NO2
6
—CH2CH(Me)CH2
CH2
CF3
5′,5′-diMe
O


85
N(Me)2
2-NO2
6
—CH2CH2CH2CH2
CH2
H
5′-MeC(O)
S(O)


86
HN(Me) C(O)
2-Cl
6
—CH2CH2CH2CH2CH2
CH(Me)
Me
5′-PhC(O)
O


87
HN (Me) C(O)
2,5-diMe
6
—CH2CH2—O—CH2CH2
C(Me)2
Ph
5′-MeOC(O)
O


88
HN (Me) C(O)
2,5-diMe
6
—CH2CH2—C(O)—CH2CH2
NH
PhCH2
4′-oxo′
O


89
HN (Me) C(O)
2,5-diMe
6
—CH2CH2CH(OEt)CH2CH2
N(Me)
Tosyl
4′-Me
O


90
HN (Me) C(O)
2,5-diMe
6
—CH2CH2—N(Me)—CH2CH2
CH2
MeC(O)
4′-MeO
S(O)2
















91
MeOC(O)
2-Cl
3
Me
Me
CH2
PhC(O)
4′,4′-diMe
O


92
MeOC(O)
2,5-diCl
3
Et
Et
CH2
CH═CH
4′-MeC(O)
O


93
MeOC(O)
2,5-diCl
3
n-Pr
n-Pr
CH2
CH≡C
4′-PhC(O)
O


94
MeOC(O)
2,5-diCl
3
Me
c-Pr
CH2
2-Pyridyl
4′-MeOC(O)
O


95
MeOC(O)
2,5-diCl
3
Me
CF3
CH2
H

NH


96
c-Pentyloxy
2-Cl
3
Me
CH2═CHCH2
CH(Me)
MeSO2

O


97
c-Pentyloxy

3
Me
CH≡CCH2
C(Me)2
PhSO2

O


98
c-Pentyloxy

3
Me
Ph
NH
N(Me)2SO2

O


99
c-Pentyloxy

3
Me
2-Thienyl
N(Me)
H

O


100
c-Pentyloxy

3
Me
2-Furyl
CH2
CF3
5′-Me
N(Me)
















TABLE 4









embedded image









embedded image







Exanple of Compound (3)



















Position








No.
E
(R1)p
of a
R2
R3
R5
R8
R9
G



















1
H
2-Cl
3
Me
Me
H
H
H
O


2
H
2-Cl
3
Et
Et
CF3
H
H
O


3
H
2-Cl
3
n-Pr
n-Pr
H
H
H
O


4
H
2-Cl
3
Me
c-Pr
Me
H
H
O


5
H
2-Cl
3
Me
CF3
Ph
H
H
S


6
Me
2-Cl
3
Me
CH2═CHCH2
PhCH2
H
H
O


7
Me
2-Cl
3
Me
CH≡CCH2
Tosyl
H
H
O


8
Me
2-Cl
3
Me
Ph
MeC(O)
H
H
O


9
Me
2-Cl
3
Me
2-Thienyl
PhC(O)
H
H
O


10
Me
2-Cl
3
Me
2-Furyl
CH2═CH
H
H
S(O)


11
CF3
2-Cl
3
Me
2-Pyridyl
CH≡C
H
Me
O


12
CF3
2-Cl
3
Me
4-Piperidyl
2-Pyridyl
H
CF3
O















13
CF3
2-Cl
3
—CH2CH2CH2
CH2
H
i-Pr
O


14
CF3
2-Cl
3
—CH2CH(Me)CH2
CH2
Me
H
O


15
CF3
2-Cl
3
—CH2CH2CH2CH2
PhSO2
CF3
H
S(O)2


16
MeO
2-Cl
3
—CH2CH2CH2CH2CH2
N(Me)2SO2
i-Pr
H
O


17
MeO
2-Cl
3
—CH2CH2—O—CH2CH2
H
Me
Me
O


18
MeO
2-Cl
3
—CH2CH2—C(O)—CH2CH2
CF3
CF3
CF3
O


19
MeO
2-Cl
3
—CH2CH2CH(OEt)CH2CH2
H
Me
Et
O


20
MeO
2-Cl
3
—CH2CH2—N(Me)—CH2CH2
Me
Et
Me
NH
















21
Ph
2-Cl
3
Me
Me
EtOC(O)
H
H
O


22
Ph
2-Cl
3
Et
Et
MeSC(O)
H
H
O


23
Ph
2-Cl
3
n-Pr
n-Pr
PhC(O)
H
H
O


24
Ph
2-Cl
3
Me
c-Pr
Me
H
H
O


25
Ph
2-Cl
3
Me
CF3
PhC(O)
H
H
N(Me)


26
NH2
2-Cl
3
Me
CH2═CHCH2
CH2═CH
H
H
O


27
NH2
2-Me
3
Me
CH≡CCH2
CH≡C
H
H
O


28
NH2
2-Me
3
Me
Ph
2-Pyridyl
H
H
O


29
NH2
2-Me
3
Me
2-Thienyl
H
H
H
O


30
NH2
2-Me
3
Me
2-Furyl
MeSO2
H
H
S


31
N(Me)2
2-Cl
3
Me
2-Pyridyl
PhSO2
H
Me
O


32
N(Me)2
2-Me
3
Me
4-Piperidyl
N(Me)2SO2
H
CF3
O















33
N(Me)2
2-Me
3
—CH2CH2CH2
H
H
i-Pr
O


34
N(Me)2
2-Me
3
—CH2CH(Me)CH2
CF3
Me
H
O


35
N(Me)2
2-Me
3
—CH2CH2CH2CH2
H
CF3
H
S(O)


36
HN (Me) C(O)
2-Cl
3
—CH2CH2CH2CH2CH2
Me
i-Pr
H
O


37
HN (Me) C(O)
2-CF3
3
—CH2CH2—O—CH2CH2
Ph
Me
Me
O


38
HN (Me) C(O)
2-CF3
3
—CH2CH2—C(O)—CH2CH2
PhCH2
CF3
CF3
O


39
HN (Me) C(O)
2-CF3
3
—CH2CH2CH(OEt)CH2CH2
Tosyl
Me
CF3
O


40
HN(Me) C(O)
2-CF3
3
—CH2CH2—N(Me)—CH2CH2
MeC(O)
CF3
Me
S(O)2
















41
MeOC(O)
2-Cl
3
Me
Me
PhC(O)
H
H
O


42
MeOC(O)
2-CF3
3
Et
Et
CH2═CH
H
H
O


43
MeOC(O)
2-CF3
3
n-Pr
n-Pr
CH≡C
H
H
O


44
MeOC(O)
2-CF3
3
Me
c-Pr
2-Pyridyl
H
H
O


45
MeOC(O)
2-CF3
3
Me
CF3
H
H
H
NH


46
c-Propoxy
2-Cl
3
Me
CH2═CHCH2
MeSO2
H
H
O


47
c-Pentyloxy
2-OH
3
Me
CH≡CCH2
PhSO2
H
H
O


48
c-Pentyloxy
2-OH
3
Me
Ph
N(Me)2SO2
H
H
O


49
c-Pentyloxy
2-OH
3
Me
2-Thienyl
H
H
H
O


50
c-Pentyloxy
2-OH—
3
Me
2-Furyl
CF3
H
Me
N(Me)


51
H
2-Cl
5
Me
Me
H
H
i-Pr
O


52
H
2-MeO
5
Et
Et
CF3
Me
H
O


53
H
2-MeO
5
n-Pr
n-Pr
H
CF3
H
O


54
H
2-MeO
5
Me
c-Pr
Me
i-Pr
H
O


55
H
2-MeO
5
Me
CF3
Ph
Me
Me
S


56
Me
2-Cl
5
Me
CH2═CHCH2
PhCH2
CF3
CF3
O


57
Me
2-CF3O
5
Me
CH≡CCH2
Tosyl
Me
Et
O


58
Me
2-CF3O
5
Me
Ph
MeC(O)
CF3
Me
O


59
Me
2-CF3O
5
Me
2-Thienyl
PhC(O)
H
H
O


60
Me
2-CF3O
5
Me
2-Furyl
CH2═CH
H
H
S(O)


61
CF3
2-Cl
5
Me
2-Pyridyl
CH≡C
H
H
O


62
CF3
2-CF3O
5
Me
4-Piperidyl
2-Pyridyl
H
H
O















63
CF3
2-CF3O
5
—CH2CH2CH2
H
H
H
O


64
CF3
2-CF3O
5
—CH2CH(Me)CH2
MeSO2
H
H
O


65
CF3
2-CF3O
5
—CH2CH2CH2CH2
PhSO2
H
H
S(O)2


66
MeO
2-Cl
5
—CH2CH2CH2CH2CH2
N(Me)2SO2
H
H
O


67
MeO
2-SH
5
—CH2CH2—O—CH2CH2
H
H
H
O


68
MeO
2-SH
5
—CH2CH2—C(O)—CH2CH2
CF3
H
H
O


69
MeO
2-SH
5
—CH2CH2CH(OEt)CH2CH2
H
H
H
O


70
MeO
2-SH
5
—CH2CH2—N(Me)—CH2CH2
Me
H
H
NH
















71
PhC(O)
2-Cl
6
Me
Me
Ph
H
Me
O


72
Ph
2-MeS
6
Et
Et
PhCH2
H
i-Pr
O


73
Ph
2-MeS
6
n-Pr
n-Pr
Tosyl
Me
H
O


74
Ph
2-MeS
6
Me
c-Pr
MeC(O)
CF3
H
O


75
Ph
2-MeS
6
Me
CF3
PhC(O)
i-Pr
H
N(Me)


76
NH2
2-Cl
6
Me
CH2═CHCH2
CH2═CH
Me
Me
O


77
NH2
2-MeS(O)2
6
Me
CH≡CCH2
CH≡C
CF3
CF3
O


78
NH2
2-MeS(O)2
6
Me
Ph
2-Pyridyl
Me
CF3
O


79
CN
2-MeS(O)2
6
Me
2-Thienyl
H
Et
Me
O


80
EtS
2-MeS(O)2
6
Me
2-Furyl
MeSO2
H
H
S


81
N(Me)2
2-Ph
6
Me
2-Pyridyl
PhSO2
H
H
O


82
N(Me)2
2-NO2
6
Me
4-Piperidyl
N(Me)2SO2
H
H
O















83
N(Me)2
2-NO2
6
—CH2CH2CH2
H
H
H
O


84
N(Me)2
2-NO2
6
—CH2CH(Me)CH2
CF3
H
H
O


85
N(Me)2
2-NO2
6
—CH2CH2CH2CH2
H
H
H
S(O)


86
HN(Me) C(O)
2-Cl
6
—CH2CH2CH2CH2CH2
Me
H
H
O


87
HN (Me) C(O)
2,5-diMe
6
—CH2CH2—O—CH2CH2
Ph
H
H
O


88
HN (Me) C(O)
2,5-diMe
6
—CH2CH2—C(O)—CH2CH2
PhCH2
H
H
O


89
HN (Me) C(O)
2,5-diMe
6
—CH2CH2CH(OEt)CH2CH2
Tosyl
H
H
O


90
HN (Me) C(O)
2,5-diMe
6
—CH2CH2—N(Me)—CH2CH2
MeC(O)
H
H
S(O)2
















91
MeOC(O)
2-Cl
3
Me
Me
PhC(O)
H
Me
N(Et)


92
MeOC(O)
2,5-diCl
3
Et
Et
CH2═CH
H
i-Pr
O


93
MeOC(O)
2,5-diCl
3
n-Pr
n-Pr
CH≡C
Me
H
O


94
MeOC(O)
2,5-diCl
3
Me
c-Pr
2-Pyridyl
Et
H
O


95
MeOC(O)
2,5-diMe2N
3
Me
CF3
H
i-Pr
H
NH


96
c-Pentyloxy
2-Cl
3
Me
CH2═CHCH2
MeSO2
Me
Me
O


97
c-Pentyloxy

3
Me
CH≡CCH2
PhSO2
Et
Et
O


98
c-Pentyloxy

3
Me
Ph
N(Me)2SO2
Me
Et
O


99
c-Pentyloxy

3
Me
2-Thienyl
H
Et
Me
O


100
2-Imidazolyl

3
Me
2-Furyl
CF3
H
H
N(Me)
















TABLE 5









embedded image









embedded image







Exanple of Compound (4)



















Position








No.
E
(R1)p
of A
R2
R3
R5
R4
R6
G



















1
H
2-Cl
3
Me
Me
H
H
CN
O


2
H
2-Cl
3
Et
Et
CF3
H
CN
O


3
H
2-Cl
3
n-Pr
n-Pr
H
H
CN
O


4
H
2-Cl
3
Me
c-Pr
Me
H
CN
O


5
H
2-Cl
3
Me
CF3
Ph
H
CN
S


6
Me
2-Cl
3
Me
CH2═CHCH2
PhCH2
H
CN
O


7
Me
2-Cl
3
Me
CH≡CCH2
Tosyl
H
CN
O


8
Me
2-Cl
3
Me
Ph
MeC(O)
H
CN
O


9
Me
2-Cl
3
Me
2-Thienyl
PhC(O)
H
CN
O


10
Me
2-Cl
3
Me
2-Furyl
CH2═CH
H
CN
S(O)


11
CF3
2-Cl
3
Me
2-Pyridyl
CH≡C
H
MeC(O)
O


12
CF3
2-Cl
3
Me
4-Piperidyl
2-Pyridyl
H
PhC(O)
O















13
CF3
2-Me2N
3
—CH2CH2CH2
H
H
MeOC(O)
O


14
CF3
2-Cl
3
—CH2CH(Me)CH2
MeSO2
H
HN═CPh
O


15
CF3
2-Cl
3
—CH2CH2CH2CH2
PhSO2
Me
N(Me)═CH
S(O)2


16
MeO
2-Cl
3
—CH2CH2CH2CH2CH2
N(Me)2SO2
CF3
1-tetrazolyl
O


17
MeO
2-Cl
3
—CH2CH2—O—CH2CH2
H
c-Pr
CN
O


18
MeO
2-Cl
3
—CH2CH2—C(O)—CH2CH2
CF3
c-Hexyl
CN
O


19
MeO
2-Cl
3
—CH2CH2CH(OEt)CH2CH2
H
NH2
CN
O


20
MeO
2-Cl
3
—CH2CH2—N(Me)—CH2CH2
Me
N(Me)2
CN
NH
















21
Ph
2-Cl
3
Me
Me
Et
Me
CN
O


22
Ph
2-Cl
3
Et
Et
5′-MeC(O)
CF3
CN
O


23
Ph
2-Cl
3
n-Pr
n-Pr
5′-PhC(O)
c-Pr
CN
O


24
Ph
2-Cl
3
Me
c-Pr
5′-MeOC(O)
c-Hexyl
CN
O


25
Ph
2-Cl
3
Me
CF3
PhC(O)
NH2
CN
N(Me)


26
NH2
2-Cl
3
Me
CH2═CHCH2
CH2═CH
N(Me)2
CN
O


27
NH2
2-Me
3
Me
CH≡CCH2
CH≡C
H
CN
O


28
NH2
2-Me
3
Me
Ph
2-Pyridyl
H
CN
O


29
NH2
2-Me
3
Me
2-Thienyl
H
H
MeC(O)
O


30
NH2
2-Me
3
Me
2-Furyl
MeSO2
H
PhC(O)
S


31
N(Me)2
2-Cl
3
Me
2-Pyridyl
PhSO2
H
MeOC(O)
O


32
N(Me)2
2-Me
3
Me
4-Piperidyl
N(Me)2SO2
H
HN═CH
O















33
N(Me)2
2-Me
3
—CH2CH2CH2
MeSC(O)
H
N(Me)═CH
O


34
N(Me)2
2-Me
3
—CH2CH(Me)CH2
CF3
H
1-tetrazolyl
O


35
N(Me)2
2-Me
3
—CH2CH2CH2CH2
EtOC(O)
H
CN
S(O)


36
HN (Me) C(O)
2-Cl
3
—CH2CH2CH2CH2CH2
Me
H
EtN═CMe
O


37
HN (Me) C(O)
2-CF3
3
—CH2CH2—O—CH2CH2
Ph
H
CN
O


38
HN (Me) C(O)
2-CF3
3
—CH2CH2—C(O)—CH2CH2
PhCH2
H
CN
O


39
HN (Me) C(O)
2-CF3
3
—CH2CH2CH(OEt)CH2CH2
Tosyl
H
CN
O


40
HN(Me) C(O)
2-CF3
3
—CH2CH2—N(Me)—CH2CH2
MeC(O)
H
CN
S(O)2
















41
MeOC(O)
2-Cl
3
Me
Me
PhC(O)
H
CN
O


42
MeOC(O)
2-CF3
3
Et
Et
CH2═CH
H
CN
O


43
MeOC(O)
2-CF3
3
n-Pr
n-Pr
CH≡C
H
CN
O


44
MeOC(O)
2-CF3
3
Me
c-Pr
2-Pyridyl
H
CN
O


45
MeOC(O)
2-CF3
3
Me
CF3
H
Me
CN
NH


46
c-Pentyloxy
2-Cl
3
Me
CH2═CHCH2
MeSO2
CF3
CN
O


47
c-Pentyloxy
2-OH
3
Me
CH≡CCH2
PhSO2
c-Pr
MeC(O)
O


48
c-Pentyloxy
2-OH
3
Me
Ph
N(Me)2SO2
c-Hexyl
PhC(O)
O


49
c-Pentyloxy
2-OH
3
Me
2-Thienyl
H
NH2
MeOC(O)
O


50
c-Pentyloxy
2-OH
3
Me
2-Furyl
CF3
N(Me)2
HN═CH
N(Me)


51
H
2-Cl
5
Me
Me
H
H
N(Me)═CH
O


52
H
2-MeO
5
Et
Et
CF3
H
5-tetrazolyl
O


53
H
2-MeO
5
n-Pr
n-Pr
H
H
CN
O


54
H
2-MeO
5
Me
c-Pr
Me
H
CN
O


55
PhC(O)
2-MeO
5
Me
CF3
Ph
H
CN
S


56
CN
2-Cl
5
Me
CH2═CHCH2
PhCH2
H
CN
O


57
EtS
2-CF3O
5
Me
CH≡CCH2
Tosyl
H
CN
O


58
Me
2-CF3O
5
Me
Ph
MeC(O)
H
CN
O


59
Me
2-CF3O
5
Me
2-Thienyl
PhC(O)
H
CN
O


60
Me
2-CF3O
5
Me
2-Furyl
CH2═CH
H
CN
S(O)


61
CF3
2-Cl
5
Me
2-Pyridyl
CH≡C
H
CN
O


62
CF3
2-CF3O
5
Me
4-Piperidyl
2-Pyridyl
H
CN
O















63
CF3
2-CF3O
5
—CH2CH2CH2
H
Me
MeC(O)
O


64
CF3
2-CF3O
5
—CH2CH(Me)CH2
MeSO2
CF3
PhC(O)
O


65
CF3
2-CF3O
5
—CH2CH2CH2CH2
PhSO2
c-Pr
MeOC(O)
S(O)2


66
MeO
2-Cl
5
—CH2CH2CH2CH2CH2
N(Me)2SO2
c-Hexyl
HN═CH
O


67
MeO
2-SH
5
—CH2CH2—O—CH2CH2
H
NH2
N(Me)═CH
O


68
MeO
2-SH
5
—CH2CH2—C(O)—CH2CH2
CF3
N(Me)2
1-tetrazolyl
O


69
MeO
2-SH
5
—CH2CH2CH(OEt)CH2CH2
H
H
CN
O


70
MeO
2-SH
5
—CH2CH2—N(Me)—CH2CH2
Me
H
CN
NH
















71
3-Pyridyl
2-Cl
6
Me
Me
Ph
H
CN
O


72
Ph
2-MeS
6
Et
Et
PhCH2
H
CN
O


73
Ph
2-MeS
6
n-Pr
n-Pr
Tosyl
H
CN
O


74
Ph
2-MeS
6
Me
c-Pr
MeC(O)
H
CN
O


75
Ph
2-MeS
6
Me
CF3
PhC(O)
H
CN
N(Me)


76
NH2
2-Cl
6
Me
CH2═CHCH2
CH2═CH
H
CN
O


77
NH2
2-MeS(O)2
6
Me
CH≡CCH2
CH≡C
H
MeC(O)
O


78
NH2
2-MeS(O)2
6
Me
Ph
2-Pyridyl
H
PhC(O)
O


79
NH2
2-MeS(O)2
6
Me
2-Thienyl
H
H
MeOC(O)
O


80
NH2
2-MeS(O)2
6
Me
2-Furyl
Me2NC(O)
H
HN═CH
S


81
N(Me)2
2-Cl
6
Me
2-Pyridyl
PhSO2
H
N(Me)═CH
O


82
N(Me)2
2-NO2
6
Me
4-Piperidyl
N(Me)2SO2
H
5-tetrazolyl
O















83
N(Me)2
2-NO2
6
—CH2CH2CH2
H
H
CN
O


84
N(Me)2
2-NO2
6
—CH2CH(Me)CH2
CF3
H
CN
O


85
N(Me)2
2-NO2
6
—CH2CH2CH2CH2
H
H
CN
S(O)


86
HN(Me) C(O)
2-Cl
6
—CH2CH2CH2CH2CH2
Me
H
CN
O


87
HN (Me) C(O)
2,5-diMe
6
—CH2CH2—O—CH2CH2
Ph
H
CN
O


88
HN (Me) C(O)
2,5-diMe
6
—CH2CH2—C(O)—CH2CH2
PhCH2
H
CN
O


89
HN (Me) C(O)
2,5-diMe
6
—CH2CH2CH(OEt)CH2CH2
Tosyl
H
CN
O


90
HN (Me) C(O)
2,5-diMe
6
—CH2CH2—N(Me)—CH2CH2
MeC(O)
H
CN
S(O)2
















91
MeOC(O)
2-Cl
3
Me
Me
PhC(O)
Me
CN
O


92
MeOC(O)
2,5-diCl
3
Et
Et
CH2═CH
CF3
CN
O


93
MeOC(O)
2,5-diCl
3
n-Pr
n-Pr
CH≡C
c-Pr
CN
O


94
MeOC(O)
2,5-diCl
3
Me
c-Pr
2-Pyridyl
c-Hexyl
CN
O


95
MeOC(O)
2,5-diCl
3
Me
CF3
H
NH2
CN
NH


96
c-Pentyloxy
2-Cl
3
Me
CH2═CHCH2
MeSO2
N(Me)2
CN
O


97
c-Pentyloxy

3
Me
CH≡CCH2
PhSO2
H
CN
O


98
c-Pentyloxy

3
Me
Ph
N(Me)2SO2
H
CN
O


99
c-Pentyloxy

3
Me
2-Thienyl
H
Et
CN
O


100
c-Pentyloxy

3
Me
2-Furyl
CF3
H
CN
N(Me)
















TABLE 6









embedded image









embedded image







Exanple of Compound (5)


















Position







No.
E
(R1)p
of A
R2
R3
R5
R7
G


















1
MeC(O)
2-Cl
3
Me
Me
H
H
O


2
2-Thienyl
2-Cl
3
Et
Et
CF3
H
O


3
H
2-Cl
3
n-Pr
n-Pr
H
H
O


4
H
2-Cl
3
Me
c-Pr
Me
H
O


5
H
2-Cl
3
Me
CF3
Ph
H
S


6
Me
2-Cl
3
Me
CH2═CHCH2
PhCH2
H
O


7
Me
2-Cl
3
Me
CH≡CCH2
Tosyl
H
O


8
Me
2-Cl
3
Me
Ph
MeC(O)
H
O


9
Me
2-Cl
3
Me
2-Thienyl
PhC(O)
H
O


10
Me
2-Cl
3
Me
2-Furyl
CH2═CH
H
S(O)


11
CF3
2-Cl
3
Me
2-Pyridyl
CH≡C
H
O


12
CF3
2-Cl
3
Me
4-Piperidyl
2-Pyridyl
H
O














13
CF3
2-Cl
3
—CH2CH2CH2
CH2
H
O


14
CF3
2-Cl
3
—CH2CH(Me)CH2
CH2
Me
O


15
CF3
2-NH2
3
—CH2CH2CH2CH2
PhSO2
CF3
S(O)2


16
MeO
2-Cl
3
—CH2CH2CH2CH2CH2
N(Me)2SO2
i-Pr
O


17
MeO
2-Cl
3
—CH2CH2—O—CH2CH2
H
MeO
O


18
MeO
2-Cl
3
—CH2CH2—C(O)—CH2CH2
CF3
EtO
O


19
MeO
2-Cl
3
—CH2CH2CH(OEt)CH2CH2
H
H
O


20
MeO
2-Cl
3
—CH2CH2—N(Me)—CH2CH2
Me
H
NH















21
Ph
2-Cl
3
Me
Me
MeOC(O)
Me
O


22
Ph
2-Cl
3
Et
Et
EtSC(O)
CF3
O


23
Ph
2-Cl
3
n-Pr
n-Pr
Et2NC(O)
i-Pr
O


24
Ph
2-Cl
3
Me
c-Pr
Me2NC(O)
MeO
O


25
Ph
2-Cl
3
Me
CF3
PhC(O)
EtO
N(Me)


26
NH2
2-Cl
3
Me
CH2═CHCH2
CH2═CH
H
O


27
NH2
2-Me
3
Me
CH≡CCH2
CH≡C
H
O


28
NH2
2-Me
3
Me
Ph
2-Pyridyl
H
O


29
NH2
2-Me
3
Me
2-Thienyl
H
H
O


30
NH2
2-Me
3
Me
2-Furyl
MeSO2
H
S


31
N(Me)2
2-Cl
3
Me
2-Pyridyl
PhSO2
H
O


32
N(Me)2
2-Me
3
Me
4-Piperidyl
N(Me)2SO2
H
O














33
N(Me)2
2-Me
3
—CH2CH2CH2
H
H
O


34
N(Me)2
2-Me
3
—CH2CH(Me)CH2
CF3
H
O


35
N(Me)2
2-Me
3
—CH2CH2CH2CH2
H
H
S(O)


36
HN (Me) C(O)
2-Cl
3
—CH2CH2CH2CH2CH2
Me
H
O


37
HN (Me) C(O)
2-CF3
3
—CH2CH2—O—CH2CH2
Ph
H
O


38
HN (Me) C(O)
2-CF3
3
—CH2CH2—C(O)—CH2CH2
PhCH2
H
O


39
HN (Me) C(O)
2-CF3
3
—CH2CH2CH(OEt)CH2CH2
Tosyl
H
O


40
HN(Me) C(O)
2-CF3
3
—CH2CH2—N(Me)—CH2CH2
MeC(O)
H
S(O)2















41
MeOC(O)
2-Cl
3
Me
Me
PhC(O)
H
O


42
MeOC(O)
2-CF3
3
Et
Et
CH2═CH
H
O


43
MeOC(O)
2-CF3
3
n-Pr
n-Pr
CH≡C
H
O


44
MeOC(O)
2-CF3
3
Me
c-Pr
2-Pyridyl
H
O


45
MeOC(O)
2-CF3
3
Me
CF3
H
H
NH


46
c-Pentyloxy
2-Cl
3
Me
CH2═CHCH2
MeSO2
H
O


47
c-Pentyloxy
2-OH
3
Me
CH≡CCH2
PhSO2
H
O


48
c-Pentyloxy
2-OH
3
Me
Ph
N(Me)2SO2
H
O


49
c-Pentyloxy
2-OH
3
Me
2-Thienyl
H
H
O


50
c-Pentyloxy
2-OH
3
Me
2-Furyl
CF3
H
N(Me)


51
H
2-Cl
5
Me
Me
H
H
O


52
H
2-MeO
5
Et
Et
CF3
Me
O


53
H
2-MeO
5
n-Pr
n-Pr
H
CF3
O


54
H
2-MeO
5
Me
c-Pr
Me
i-Pr
O


55
H
2-MeO
5
Me
CF3
Ph
MeO
S


56
Me
2-Cl
5
Me
CH2═CHCH2
PhCH2
EtO
O


57
Me
2-CF3O
5
Me
CH≡CCH2
Tosyl
i-Pr O
O


58
Me
2-CF3O
5
Me
Ph
MeC(O)
H
O


59
Me
2-CF3O
5
Me
2-Thienyl
PhC(O)
H
O


60
MeS
2-CF3O
5
Me
2-Furyl
CH2═CH
H
S(O)


61
CN
2-Cl
5
Me
2-Pyridyl
CH≡C
H
O


62
CF3
2-CF3O
5
Me
4-Piperidyl
2-Pyridyl
H
O














63
CF3
2-CF3O
5
—CH2CH2CH2
H
H
O


64
CF3
2-CF3O
5
—CH2CH(Me)CH2
MeSO2
H
O


65
CF3
2-CF3O
5
—CH2CH2CH2CH2
PhSO2
H
S(O)2


66
MeO
2-Cl
5
—CH2CH2CH2CH2CH2
N(Me)2SO2
H
O


67
MeO
2-SH
5
—CH2CH2—O—CH2CH2
H
H
O


68
MeO
2-SH
5
—CH2CH2—C(O)—CH2CH2
CF3
H
O


69
MeO
2-SH
5
—CH2CH2CH(OEt)CH2CH2
H
H
O


70
MeO
2-SH
5
—CH2CH2—N(Me)—CH2CH2
Me
H
NH















71
Ph
2-Cl
6
Me
Me
Ph
H
O


72
Ph
2-MeS
6
Et
Et
PhCH2
H
O


73
Ph
2-MeS
6
n-Pr
n-Pr
Tosyl
Me
O


74
Ph
2-MeS
6
Me
c-Pr
MeC(O)
CF3
O


75
Ph
2-MeS
6
Me
CF3
PhC(O)
i-Pr
N(Me)


76
NH2
2-Cl
6
Me
CH2═CHCH2
CH2═CH
MeO
O


77
NH2
2-MeS(O)2
6
Me
CH≡CCH2
CH≡C
EtO
O


78
NH2
2-MeS(O)2
6
Me
Ph
2-Pyridyl
i-PrO
O


79
NH2
2-MeS(O)2
6
Me
2-Thienyl
H
H
O


80
NH2
2-MeS(O)2
6
Me
2-Furyl
MeSO2
H
S


81
N(Me)2
2-Cl
6
Me
2-Pyridyl
PhSO2
H
O


82
N(Me)2
2-NO2
6
Me
4-Piperidyl
N(Me)2SO2
H
O














83
N(Me)2
2-NO2
6
—CH2CH2CH2
H
H
O


84
N(Me)2
2-NO2
6
—CH2CH(Me)CH2
CF3
H
O


85
N(Me)2
2-NO2
6
—CH2CH2CH2CH2
H
H
S(O)


86
HN(Me) C(O)
2-Cl
6
—CH2CH2CH2CH2CH2
Me
H
O


87
HN (Me) C(O)
2,5-diMe
6
—CH2CH2—O—CH2CH2
Ph
H
O


88
HN (Me) C(O)
2,5-diMe
6
—CH2CH2—C(O)—CH2CH2
PhCH2
H
O


89
HN (Me) C(O)
2,5-diMe
6
—CH2CH2CH(OEt)CH2CH2
Tosyl
H
O


90
HN (Me) C(O)
2,5-diMe
6
—CH2CH2—N(Me)—CH2CH2
MeC(O)
H
S(O)2















91
MeOC(O)
2-Cl
3
Me
Me
PhC(O)
H
S


92
MeOC(O)
2,5-diCl
3
Et
Et
CH2═CH
H
O


93
MeOC(O)
2,5-diCl
3
n-Pr
n-Pr
CH≡C
Me
O


94
MeOC(O)
2,5-diCl
3
Me
c-Pr
2-Pyridyl
CF3
O


95
MeOC(O)
2,5-diCl
3
Me
CF3
H
i-Pr
NH


96
c-Pentyloxy
2-Cl
3
Me
CH2═CHCH2
MeSO2
MeO
O


97
c-Pentyloxy

3
Me
CH≡CCH2
PhSO2
EtO
O


98
c-Pentyloxy

3
Me
Ph
N(Me)2SO2
i-PrO
O


99
c-Pentyloxy

3
Me
2-Thienyl
H
H
O


100
c-Pentyloxy

3
Me
2-Furyl
CF3
H
N(Me)
















TABLE 7









embedded image







Example of Compound (6)


















Position







No.
E
(R1)p
of A
R2
R3
R10
R11
G


















1
H
2-Cl
3
Me
Me
H
H
O


2
H
2-Cl
3
Et
Et
H
H
O


3
H
2-Cl
3
n-Pr
n-Pr
H
H
O


4
2-Furyl
2-Cl
3
Me
c-Pr
H
H
O


5
PhC(O)
2-Cl
3
Me
CF3
H
H
S


6
Me
2-Cl
3
Me
CH2═CHCH2
H
H
O


7
Me
2-Cl
3
Me
CH≡CCH2
H
H
O


8
Me
2-Cl
3
Me
Ph
H
H
O


9
Me
2-Cl
3
Me
2-Thienyl
H
H
O


10
Me
2-Cl
3
Me
2-Furyl
H
H
S(O)


11
CF3
2-Cl
3
Me
2-Pyridyl
Me
H
O


12
CF3
2-Cl
3
Me
4-Piperidyl
CF3
H
O














13
CF3
2-Cl
3
—CH2CH2CH2
i-Pr
H
O


14
CF3
2-Cl
3
—CH2CH(Me)CH2
c-Pr
Me
O


15
CF3
2-Cl
3
—CH2CH2CH2CH2
c-Hexyl
CF3
S(O)2


16
MeO
2-Cl
3
—CH2CH2CH2CH2CH2
H
c-Pr
O


17
MeO
2-Cl
3
—CH2CH2—O—CH2CH2
H
c-Hexyl
O


18
MeO
2-Cl
3
—CH2CH2—C(O)—CH2CH2
H
H
O


19
MeO
2-Cl
3
—CH2CH2CH(OEt)CH2CH2
H
H
O


20
MeO
2-Cl
3
—CH2CH2—N(Me)—CH2CH2
H
H
NH















21
Ph
2-Cl
3
Me
Me
H
Me
O


22
Ph
2-Cl
3
Et
Et
H
CF3
O


23
Ph
2-Cl
3
n-Pr
n -Pr
H
i-Pr
O


24
Ph
2-Cl
3
Me
c-Pr
H
c-Pr
O


25
Ph
2-Cl
3
Me
CF3
Me
c-Hexyl
N(Me)


26
NH2
2-Cl
3
Me
CH2═CHCH2
CF3
H
O


27
NH2
2-Me
3
Me
CH≡CCH2
i-Pr
H
O


28
NH2
2-Me
3
Me
Ph
c-Pr
H
O


29
NH2
2-Me
3
Me
2-Thienyl
c-Hexyl
H
O


30
NH2
2-Me
3
Me
2-Furyl
H
H
S


31
N(Me)2
2-Cl
3
Me
2-Pyridyl
H
H
O


32
N(Me)2
2-Me
3
Me
4-Piperidyl
H
H
O














33
N(Me)2
2-Me
3
—CH2CH2CH2
H
H
O


34
N(Me)2
2-Me
3
—CH2CH(Me)CH2
H
H
O


35
N(Me)2
2-Me
3
—CH2CH2CH2CH2
H
H
S(O)


36
HN(Me)C(O)
2-Cl
3
—CH2CH2CH2CH2CH2
Me
H
O


37
HN(Me)C(O)
2-CF3
3
—CH2CH2—O—CH2CH2
CF3
H
O


38
HN(Me)C(O)
2-CF3
3
—CH2CH2—C(O)—CH2CH2
i-Pr
H
O


39
HN(Me)C(O)
2-CF3
3
—CH2CH2CH(OEt)CH2CH2
c-Pr
H
O


40
HN(Me)C(O)
2-CF3
3
—CH2CH2—N(Me)—CH2CH2
c-Hexyl
H
S(O)2















41
MeOC(O)
2-Cl
3
Me
Me
H
Me
O


42
MeOC(O)
2-CF3
3
Et
Et
H
CF3
O


43
MeOC(O)
2-CF3
3
n-Pr
n-Pr
H
i-Pr
O


44
MeOC(O)
2-CF3
3
Me
c-Pr
H
c-Pr
O


45
MeOC(O)
2-CF3
3
Me
CF3
H
c-Hexyl
NH


46
c-Pentyloxy
2-Cl
3
Me
CH2═CHCH2
H
H
O


47
c-Pentyloxy
2-OH
3
Me
CH≡CCH2
H
H
O


48
c-Pentyloxy
2-OH
3
Me
Ph
H
H
O


49
c-Pentyloxy
2-OH
3
Me
2-Thienyl
H
H
O


50
c-Pentyloxy
2-OH -
3
Me
2-Furyl
CF3
H
N(Me)


51
H
2-Cl
5
Me
Me
H
H
O


52
H
2-MeO
5
Et
Et
CF3
Me
O


53
H
2-MeO
5
n-Pr
n-Pr
H
Et
O


54
H
2-MeO
5
Me
c-Pr
Me
i-Pr
O


55
H
2-MeO
5
Me
CF3
H
c-Pr
S


56
Me
2-Cl
5
Me
CH2═CHCH2
H
c-Hexyl
O


57
Me
2-CF3O
5
Me
CH≡CCH2
H
H
O


58
Me
2-CF3O
5
Me
Ph
H
H
O


59
MeS
2-CF3O
5
Me
2-Thienyl
H
H
O


60
CN
2-CF3O
5
Me
2-Furyl
H
H
S(O)


61
CF3
3-Me2N
5
Me
2-Pyridyl
H
H
O


62
CF3
2-CF3O
5
Me
4-Piperidyl
H
H
O














63
CF3
2-CF3O
5
—CH2CH2CH2
H
H
O


64
CF3
2-CF3O
5
—CH2CH(Me)CH2
H
c-Pr
O


65
CF3
2-CF3O
5
—CH2CH2CH2CH2
H
c-Hexyl
S(O)2


66
MeO
2-Cl
5
—CH2CH2CH2CH2CH2
H
H
O


67
MeO
2-SH
5
—CH2CH2—O—CH2CH2
H
H
O


68
MeO
2-SH
5
—CH2CH2—C(O)—CH2CH2
CF3
H
O


69
MeO
2-SH
5
—CH2CH2CH(OEt)CH2CH2
H
H
O


70
MeO
2-SH
5
—CH2CH2—N(Me)—CH2CH2
Me
H
NH















71
Ph
2-Cl
6
Me
Me
CF3
H
O


72
Ph
2-MeS
6
Et
Et
H
H
O


73
Ph
2-MeS
6
n-Pr
n-Pr
H
Me
O


44
Ph
2-MeS
6
Me
c-Pr
H
Et
O


75
Ph
2-MeS
6
Me
CF3
H
i-Pr
N(Me)


76
NH2
2-Cl
6
Me
CH2═CHCH2
H
Et
O


77
NH2
2-MeS(O)2
6
Me
CH≡CCH2
H
c-Pr
O


78
NH2
2-MeS(O)2
6
Me
Ph
H
c-Hexyl
O


79
NH2
2-MeS(O)2
6
Me
2-Thienyl
H
H
O


80
NH2
2-MeS(O)2
6
Me
2-Furyl
H
H
S


81
N(Me)2
2-Cl
6
Me
2-Pyridyl
H
H
O


82
N(Me)2
2-NO2
6
Me
4-Piperidyl
H
H
O














83
N(Me)2
2-NO2
6
—CH2CH2CH2
H
H
O


84
N(Me)2
2-NO2
6
—CH2CH(Me)CH2
CF3
H
O


85
N(Me)2
2-NO2
6
—CH2CH2CH2CH2
H
H
S(O)


86
HN(Me)C(O)
2-Cl
6
—CH2CH2CH2CH2CH2
Me
H
O


87
HN(Me)C(O)
2,5-diMe
6
—CH2CH2—O—CH2CH2
H
H
O


88
HN(Me)C(O)
2,5-diMe
6
—CH2CH2—C(O)—CH2CH2
H
H
O


89
HN(Me)C(O)
2,5-diMe
6
—CH2CH2CH(OEt)CH2CH2
H
H
O


90
HN(Me)C(O)
2,5-diMe
6
—CH2CH2—N(Me)—CH2CH2
H
H
S(O)2















91
MeOC(O)
2-Cl
3
Me
Me
H
H
O


92
MeOC(O)
2,5-diCl
3
Et
Et
H
H
O


93
MeOC(O)
2,5-diCl
3
n-Pr
n-Pr
Me
Me
O


94
MeOC(O)
2,5-diCl
3
Me
c-Pr
c-Pr
Et
O


95
MeOC(O)
2,5-diCl
3
Me
CF3
c-Hexyl
i-Pr
NH


96
c-Pentyloxy
2-Cl
3
Me
CH2═CHCH2
H
c-Pr
O


97
c-Pentyloxy

3
Me
CH≡CCH2
H
c-Hexyl
O


98
c-Pentyloxy

3
Me
Ph
H
H
O


99
c-Pentyloxy

3
Me
2-Thienyl
H
H
O


100 
c-Pentyloxy

3
Me
2-Furyl
CF3
H
N(Me)







embedded image















TABLE 8









embedded image







Example of Compound (7)


















Position







No.
E
(R1)p
of A
R2
R3
R5
R7
R4


















1
H
2-Cl
3
Me
Me
H
H
H


2
H
2-Cl
3
Et
Et
CF3
H
H


3
H
2-Cl
3
n-Pr
n-Pr
H
H
H


4
H
2-Cl
3
Me
c-Pr
Me
H
H


5
H
2-Cl
3
Me
CF3
Ph
H
Me


6
Me
2-Cl
3
Me
CH2═CHCH2
PhCH2
H
H


7
Me
2-Cl
3
Me
CH≡CCH2
Tosyl
H
H


8
Me
2-Cl
3
Me
Ph
MeC(O)
H
H


9
Me
2-Cl
3
Me
2-Thienyl
PhC(O)
H
H


10
Me
2-Cl
3
Me
2-Furyl
CH2═CH
H
CF3


11
CF3
2-Cl
3
Me
2-Pyridyl
CH≡C
H
H


12
CF3
2-Cl
3
Me
4-Piperidyl
2-Pyridyl
H
H














13
CF3
2-Cl
3
—CH2CH2CH2
CH2
H
H


14
CF3
2-Cl
3
—CH2CH(Me)—CH2
CH2
Me
H


15
CF3
2-NH2
3
—CH2CH2CH2CH2
PhSO2
CF3
c-Pr


16
MeO
2-Cl
3
—CH2CH2CH2CH2CH2
N(Me)2SO2
i-Pr
H


17
MeO
2-Cl
3
—CH2CH2—O—CH2CH2
H
Me O
H


18
MeO
2-Cl
3
—CH2CH2—C(O)—CH2CH2
CF3
EtO
H


19
MeO
2-Cl
3
—CH2CH2CH(OEt)CH2CH2
H
H
H


20
MeO
2-Cl
3
—CH2CH2—N(Me)—CH2CH2
Me
H
NH2















21
Ph
2-Cl
3
Me
Me
MeOC(O)
Me
H


22
Ph
2-Cl
3
Et
Et
MeSC(O)
CF3
H


23
Ph
2-Cl
3
n-Pr
n-Pr
PhC(O)
i-Pr
H


24
Ph
2-Cl
3
Me
c-Pr
H2NC(O)
MeO
H


25
Ph
2-Cl
3
Me
CF3
PhC(O)
EtO
N(Me)


26
NH2
2-Cl
3
Me
CH2═CHCH2
CH2═CH
H
H


27
NH2
2-Me
3
Me
CH≡CCH2
CH≡C
H
H


28
NH2
2-Me
3
Me
Ph
2-Pyridyl
H
H


29
NH2
2-Me
3
Me
2-Thienyl
H
H
H


30
NH2
2-Me
3
Me
2-Furyl
MeSO2
H
Me


31
N(Me)2
2-Cl
3
Me
2-Pyridyl
PhSO2
H
H


32
N(Me)2
2-Me
3
Me
4-Piperidyl
N(Me)2SO2
H
H














33
N(Me)2
2-Me
3
—CH2CH2CH2
H
H
H


34
N(Me)2
2-Me
3
—CH2CH(Me)CH2
CF3
H
H


35
N(Me)2
2-Me
3
—CH2CH2CH2CH2
H
H
CF3


36
HN(Me)C(O)
2-Cl
3
—CH2CH2CH2CH2CH2
Me
H
H


37
HN(Me)C(O)
2-CF3
3
—CH2CH2—O—CH2CH2
Ph
H
H


38
HN(Me)C(O)
2-CF3
3
—CH2CH2—C(O)—CH2CH2
PhCH2
H
H


39
HN(Me)C(O)
2-CF3
3
—CH2CH2CH(OEt)CH2CH2
Tosyl
H
H


40
HN(Me)C(O)
2-CF3
3
—CH2CH2—N(Me)—CH2CH2
MeC(O)
H
c-Pr















41
MeOC(O)
2-Cl
3
Me
Me
PhC(O)
H
H


42
MeOC(O)
2-CF3
3
Et
Et
CH2═CH
H
H


43
MeOC(O)
2-CF3
3
n-Pr
n-Pr
CH≡C
H
H


44
MeOC(O)
2-CF3
3
Me
c-Pr
2-Pyridyl
H
H


45
MeOC(O)
2-CF3
3
Me
CF3
H
H
NH2


46
c-Pentyloxy
2-Cl
3
Me
CH2═CHCH2
MeSO2
H
H


47
c-Pentyloxy
2-OH
3
Me
CH≡CCH2
PhSO2
H
H


48
c-Pentyloxy
2-OH
3
Me
Ph
N(Me)2SO2
H
H


49
c-Pentyloxy
2-OH
3
Me
2-Thienyl
H
H
H


50
c-Pentyloxy
2-OH -
3
Me
2-Furyl
CF3
H
N(Me)


51
MeS
2-Cl
5
Me
Me
H
H
H


52
CN
2-MeO
5
Et
Et
CF3
Me
H


53
EtC(O)
2-MeO
5
n-Pr
n-Pr
H
CF3
H


54
2-Pyridyl
2-MeO
5
Me
c-Pr
Me
i-Pr
H


55
H
2-MeO
5
Me
CF3
Ph
MeO
Me


56
Me
2-Cl
5
Me
CH2═CHCH2
PhCH2
EtO
H


57
Me
2-CF3O
5
Me
CH≡CCH2
Tosyl
i-PrO
H


58
Me
2-CF3O
5
Me
Ph
MeC(O)
H
H


59
Me
2-CF3O
5
Me
2-Thienyl
PhC(O)
H
H


60
Me
2-CF3O
5
Me
2-Furyl
CH2═CH
H
CF3


61
CF3
2-Cl
5
Me
2-Pyridyl
CH≡C
H
H


62
CF3
2-CF3O
5
Me
4-Piperidyl
2-Pyridyl
H
H














63
CF3
2-CF3O
5
—CH2CH2CH2
H
H
H


64
CF3
2-CF3O
5
—CH2CH(Me)CH2
MeSO2
H
H


65
CF3
2-CF3O
5
—CH2CH2CH2CH2
PhSO2
H
c-Pr


66
MeO
2-Cl
5
—CH2CH2CH2CH2CH2
N(Me)2SO2
H
H


67
MeO
2-SH
5
—CH2CH2—O—CH2CH2
H
H
H


68
MeO
2-SH
5
—CH2CH2—C(O)—CH2CH2
CF3
H
H


69
MeO
2-SH
5
—CH2CH2CH(OEt)CH2CH2
H
H
H


70
MeO
2-SH
5
—CH2CH2—N(Me)—CH2CH2
Me
H
NH2















71
Ph
2-Cl
6
Me
Me
Ph
H
H


72
Ph
2-MeS
6
Et
Et
PhCH2
H
H


73
Ph
2-MeS
6
n-Pr
n-Pr
Tosyl
Me
H


44
Ph
2-MeS
6
Me
c-Pr
MeC(O)
CF3
H


75
Ph
2-MeS
6
Me
CF3
PhC(O)
i-Pr
N(Me)2


76
NH2
2-Cl
6
Me
CH2═CHCH2
CH2═CH
MeO
H


77
NH2
2-MeS(O)2
6
Me
CH≡CCH2
CH ≡C
EtO
H


78
NH2
2-MeS(O)2
6
Me
Ph
2-Pyridyl
i-PrO
H


79
NH2
2-MeS(O)2
6
Me
2-Thienyl
H
H
H


80
NH2
2-MeS(O)2
6
Me
2-Furyl
MeSO2
H
Me


81
N(Me)2
2-Cl
6
Me
2-Pyridyl
PhSO2
H
H


82
N(Me)2
2-NO2
6
Me
4-Piperidyl
N(Me)2SO2
H
H














83
N(Me)2
2-NO2
6
—CH2CH2CH2
H
H
H


84
N(Me)2
2-NO2
6
—CH2CH(Me)CH2
CF3
H
H


85
N(Me)2
2-NO2
6
—CH2CH2CH2CH2
H
H
CF3


86
HN(Me)C(O)
2-Cl
6
—CH2CH2CH2CH2CH2
Me
H
H


87
HN(Me)C(O)
2,5-diMe
6
—CH2CH2—O—CH2CH2
Ph
H
H


88
HN(Me)C(O)
2,5-diMe
6
—CH2CH2—C(O)—CH2CH2
PhCH2
H
H


89
HN(Me)C(O)
2,5-diMe
6
—CH2CH2CH(OEt)CH2CH2
Tosyl
H
H


90
HN(Me)C(O)
2,5-diMe
6
—CH2CH2—N(Me)—CH2CH2
MeC(O)
H
c-Pr















91
MeOC(O)
2-Cl
3
Me
Me
PhC(O)
H
H


92
MeOC(O)
2,5-diCl
3
Et
Et
CH2═CH
H
H


93
MeOC(O)
2,5-diCl
3
n-Pr
n-Pr
CH≡C
Me
H


94
MeOC(O)
2,5-diCl
3
Me
c-Pr
2-Pyridyl
CF3
H


95
MeOC(O)
2,5-diCl
3
Me
CF3
H
i-Pr
NH2


96
c-Pentyloxy
2-Cl
3
Me
CH2═CHCH2
MeSO2
MeO
H


97
c-Pentyloxy

3
Me
CH≡CCH2
PhSO2
EtO
H


98
c-Pentyloxy

3
Me
Ph
N(Me)2SO2
i-PrO
H


99
c-Pentyloxy

3
Me
2-Thienyl
H
H
H


100 
c-Pentyloxy

3
Me
2-Furyl
CF3
H
N(Me)2







embedded image















TABLE 9









embedded image







Example of Compound (8)

















Position






No.
E
(R1)p
of A
R2
R3
R4
R6

















1
H
2-Cl
3
Me
Me
H
CN


2
H
2-Cl
3
Et
Et
H
MeC(O)


3
H
2-Cl
3
n-Pr
n-Pr
H
PhC(O)


4
H
2-Cl
3
Me
c-Pr
H
MeOC(O)


5
H
2-Cl
3
Me
CF3
H
HN═CH


6
Me
2-Cl
3
Me
CH2═CHCH2
H
N(Me)═CH


7
Me
2-Cl
3
Me
CH≡CCH2
H
1-tetrazolyl


8
Me
2-Cl
3
Me
Ph
H
HC(O)


9
Me
2-Cl
3
Me
2-Thenyl
H
EtC(O)


10
Me
2-Cl
3
Me
2-Thienyl
H
EtC(O)


11
CF3
2-Cl
3
Me
2-Pyridyl
H
CN


12
CF3
2-Cl
3
Me
4-Piperidyl
H
MeC(O)













13
CF3
2-Cl
3
—CH2CH2CH2
H
PhC(O)


14
CF3
2-Cl
3
—CH2CH(Me)CH2
H
MeOC(O)


15
CF3
2-Cl
3
—CH2CH2CH2CH2
Me
HN═CH


16
MeO
2-NH2
3
—CH2CH2CH2CH2CH2
CF3
N(Me)═CH


17
MeO
2-Cl
3
—CH2CH2—O—CH2CH2
c-Pr
5-tetrazolyl


18
MeO
2-Cl
3
—CH2CH2—C(O)—CH2CH2
c-Hexyl
HC(O)


19
SMO
2-Cl
3
—CH2CH2CH(OEt)CH2CH2
NH2
EtC(O)


20
MeO
2-Cl
3
—CH2CH2—N(Me)—CH2CH2
N(Me)2
n-PrOC(O)














21
Ph
2-Cl
3
Me
Me
Me
CN


22
Ph
2-Cl
3
Et
Et
CF3
MeC(O)


23
Ph
2-Cl
3
n-Pr
n-Pr
c-Pr
PhC(O)


24
Ph
2-Cl
3
Me
c-Pr
c-Hexyl
MeOC(O)


25
Ph
2-Cl
3
Me
CF3
NH2
HN═CH


26
NH2
2-Cl
3
Me
CH2═CHCH2
N(Me)2
N(Me)═CH


27
NH2
2-Me
3
Me
CH≡CCH2
H
1-tetrazolyl


28
NH2
2-Me
3
Me
Ph
H
HC(O)


29
NH2
2-Me
3
Me
2-Thienyl
H
EtC(O)


30
NH2
2-Me
3
Me
2-Furyl
H
n-PrOC(O)


31
N(Me)2
2-Cl
3
Me
2-Pyridyl
H
CN


32
N(Me)2
2-Me
3
Me
4-Piperidyl
H
MeC(O)













33
N(Me)2
2-Me
3
—CH2CH2CH2
H
PhC(O)


34
N(Me)2
2-Me
3
—CH2CH(Me)CH2
H
MeOC(O)


35
N(Me)2
2-Me
3
—CH2CH2CH2CH2
H
HN═CH


36
HN(Me)C(O)
2-Cl
3
—CH2CH2CH2CH2CH2
H
N(Me)═CH


37
HN(Me)C(O)
2-CF3
3
—CH2CH2—O—CH2CH2
H
1-tetrazolyl


38
HN(Me)C(O)
2-CF3
3
—CH2CH2—C(O)—CH2CH2
H
HC(O)


39
HN(Me)C(O)
2-CF3
3
—CH2CH2CH(OEt)CH2CH2
H
EtC(O)


40
HN(Me)C(O)
2-CF3
3
—CH2CH2—N(Me)—CH2CH2
H
n-PrOC(O)














41
MeOC(O)
2-Cl
3
Me
Me
H
CN


42
MeOC(O)
2-CF3
3
Et
Et
H
MeC(O)


43
MeOC(O)
2-CF3
3
n-Pr
n-Pr
H
PhC(O)


44
MeOC(O)
2-CF3
3
Me
c-Pr
H
MeOC(O)


45
MeOC(O)
2-CF3
3
Me
CF3
Me
HN═CH


46
c-Pentyloxy
2-Cl
3
Me
CH2═CHCH2
CF3
N(Me)═CH


47
c-Pentyloxy
2-OH
3
Me
CH≡CCH2
c-Pr
5-tetrazolyl


48
c-Pentyloxy
2-OH
3
Me
Ph
c-Hexyl
HC(O)


49
c-Pentyloxy
2-OH
3
Me
2-Thienyl
NH2
EtC(O)


50
c-Pentyloxy
2-OH -
3
Me
2-Furyl
N(Me)2
n-PrOC(O)


51
MeS
2-Cl
5
Me
Me
H
CN


52
CN
2-MeO
5
Et
Et
H
MeC(O)


53
CF3C(O)
2-MeO
5
n-Pr
n-Pr
H
PhC(O)


54
2-Furyl
2-MeO
5
Me
c-Pr
H
MeOC(O)


55
H
2-MeO
5
Me
CF3
H
HN═CH


56
Me
2-Cl
5
Me
CH2═CHCH2
H
N(Me)═CH


57
Me
2-CF3O
5
Me
CH≡CCH2
H
1-tetrazolyl


58
Me
2-CF3O
5
Me
Ph
H
HC(O)


59
Me
2-CF3O
5
Me
2-Thienyl
H
EtC(O)


60
Me
2-CF3O
5
Me
2-Furyl
H
n-PrOC(O)


61
CF3
2-Cl
5
Me
2-Pyridyl
H
CN


62
CF3
2-CF3O
5
Me
4-Piperidyl
H
MeC(O)













63
CF3
2-CF3O
5
—CH2CH2CH2
Me
PhC(O)


64
CF3
2-CF3O
5
—CH2CH(Me)CH2
CF3
MeOC(O)


65
CF3
2-CF3O
5
—CH2CH2CH2CH2
c-Pr
HN═CH


66
MeO
2-Cl
5
—CH2CH2CH2CH2CH2
c-Hexyl
N(Me)═CH


67
MeO
2-SH
5
—CH2CH2—O—CH2CH2
NH2
1-tetrazolyl


68
MeO
2-SH
5
—CH2CH2—C(O)—CH2CH2
N(Me)2
HC(O)


69
MeO
2-SH
5
—CH2CH2CH(OEt)CH2CH2
H
EtC(O)


70
MeO
2-SH
5
—CH2CH2—N(Me)—CH2CH2
H
n-PrOC(O)














71
Ph
2-Cl
6
Me
Me
H
CN


72
Ph
2-MeS
6
Et
Et
H
MeC(O)


73
Ph
2-MeS
6
n-Pr
n-Pr
H
PhC(O)


74
Ph
2-MeS
6
Me
c-Pr
H
MeOC(O)


75
Ph
2-MeS
6
Me
CF3
H
HN═CH


76
NH2
2-Cl
6
Me
CH2═CHCH2
H
N(Me)═CH


77
NH2
2-MeS(O)2
6
Me
CH≡CCH2
H
5-tetrazolyl


78
NH2
2-MeS(O)2
6
Me
Ph
H
HC(O)


79
NH2
2-MeS(O)2
6
Me
2-Thienyl
H
EtC(O)


80
NH2
2-MeS(O)2
6
Me
2-Furyl
H
n-PrOC(O)


81
N(Me)2
2-Cl
6
Me
2-Pyridyl
H
CN


82
N(Me)2
2-NO2
6
Me
4-Piperidyl
H
MeC(O)













83
N(Me)2
2-NO2
6
—CH2CH2CH2
H
PhC(O)


84
N(Me)2
2-NO2
6
—CH2CH(Me)CH2
H
MeOC(O)


85
N(Me)2
2-NO2
6
—CH2CH2CH2CH2
H
HN═CH


86
HN(Me)C(O)
2-Cl
6
—CH2CH2CH2CH2CH2
H
N(Me)═CH


87
HN(Me)C(O)
2,5-diMe
6
—CH2CH2—O—CH2CH2
H
1-tetrazolyl


88
HN(Me)C(O)
2,5-diMe
6
—CH2CH2—C(O)—CH2CH2
H
HC(O)


89
HN(Me)C(O)
2,5-diMe
6
—CH2CH2CH(OEt)CH2CH2
H
EtC(O)


90
HN(Me)C(O)
2,5-diMe
6
—CH2CH2—N(Me)—CH2CH2
H
n-PrOC(O)














91
MeOC(O)
2-Cl
3
Me
Me
Me
CN


92
MeOC(O)
2,5-diCl
3
Et
Et
CF3
MeC(O)


93
MeOC(O)
2,5-diCl
3
n-Pr
n-Pr
c-Pr
PhO(O)


94
MeOC(O)
2,5-diCl
3
Me
c-Pr
c-Hexyl
MeOC(O)


95
MeOC(O)
2,5-diCl
3
Me
CF3
NH2
HN═CH


96
c-Pentyloxy
2-Cl
3
Me
CH2═CHCH2
N(Me)2
N(Me)═CH


97
c-Pentyloxy

3
Me
CH≡CCH2
H
1-tetrazolyl


98
c-Pentyloxy

3
Me
Ph
H
HC(O)


99
c-Pentyloxy

3
Me
2-Thienyl
Et
EtC(O)


100 
c-Pentyloxy

3
Me
2-Furyl
H
n-PrOC(O)







embedded image








2) Production Method of the Compound of the Present Invention

The compound of the present invention can be produced by a well-known method, and also can be produced by the method described in Examples. An example of the production method of the compound of the present invention will be described below.


In the compound of the present invention, the compound represented by formula (I), wherein Q is Q1, Q2 or Q3 described above, R5 is hydrogen atom, and G is oxygen atom, can be produced by the method described in the formula below.




embedded image


(In the formula, E, R1 to R4, R7 and p are as defined above, T represents a halogen atom, an elimination group such as imidazolyl group or the like).


In the compound of the present invention, the compound represented by formula (I), wherein Q is Q1, Q2, Q3 described above, R5 in Q1, Q2 and Q3 represents a group other than hydrogen atom, G is oxygen atom, can be produced by the method described in the formula below.




embedded image


(In the formula, E, R1 to R5, R7 and p are as defined above, W is an elimination group including a halogen atom such as fluorine atom, chlorine atom, bromine atom, iodine atom or the like; a sulfonyloxy group such as methane sulfonyloxy group, p-toluene sulfonyloxy group, trifluoromethane sulfonyloxy group or the like, an acyloxy group such as acetoxy group, benzoyloxy group or the like; and the like).


In the compound of the present invention, the compound represented by formula (I), wherein Q is Q1, Q2, Q3 described above, R5 in Q1, Q2 and Q3 represents a group other than hydrogen atom, G is sulfur atom, can be produced by the method described in the formula below.




embedded image


(In the formula, E, R1 to R5, R7, W and p are as defined above).


In the compound of the present invention, the compound represented by formula (I), wherein Q is a group represented by Q8, can be produced by the method described in the formula below,




embedded image


(In the formula, E, R1 to R4, R6 and p are as defined above).


In the compound of the present invention, the compound represented by formula (I), wherein Q is a group represented by Q6, G is oxygen atom, can be produced by the method described in the formula below.




embedded image


(In the formula, E, R1 to R3, R10, R11 and p are as defined above, R22 represent an alkyl group such as methyl group, ethyl group, n-propyl group, isopropyl group, t-butyl group or the like; a benzyl group; or a phenyl group, R23 and R24 each independently represents hydrogen atom, an alkyl group such as methyl group, ethyl group or the like; an alkoxy group such as methoxy group, ethoxy group, n-propoxy group or the like; a phenyl group; or a substituted or unsubstituted amino group such as amino group, dimethyl amino group, diethyl amino group or the like; provided that both R23 and R24 do not simultaneously represent an alkyl group and a phenyl group.


In the compound of the present invention, the compound represented by formula (I), wherein Q is a group represented by Q6, G is sulfur atom, can be produced by the method described in the formula below.




embedded image


(In the formula, E, R1 to R3, R11 and p are as defined above).


The compound represented by formula (III) which is a raw material can be produced by the method described in the formula below.




embedded image


(In the formula, E, R1 to R3, p and W are as defined above, R25 represents an alkyl group having 1 to 6 carbon atoms; a haloalkyl group having 1 to 6 carbon atoms; or a phenyl group which is optionally substituted by an alkyl group having 1 to 3 carbon atoms, a haloalkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 3 carbon atoms, an alkyl thio group having 1 to 3 carbon atoms, alkyl sulfonyl group having 1 to 3 carbon atoms, nitro group, cyano group, a halogen atom or the like; or the like).


Namely, the compound of the present invention can be produced by reacting benzoate ester (IX) with sulfoximine (X) by a well-known method to produce benzoate ester (IV), followed by hydrolyzing under the general hydrolysis conditions.


Benzoate ester (IX) which is a raw material can also be produced by a well-known method. In addition, this compound can also be synthesized by combining the general organic synthetic methods.


Sulfoximine (X) can also be synthesized by a well-known method.


In either of these reactions, if purification of the product is required after the completion of the reaction, known, commonly used purification means, such as distillation, recrystallization or column chromatography, can be employed following carrying out an ordinary post-treatment operation.


3) Herbicide

The compounds of the present invention (the compounds represented by formula (I) or salts thereof) exhibit high herbicidal activity in either soil treatment or foliar treatment under upland farming conditions; are effective on various upland weeds such as crabgrass, giant foxtail, velvetleaf, and pigweed; and also include compounds which exhibit selectivity toward crops such as corn, wheat or the like.


Moreover, the compounds of the present invention include compounds which exhibit plant growth-regulating activity such as retarding toward useful plants such as agricultural crops, ornamental plants, and fruit trees.


Additionally, the compounds of the present invention include compounds which have excellent exhibit herbicidal activity on various lowland weeds and which exhibit selectivity toward rice.


Furthermore, the compounds of the present invention can also be applied for controlling weeds in such places as fruit farms, lawns, railway track margins, and vacant lands.


The herbicide of the present invention includes one type, or two or more types of the compounds of the present invention as active ingredients. The herbicide of the present invention can be used in pure form without adding any other components to the compound of the present invention when applied practically, and also can be used, with an objective to use as agrochemicals, in the form which general agrochemicals may adopt, that is, wettable powder, granules, dusting powder, emulsifiable concentrates, water-soluble powder, suspending agent, flowable, or the like.


As additives and carriers, vegetable powders such as soy flour and wheat flour; fine mineral powder such as diatomaceous earth, apatite, gypsum, talc, bentonite, pyrophyllite, and clay; and organic and inorganic compounds such as sodium benzoate, urea, and sodium sulfate are used when solid formulation is required.


When a liquid formulation is required, petroleum fractions such as kerosene, xylene, and solvent naphtha, and cyclohexane, cyclohexanone, dimethylformamide, dimethyl sulfoxide, alcohol, acetone, trichloroethylene, methyl isobutyl ketone, mineral oil, vegetable oil, water, or the like, are used as a solvent.


Additionally, in order to achieve homogenous and stable forms in these formulations, it is also possible to add surfactants if necessary.


Although surfactants are not particularly limited, examples thereof include, for instance, nonionic surfactants such as alkylphenyl ether where polyoxyethylene is added, alkyl ether where polyoxyethylene is added, higher fatty acid ester where polyoxyethylene is added, sorbitan higher fatty acid ester where polyoxyethylene is added, and tristyryl phenyl ether where polyoxyethylene is added; sulfate ester of alkyl phenyl ether where polyoxyethylene is added, alkyl naphthalene sulfonate, polycarboxylate, lignin sulfonate, formaldehyde condensate of alkyl naphthalene sulfonate, and isobutylene-maleic anhydride copolymer.


Although concentrations of active ingredients in herbicides of the present invention vary depending on the aforementioned forms of formulation, in wettable powder for instance, the concentration of 5 to 90 weight % (hereinafter written simply as “%”) and preferably 10 to 85% is used; 3 to 70% and preferably 5 to 60% is used in emulsion; and 0.01 to 50% and preferably 0.05 to 40% is used in granules.


Wettable powder and emulsifiable concentrate obtained in this way, which are diluted to predetermined concentrations by water, are sprayed or mixed in soil as emulsion solution or suspension solution before or after the weed germination. When herbicides of the present invention are practically used, an adequate amount of active ingredients, which is 0.1 g or more per 1 hectare, is applied.


Herbicides of the present invention can also be used by mixing with known fungicides, insecticides, acaricides, other herbicides, plant growth regulators, fertilizers, antidotes or the like.


Especially, if it is used by mixing with the herbicides, the used amount of chemicals can be reduced.


In addition, not only labor saving but also a further higher effect can be expected due to synergism with mixed chemicals. In this case, combined use with a two or more of known herbicides is also possible.


Other active ingredients of the herbicide using in the present invention are not particularly limited. Examples of the active ingredients include the following (a) to (k).


(a) phenoxy type such as 2,4-D, 2,4-DB, 2,4-DP, MCPA, MCPB, MCPP, clomeprop or the like; aromatic carboxylic acid type such as 2,3,6-TBA, dicamba, chloramben, picloram, triclopyr, clopyralid, aminopyralid, fluoroxypyr or the like; others demonstrating their herbicidal effect by disturbance of plant hormone action, such as naptalam, benazolin, quinclorac, quinmerac, diflufenzopyr or the like;


(b) urea type such as chlorotoluron, diuron, fluometuron, linuron, isoproturon, tebuthiuron, isouron, siduron, chloroxuron, chlorobromuron, dimefuron, ethidimuron, fenuron, methabenzthiazuron, metobromuron, metoxuron, monolinuron, neburon or the like; triazine type such as simazine, atrazine, atratone, simetryn, prometryn, dimethametryn, hexazinone, metribuzin, metamitron, terbuthylazine, cyanazine, ametryn, cybutryne, propazine, desmetryne, prometon, terbumeton, terbutryne, trietazine or the like; uracil type such as bromacil, lenacil, terbacil or the like; anilide type such as propanil, pentanochlor or the like; carbamate type such as desmedipham, phenmedipham or the like; hydroxybenzonitrile type such as bromoxynil, ioxynil, bromofenoxim or the like; others demonstrating their herbicidal effect by inhibition of plant photosynthesis, such as pyridate, chloridazon, bentazon, amicarbazone, methazole, pyridafol or the like;


(c) quaternary ammonium salt type demonstrating their rapid herbicidal effect by allowing themselves to become a free radical and generate active oxygen, such as paraquat, diquat or the like;


(d) diphenyl ether type such a chlomethoxyfen, bifenox, acifluorfen-sodium, fomesafen, oxyfluorfen, lactofen, ethoxyfen-ethyl, fluoroglycofen-ethyl, halosafen or the like; cyclic imide type such as chlorphthalim, flumioxazin, flumiclorac-pentyl, cinidon-ethyl or the like; thiadiazole type such as fluthiacet-methyl, thidiazimin or the like; oxadiazole type such as oxadiargyl, oxadiazon or the like; triazolinone type such as azafenidin, sulfentrazone, carfentrazone-ethyl, bencarbazone or the like; phenyl pyrazole type such as fluazolate, pyraflufen-ethyl or the like; pyrimidine dione type such as benzfendizone, butafenacil or the like; others demonstrating their herbicidal effect by inhibition of chlorophyll biosynthesis to cause abnormal accumulation of photosensitized peroxidation in the plant body, such as pentoxazone, profluazol, pyrachlonil, flufenpyr-ethyl or the like;


(e) pyrazole type such as pyrazolynate, pyrazoxyfen, benzofenap, topramezone (BAS-670H), pyrasulfotole or the like; triketone type such as sulcotrione, mesotrione, tefuryltrione (AVH-301), tembotrione or the like; isoxazole type such as isoxaflutole, isoxachlortole or the like; others demonstrating their herbicidal effect by inhibition of biosynthesis of plant pigment such as carotenoid or the like to show whitening effect, such as amitrol, fluometuron, aclonifen, norflurazon, fluridone, flurtamone, diflufenican, clomazone, benzobicyclone, picolinafen, beflubutamid, fluorochloridone or the like;


(f) aryloxyphenoxypropionic acid type such as diclofop-methyl, flamprop-M-methyl, fluazifop-butyl, haloxyfop-methyl, quizalofop-ethyl, cyhalofop-butyl, fenoxaprop-ethyl, metamifop, clodinafop-propargyl, propaquizafop-P-ethyl or the like; cyclohexanedione type such as alloxydim-sodium, clethodim, sethoxydim, tralkoxydim, butroxydim, tepraloxydim, profoxydim, cycloxydim or the like; phenyl pyrazoline type such as pinoxaden or the like demonstrating their herbicidal effect by inhibition of acetyl-CoA carboxylase of plant;


(g) sulfonyl urea type such as chlorimuron-ethyl, sulfometuron-methyl, primisulfuron-methyl, bensulfuron-methyl, chlorsulfuron, metsulfuron-methyl, cinosulfuron, pyrazosulfuron-ethyl, azimsulfuron, flazasulfuron, rimsulfuron, nicosulfuron, imazosulfuron, cyclocyclosulfamuron, prosulfuron, flupyrsulfuron, halosulfuron-methyl, thifensulfuron-methyl, ethoxysulfuron, oxasulfuron, ethametsulfuron-methyl, iodosulfuron, sulfosulfuron, triasulfuron, tribenuron-methyl, tritosulfuron, foramsulfuron, trifloxysulfuron, mesosulfuron-methyl, orthosulfamuron, triflusulfuron-methyl, amidesulfuron, TH-547 or the like; triazolopyrimidine sulfonamide type such flumetsulam, metosulam, diclosulam, cloransulam-methyl, florasulam, metosulfam, penoxsulam, pyroxsulam or the like; imidazolinone type such as imazapyr, imazethapyr, imazaquin, imazamox, imazamethabenz, imazapic or the like; pyrimidinyl salicylic acid type such as pyrithiobac-sodium, bispyribac-sodium, pyriminobac-methyl, pyribenzoxim, pyriftalid, pyrimisulfan or the like; sulfonyl aminocarbonyl triazolinone type such as flucarbazone, propoxycarbazone, thiencarbazone-methyl or the like; others demonstrating their herbicidal effect by inhibition of plant amino-acid biosynthesis, such as glyphosate, glyphosate-ammonium, glyphosate-isopropylamine, sulfosate, glufosinate, glufosinate-ammonium, bilanafos or the like;


(h) dinitroaniline type such as trifluralin, oryzalin, pendimethalin, ethalfluralin, benfluralin, prodiamine, butralin, dinitramine or the like; benzamide type such as pronamide, tebutam or the like; organic phosphorus type such as amiprofos-methyl, butamifos or the like; phenyl carbamate type such as propham, chlorpropham, carbetamide or the like; pyridine type such as dithiopyr, thiazopyr or the like; others demonstrating their herbicidal effect by inhibition of plant cell mitosis, such as DCPA or the like;


(i) chloroacetamide type such as alachlor, metazachlor, butachlor, pretilachlor, metolachlor, S-metolachlor, thenylchlor, pethoxamid, acetochlor, propachlor, propisochlor, dimethenamid, dimethenamid-P, dimethachlor or the like; acetamide type such as diphenamid, napropamide, naproanilide or the like; oxyacetamide type such as flufenacet, mefenacet or the like; others demonstrating their herbicidal effect by inhibition of plant cell devision or inhibition of very long chain fatty acid biosynthesis such as fentrazamide, cafenstrole, indanofan, anilofos, piperophos or the like;


(j) thiocarbamate type such as molinate, dimepiperate, EPTC, butylate, cycloate, esprocarb, orbencarb, pebulate, prosulfocarb, thiobencarb, tiocarbazil, triallate, vernolate or the like; benzofuran type such as benfuresate, ethofumesate or the like; others demonstrating their herbicidal effect by inhibition of plant lipid biosynthesis, such as bensulide, TCA, dalapon, flupropanate or the like;


(k) other herbicides such as asulam, DNOC, dinoseb, dinoterb, flupoxam, dichlobenil, chlorthiamid, isoxaben, quinclorac, MSMA, DSMA, endothall, sodiumchlorate, pelargonic acid, fosamine, flamprop-isopropyl, difenzoquat, bromobutide, chlorflurenol, cinmethylin, cumyluron, dazomet, daimuron, methyl-dymron, etobenzanid, matam, oxaziclomefone, oleic acid, pyributicarb, pyroxasulfone (KIH-485), HOK-201 or the like.


EXAMPLES

Next, the present invention will be described in more detail using Examples and Reference examples. However, the present invention is not limited by Examples and Reference examples.


(1) Synthesis of Precursor
Reference Example 1
2-chloro-3-(1-oxothianylidene amino)terephthalic acid 4-methyl ester
Step 1) Synthesis of 2-chloro-3-dimethoxymethyl phenol

23.1 g of 2-chloro-3-hydroxybenzaldehyde was dissolved in 150 ml of methanol, and 20.2 g of orthoformic acid trimethyl was added to the resulting solution, followed by 0.5 ml of hydrochloric acid. The resulting reaction solution was heated under reflux for one night and concentrated under reduced pressure. 100 ml of sodium bicarbonate water was added to the residue, and extracted with 200 ml of ethyl acetate twice. The organic layer was washed with brine, dried with magnesium sulfate, filtered, concentrated to obtain 35.1 g (yield: 100%) of 2-chloro-3-dimethoxymethyl phenol which is colorless and oily.


Step 2) Synthesis of 4-bromo-2-chloro-3-hydroxybenzaldehyde

35.1 g of 2-chloro-3-dimethoxymethyl phenol was dissolved in 200 ml of chloroform, and 30 ml of chloroform solution of bromine including 23.5 g bromine was dropped slowly into the resulting solution under ice-cold conditions, followed by stirring for one night at room temperature. 300 ml of 5% aqueous sodium hydrogen sulfite solution was added to the resulting reaction solution under ice-cold conditions, and extracted with 300 ml of chloroform twice. The organic layer was washed with brine, dried with magnesium sulfate, filtered, concentrated to obtain 19.8 g (yield: 57.2%) of 4-bromo-2-chloro-3-hydroxybenzaldehyde which is slightly yellow and crystalline.


Step 3) Synthesis of 6-bromo-2-chloro-3-dimethoxymethyl phenol

10 g of 4-bromo-2-chloro-3-hydroxybenzaldehyde was dissolved in 66 ml of methanol, and 5.4 g of orthoformic acid trimethyl was added to the resulting solution, followed by catalyst quantity of hydrochloric acid. The resulting reaction solution was heated under reflux for one night and concentrated under reduced pressure. 50 ml of sodium bicarbonate water was added to the residue, and extracted with 100 ml of ethyl acetate twice. The organic layer was washed with brine, dried with magnesium sulfate, filtered, concentrated to obtain 12.6 g (yield: 100%) of 6-bromo-2-chloro-3-dimethoxymethyl phenol which is colorless and oily.


Step 4) Synthesis of 3-chloro-4-dimethoxymethyl-2-hydroxybenzoic acid methyl

4.0 g of 6-bromo-2-chloro-3-dimethoxymethyl phenol was dissolved in 35.5 ml of methanol, and 1.4 g of acetic acid sodium, 0.31 g of 1,1′-bis(diphenyl phosphino)ferrocene and 0.12 g of acetic acid(II)palladium were added to the resulting solution in autoclave. The autoclave was filled with carbon monoxide so that the inner pressure was 0.85 MPa, and the reaction solution was heated at 90 to 100° C. for 4 hours. After releasing the inner pressure, the resulting reaction solution was immersed in 50 ml of water, and extracted with 100 ml of ethyl acetate twice. The organic layer was washed with brine, dried with magnesium sulfate, filtered, concentrated to obtain 3.9 g (yield: 100%) of 3-chloro-4-dimethoxymethyl-2-hydroxybenzoic acid methyl which is oily and slightly yellow. The obtained compound was used to the next reaction without performing purification.


Step 5) Synthesis of 3-chloro-4-dimethoxymethyl-2-trifluoromethane sulfonyloxybenzoic acid methyl

The residue was dissolved in 30 ml of methylene chloride. In ice-cold conditions, 1.86 g of triethylamine and 4.4 g of trifluoromethane sulfonic acid anhydride were added to the resulting solution in this order. The resulting reaction solution was stirred at room temperature for one night, and concentrated under reduced pressure, then added with water, and extracted with 100 ml of ethyl acetate twice. The organic layer was washed with brine, dried with magnesium sulfate, filtered, and concentrated. The resulting residue was purified by silica gel column chromatography (eluent: ethyl acetate/n-hexane=1/9) to obtain 5.29 g (yield: 94.8%) of 3-chloro-4-dimethoxymethyl-2-trifluoromethane sulfonyloxybenzoic acid methyl which is colorless and oily.


Step 6) Synthesis of 3-chloro-4-dimethoxymethyl-2-(1-oxothianylidene amino)benzoic acid methyl

2.5 g of 3-chloro-4-dimethoxymethyl-2-trifluoromethane sulfonyloxybenzoic acid methyl was dissolved in 30 ml of toluene, and 1.10 g of 1-iminothiane-1-one, 3.10 g of cesium carbonate and 0.37 g of 4,5-bis(diphenyl phosphino)-9,9-dimethyl xanthene were added to the resulting solution. The reaction system was replaced with nitrogen gas after deaerating under reduced pressure. 0.29 g of tris(dibenzylidene acetone)dipalladium was added to the resulting solution under nitrogen atmosphere, and further sufficient nitrogen gas replacement was performed. The resulting reaction solution was heated under reflux for 3 hours. Next, the solution was cooled to room temperature, and added with 200 ml of ethyl acetate and 100 ml of water, filter the insoluble matter using Celite. Celite was washed with 100 ml of ethyl acetate and 100 ml of water, and extracted the solution. The organic layer was washed with brine, dried with magnesium sulfate, filtered, and concentrated. The residue was purified by silica gel column chromatography (eluent: ethyl acetate/n-hexane=2/1) to obtain 2.43 g (yield: 100%) of 3-chloro-4-dimethoxymethyl-2-(1-oxothianylidene amino)benzoic acid methyl which is yellow-colored and amorphous.


Step 7) Synthesis of 2-chloro-3-(1-oxothianylidene amino)terephthalic acid 4-methyl ester

3.49 g of 3-chloro-4-dimethoxymethyl-2-(1-oxothianylidene amino)benzoic acid methyl was dissolved in 23 ml of tetrahydrofuran, and 10% hydrochloric acid was added to the resulting solution. The solution was heated for 1.5 hours at 60° C. Next, the resulting reaction solution was cooled to room temperature and concentrated under reduced pressure. 100 ml of water was added to the residue, and extracted with 200 ml of ethyl acetate twice. The organic layer was washed with brine, dried with magnesium sulfate, filtered, and concentrated to obtain 3.03 g (yield: 99.8%) of 3-chloro-4-formyl-2-(1-oxothianylidene amino)benzoic acid methyl which is slightly yellow and amorphous. The obtained compound was used to the next reaction without performing purification.


3-chloro-4-formyl-2-(1-oxothianylidene amino)benzoic acid methyl was dissolved in 17 ml of tetrahydrofuran, and 18.6 ml of amide sulfuric acid aqueous solution including 1.15 g of amide sulfuric acid was dropped into the resulting solution under ice-cold conditions. The solution was stirred at the same temperature for 15 minutes, and 5 ml of sodium chlorite aqueous solution including 1.07 g of sodium chlorite was dropped into the solution. The solution was stirred at room temperature 1 hour. Next, 80 ml of water was added to the resulting reaction solution, and extracted with 150 ml of ethyl acetate twice. The organic layer was washed with 5% sodium bisulfite aqueous and brine, dried with magnesium sulfate, filtered, concentrated to obtain 1.96 g (yield: 56.6%) of 2-chloro-3-(1-oxothianylidene amino)terephthalic acid 4-methyl ester which is brown-colored and amorphous.


Reference Example 2
2-chloro-4-methoxymethyl-3-(1-oxothianylidene amino)benzaldehyde
Step 1) Synthesis of [3-chloro-4-dimethoxymethyl-2-(1-oxothianylidene amino)phenyl]methanol

1.84 g of 3-chloro-4-dimethoxymethyl-2-(1-oxothianylidene amino)benzoic acid methyl was dissolved in 26 ml of toluene. The resulting solution was cooled to −78° C., and 10.5 ml of 1.0 M toluene solution of diisobutyl aluminium hydride was slowly dropped into the solution. The resulting solution was stirred at the same temperature for 50 minutes, and stirred at 0° C. for 40 minutes, and further stirred at room temperature for 1.5 hours. Next, the resulting reaction solution was poured into ice, and the gel-like material generated was removed by Celite filtration, followed by washing the Celite with 200 ml of ethyl acetate. After concentrating the filtrate under reduced pressure, 100 ml of water added to the residue, and extracted with 200 ml of ethyl acetate twice. The organic layer was washed with brine, dried with magnesium sulfate, filtered, concentrated to obtain 1.37 g (yield: 82.0%) of [3-chloro-4-dimethoxymethyl-2-(1-oxothianylidene amino)phenyl]methanol which is colorless and amorphous. The obtained compound was used to the next reaction without performing purification.


Step 2) Synthesis of 2-chloro-4-methoxymethyl-3-(1-oxothianylidene amino)benzaldehyde

0.3 g of [3-chloro-4-dimethoxymethyl-2-(1-oxothianylidene amino)phenyl]methanol was dissolved in 5 ml of tetrahydrofuran, and 0.03 g of sodium hydrate was added to the resulting solution under ice-cold conditions, followed by stirring for 25 minutes. Next, the solution was added with 0.16 g of methyl iodide, and stirred at room temperature for one night. Next, 100 ml of water was added to the resulting reaction solution, and extracted with 30 ml of ethyl acetate twice. The organic layer was washed with brine, dried with magnesium sulfate, filtered, concentrated to obtain 0.38 g of (2-chloro-3-dimethoxymethyl-6-methoxymethyl phenyl)-(1-oxothianylidene)amine which is slight yellow and amorphous. The obtained compound was used to the next reaction without performing purification.


0.38 g of (2-chloro-3-dimethoxymethyl-6-methoxymethyl phenyl)-(1-oxothianylidene)amine was dissolved in 2.3 ml of tetrahydrofuran, and 0.9 ml of 10% hydrochloric acid was added to the resulting solution. The solution was heated at 60° C. for 1.5 hours. Next, the solution was cooled to room temperature, and concentrated under reduced pressure. 10 ml of water was added to the residue, and extracted with 30 ml of ethyl acetate twice. The organic layer was washed with brine, dried with magnesium sulfate, filtered, concentrated to obtain 0.3 g (yield: 100%) of 2-chloro-4-methoxymethyl-3-(1-oxothianylidene amino)benzaldehyde which is slightly yellow and amorphous.


Reference Example 3
2-chloro-4-cyano-3-hydroxybenzoic acid methyl
Step 1) Synthesis of 4-bromo-2-chloro-3-hydroxybenzoic acid methyl

5 g of 4-bromo-2-chloro-3-hydroxybenzaldehyde was dissolved in 30 ml of tetrahydrofuran, and 47.5 ml of amide sulfuric acid aqueous solution including 2.68 g of amide sulfuric acid was dropped into the resulting solution at room temperature. The solution was stirred at the same temperature for 20 minutes. 12 ml of sodium chlorite aqueous solution including 2.5 g of sodium chlorite was dropped into the resulting solution, and the solution was stirred at room temperature for 3.5 hours. Next, 80 ml of water added to the resulting reaction solution, and extracted with 200 ml of ethyl acetate twice. The organic layer was washed with 5% sodium bisulfate aqueous and brine, dried with magnesium sulfate, filtered, concentrated to obtain 5.8 g of 4-bromo-2-chloro-3-hydroxybenzoic acid which is slightly yellow and crystalline. The obtained compound was used to the next reaction without performing purification.


5.8 g of 4-bromo-2-chloro-3-hydroxybenzoic acid was dissolved in 120 ml of methanol, and 1 ml of sulfuric acid was added to the resulting solution. The solution was heated under reflux for 7.5 hours. Next, the resulting reaction solution was concentrated under reduced pressure, and 200 ml of saturated sodium bicarbonate water was added to the residue, and extracted with 300 ml of ethyl acetate twice. The organic layer was washed with brine, dried with magnesium sulfate, filtered, concentrated to obtain 4.99 g (yield: 88.6%) of 4-bromo-2-chloro-3-hydroxybenzoic acid methyl which is oily and slightly yellow.


Step 2) Synthesis of 4-bromo-2-chloro-3-methoxybenzoic acid methyl

4.5 g of 4-bromo-2-chloro-3-hydroxybenzoic acid methyl was dissolved in 18 ml of N,N-dimethyl formamide, and 2.8 g of potassium carbonate and 3.6 g of methyl iodide were added to the resulting solution at room temperature. The solution was stirred at room temperature for one night. Next, the resulting reaction solution was filtered using Celite and the obtained filtrate was concentrated under reduced pressure, 150 ml of water was added to the residue, and extracted with 250 ml of ethyl acetate twice. The organic layer was washed with brine, dried with magnesium sulfate, filtered, concentrated. The residue was purified by silica gel column chromatography (eluent: ethyl acetate/n-hexane=1/9) to obtain 4.36 g (yield: 92.2%) of 4-bromo-2-chloro-3-methoxybenzoic acid methyl which is oily and slightly yellow.


Step 3) Synthesis of 2-chloro-4-cyano-3-methoxybenzoic acid methyl

4.3 g of 4-bromo-2-chloro-3-methoxybenzoic acid methyl was dissolved to 76 ml of N,N-dimethyl acetamide, and 1.08 g of zinc cyanide, 0.70 g of tris(dibenzylidene acetone)dipalladium, and 0.72 g of 1,1′-bis(diphenyl phosphino)ferrocene were added to the resulting solution. The solution was heated under reflux for 2 hours. Next, the resulting reaction solution was cooled to room temperature, and filtered using Celite. Celite was washed with 200 ml of ethyl acetate, and the filtrate was concentrated under reduced pressure. 200 ml of water was added to the residue, and extracted with 300 ml of ethyl acetate twice. The organic layer was washed with brine, dried with magnesium sulfate, filtered, concentrated. The residue was purified by silica gel column chromatography (eluent: ethyl acetate/n-hexane=1/19) to obtain 3.08 g (yield: 89.2%) of 2-chloro-4-cyano-3-methoxybenzoic acid methyl which is slightly green and solid.


Step 4) Synthesis of 2-chloro-4-cyano-3-hydroxybenzoic acid methyl

2.68 g of 2-chloro-4-cyano-3-methoxybenzoic acid methyl was dissolved in 70 ml of methylene chloride, and 11.8 ml of 1.0 M boron tribromide-methylene chloride solution was slowly dropped into the resulting solution at −10° C. After dropping, the solution was stirred at 0° C. for 30 minutes, and stirred at room temperature for a whole day and night. Next, 80 ml of saturated sodium bicarbonate water was added to the resulting reaction solution, and extracted with 100 ml of chloroform. The water layer was acidized using hydrochloric acid, and extracted with 100 ml of chloroform twice. The organic layer was dried with magnesium sulfate, filtered, concentrated to obtain 1.42 g (yield: 56.8%) of 2-chloro-4-cyano-3-hydroxybenzoic acid methyl which is white and solid.


Reference Example 4
2-chloro-3-(1-oxothianylidene amino)-4-phenyl benzoic acid methyl

0.81 g of 4-bromo-2-chloro-3-(1-oxothianylidene amino)benzoic acid methyl was added to 10 ml of toluene, and replaced with nitrogen gas after deaerating under reduced pressure. 0.25 g of tetrakistriphenyl phosphine palladium was added to the resulting solution under nitrogen atmosphere, and further sufficient nitrogen gas replacement was performed. The resulting reaction solution was added to 0.52 g of phenyl boronic acid and 2 ml of 2M sodium carbonate aqueous solution, and heated under reflux for a whole day and night. Next, the solution was cooled to room temperature, and added to 200 ml of ethyl acetate and 100 ml of water to filter insoluble matter using Celite. Celite was washed with 300 ml of ethyl acetate and 300 ml of water, and extracted the solution. The organic layer was washed with brine, dried with magnesium sulfate, filtered, concentrated. The residue was purified by silica gel column chromatography (eluent: ethyl acetate/n-hexane=1/1) to obtain 0.57 g (yield: 71%) of 2-chloro-3-(1-oxothianylidene amino)-4-phenyl benzoic acid methyl which is yellow-colored and amorphous.


Reference Example 5
2,4-dimethyl-3-(1-oxothianylidene amino)benzoic acid

1.21 g of 4-bromo-2-methyl-3-(1-oxothianylidene amino)benzoic acid was added to 20 ml of dioxane, and replaced with nitrogen gas after deaeration under reduced pressure. 1.78 g of potassium carbonate and 0.39 g of tetrakistriphenyl phosphine palladium were added to the resulting solution, and further sufficient nitrogen gas replacement was performed. The resulting reaction solution was added with 0.81 g of trimethyl boroxin and heated under reflux for a whole day and night. Next, the solution was cooled to room temperature, and added with 200 ml of ethyl acetate and 100 ml of water and filtered insoluble matter using Celite. Celite was washed with 300 ml of ethyl acetate and 300 ml of water, and extracted the solution. The organic layer was washed with brine, dried with magnesium sulfate, filtered, concentrated. The residue was purified by silica gel column chromatography (eluent: ethyl acetate/n-hexane=1/1) to obtain 0.74 g (yield: 74%) of 2,4-dimethyl-3-(1-oxothianylidene amino)benzoic acid which is yellow-colored and amorphous.


(2) Synthesis of the Compound of the Present Invention
Example 1
2-chloro-1-[(5-hydroxy-1-methyl pyrazole-4-yl)carbonyl]-4-methoxy-3-(1-oxothianylidene amino)benzene
Step 1) Synthesis of 2-chloro-4-methoxy-3-(1-oxothianylidene amino)benzoic acid methyl



embedded image


4.52 g of 2-chloro-4-methoxy-3-(trifluoromethyl sulfonyloxy)benzoic acid methyl 1 was added with 1.90 g of 1-iminothiane-1-one, 5.07 g of cesium carbonate, 0.37 g of 4,5-bis(diphenyl phosphino)-9,9-dimethyl xanthene and 100 ml of toluene, and replaced with nitrogen gas after deaerating under reduced pressure. The resulting solution was added with 0.30 g of tris(dibenzylidene acetone)dipalladium under nitrogen atmosphere, and further sufficient nitrogen gas replacement was performed. The resulting reaction solution was heated under reflux for a whole day and night. Next, the solution was cooled to room temperature, and added with 200 ml of ethyl acetate and 100 ml of water and filtered insoluble matter using Celite. Celite was washed with 300 ml of ethyl acetate and 300 ml of water, and extracted the solution. The organic layer was washed with brine, dried with magnesium sulfate, filtered, concentrated. The residue was purified by silica gel column chromatography (eluent: ethyl acetate/n-hexane=3/7) to obtain 0.96 g (yield: 22%) of 2-chloro-4-methoxy-3-(1-oxothianylidene amino)benzoic acid methyl 2 which is yellow-colored and amorphous.


Step 2) Synthesis of 2-chloro-4-methoxy-3-(1-oxothianylidene amino)benzoic acid



embedded image


0.96 g of 2-chloro-4-methoxy-3-(1-oxothianylidene amino)benzoic acid methyl 2 was added with 15 ml of methanol to dissolve. The resulting solution was added with 15 ml of 1N sodium hydrate at room temperature and stirred at room temperature for a whole day and night to concentrate methanol (approximately 5 ml). The resulting solution was added with 50 ml of ice water and adjusted to pH 1 by concentrated hydrochloric acid, and extracted with 50 ml of ethyl acetate twice. The organic layer was washed with 30 ml of brine, dried with magnesium sulfate, filtered, concentrated to obtain 0.55 g (yield: 60%) of 2-chloro-4-methoxy-3-(1-oxothianylidene amino)benzoic acid 3 which is white and crystalline.


Step 3) Synthesis of 2-chloro-1-[(5-hydroxy-1-methyl pyrazole-4-yl)carbonyl]-4-methoxy-3-(1-oxothianylidene amino)benzene



embedded image


0.45 g of 2-chloro-4-methoxy-3-(1-oxothianylidene amino)benzoic acid 3 was added to 10 ml of chloroform, 0.37 g of 1,1′-carbonyl diimidazole in this order at room temperature. The resulting solution was stirred at room temperature for 1 hour. After ripening, the resulting solution was added with 0.17 g of N-methylpyrazolone and 0.17 g of triethylamine, and heated under reflux for 1 hour. Next, the resulting reaction solution was cooled and the solvent was concentrated. The residue was added with 10 ml of acetonitrile, 0.01 g of acetone cyanohydrin and 0.36 g of triethylamine, and stirred at room temperature for a whole day and night. Next, the insoluble matter was filtered, and the filtrate was concentrated. The residue was dissolved in 100 ml of chloroform, and washed with 100 ml of 1N hydrochloric acid, followed by water (100 ml). The organic layer was dried with magnesium sulfate, filtered, concentrated. The residue was purified by silica gel column chromatography (eluent: chloroform/methanol=19/1) to obtain 0.31 g (m.p. 89-91° C., yield: 55%) of 2-chloro-1-[(5-hydroxy-1-methyl pyrazole-4-yl)carbonyl)-4-methoxy-3-(1-oxothianylidene amino)benzene 5 which is white and crystalline.


Example 2
2-chloro-4-methoxy-1-{[1-methyl-5-(2-naphthyl methoxy)pyrazole-4-yl]carbonyl}-3-(1-oxothianylidene amino)benzene



embedded image


0.20 g of 2-chloro-1-[(5-hydroxy-1-methyl pyrazole-4-yl)carbonyl]-4-methoxy-3-(1-oxothianylidene amino)benzene 5 was dissolved in 2 ml of N,N-dimethyl formamide, and 0.08 g of potassium carbonate was added to the resulting solution. The solution was added with 0.12 g of 2-naphthyl methyl bromide, and stirred at room temperature for 1 hour. Water and ethyl acetate were added in the resulting reaction solution, and the organic layer was washed with brine, dried with magnesium sulfate, filtered, concentrated. The residue was purified by silica gel column chromatography (eluent: ethyl acetate/n-hexane=3/7) to obtain 0.11 g (yield: 41%) of 2-chloro-4-methoxy-1-{[1-methyl-5-(2-naphthyl methoxy)pyrazole-4-yl]carbonyl}-3-(1-oxothianylidene amino)benzene 6 which is white and amorphous. NMR of the obtained compound is shown below:



1H-NMR (CDCl3): 1.66 (m, 2H), 2.11 (m, 4H), 3.19 (m, 2H), 3.35 (m, 2H), 3.51 (s, 3H), 3.90 (s, 3H), 5.70 (s, 2H), 6.82 (d, 1H), 7.01 (d, 1H), 7.34 (s, 1H), 7.49-7.55 (m, 3H), 7.80-7.86 (m, 4H)


Examples 3 to 260

The following compounds were synthesized by well-known production methods as Example 1.











TABLE 65





Example
Structural formula
Physical property







3


embedded image


amorphous 1H-NMR(CDCl3): 1.63 (m, 2H), 2.06 (m, 6H), 2.43(t, 2H), 2.74(t, 2H), 3.16 (m, 2H), 3.31 (m, 2H), 3.88 (s, 3H), 6.83(d, 1H), 6.86 (d, 1H)





4


embedded image


m.p.: 137-139





5


embedded image


m.p.: 154-156





6


embedded image


amorphous 1H-NMR (CDCl3): 1.21 (t, 3H), .66 (m, 2H), 2.11 (m, 4H), 3.20 (m, 2H); 3.36 (m, 2H), 3.89 (q, 2H), 3.90 (s; 3H), 5.70 (s,2H), 6.82 (d, 1H),7.02 (d, 1H), 7.36 (s,1H), 7.47-7.56 (m, 3H), 7.80-7.87 (m, 4H)





7


embedded image


amorphous 1H-NMR (CDCl3): 2.04 (m, 2H), 2.44 (t, 2H), 2.75 (t, 2H), 3.28(m, 2H), 3.43(m, 2H), 3.89 (s, 3H), 4.17 (m, 4H), 6.85 (d, 1H), 6.88 (d, 1H)





8


embedded image


amorphous 1H-NMR (CDCl3): 3.32 (m, 2H), 3.46 (m, 2H), 3.70 (s, 3H), 3.93(s, 3H), 4.20 (m, 4H), 6.87 (d, 1H), 7.14 (d, 1H),7.43 (s, 1H)





9


embedded image


amorphous 1H-NMR (CDCl3): 3.31 (m, 2H), 3.48 (m, 2H), 3.52 (s, 3H), 3.91 (s, 3H), 4.16 (m, 4H), 5.70 (s, 2H), 6.84 (d, 1H), 7.03 (d, 1H), 7.35 (s, 1H), 7.47-7.55 (m, 3H), 7.80-7.87 (m, 4H)





10


embedded image


amorphous 1H-NMR (CDCl3): 1.11 (d, 3H), 1.64 (m, 2H), 2.11 (m, 6H), 2,47(m, 2H), 2.78 (m, 1H), 3.17 (m, 2H), 3.31 (m, 2H), 3,88 (s, 3H), 6.83 (d, 1H), 6.86 (d, 1H)?


















TABLE 66







11


embedded image


amorphous 1H-NMR (CDCl3): 1.44 (t, 6H), 2.03 (m, 2H), 2.43 (t, 2H), 2.74 (t, 2H), 3.22 (m, 4H), 3.88 (s, 3H), 6.82 (d, 1H), 6.88 (d, 1H)





12


embedded image


m.p.: 88-90





13


embedded image


amorphous 1H-NMR (CDCl3): 1.50 (t, 3H), 1.65 (m, 2H), 2.13 (m, 4H), 3.19 (m, 2H), 3.38 (m, 2H), 3.51 (s, 3H), 4.13 (q, 2H), 5.69 (s, 2H), 6.80 (d, 1H), 6.98 (d, 1H), 7.35 (s, 1H), 7.47-7.55 (m, 3H), 7.80-7.86 (m, 4H)





14


embedded image


amorphous 1H-NMR (CDCl3): 1.44 (t, 6H), 2.03 (m, 2H), 2.43 (t, 2H), 2.74 (t, 2H), 3.22 (m, 4H), 3.88 (s, 3H), 6.82 (d, 1H), 6.88 (d, 1H)





15


embedded image


amorphous 1H-NMR (CDCl3) 1.39 (d, 6H), 1.61 (m, 2H), 2.08 (m, 6H), 2.43 (t, 2H), 2.73 (t, 2H), 3.15 (m, 2H), 3.36 (m, 2H), 4.62 (m, 1H), 6.81 (d, 1H), 6.84 (d, 1H)





16


embedded image


m.p.: 139-141





17


embedded image


amorphous 1H-NMR (CDCl3) 1.41 (d, 6H), 1.64 (m, 2H), 2.10 (m, 4H), 3.18 (m, 2H), 3.37 (m, 2H), 3.51 (s, 3H), 4.65 (m, 1H), 5.69 (s, 2H), 6.81 (d, 1H), 6.97 (d, 1H), 7.35 (s, 1H), 7.46-7.55 (m, 3H), 7.80- 7.86 (m, 4H)





18


embedded image


amorphous 1H-NMR (CDCl3): 1.78 (m, 2H), 2.06 (m, 2H), 2.17 (m, 2H), 3.28 (m, 4H), 3.51 (s, 3H), 4.63 (br, 2H), 5.46 (s, 2H), 6.60 (d, 1H), 6.99 (d, 1H), 7.37 (m, 5H), 7.39 (s, 1H)


















TABLE 67







19


embedded image


amorphous 1H-NMR (CDCl3): 1.58 (m, 1H), 1.79 (m, 1H), 2.03 (m, 4H), 3.28 (m, 4H), 3.53 (s, 3H), 5.64 (s, 2H), 6.60 (d, 1H), 6.98 (d, 1H), 7.38 (s, 1H), 7.48-7.52 (m, 3H), 7.79-7.85 (m, 4H)





20


embedded image


amorphous 1H-NMR (CDCl3): 1.62 (m, 2H), 2.05 (m, 4H), 2.80 (s, 6H), 3.22 (m, 4H), 3.51 (s, 3H), 5.69 (s, 2H), 6.89 (d, 1H), 7.02 (d, 1H), 7.36 (s, 1H), 7.48-7.55 (m, 3H), 7.80-7.86 (m, 4H)





21


embedded image


m.p.: 204-206





22


embedded image


amorphous 1H-NMR (CDCl3): 1.52 (m, 1H), 1.83 (m, 1H), 2.13 (m, 4H), 2.99 (d, 3H), 3.21 (m, 4H), 3.70 (s, 3H), 7.18 (d, 1H), 7.33 (s, 1H), 7.37 (br, 1H), 7.81 (d, 1H)





23


embedded image


m.p.: 166-168





24


embedded image


amorphous 1H-NMR (CDCl3): 1.30 (m, 1H), 1.63 (m, 1H), 1.89 (m, 4H), 2.77 (m, 4H), 3.71 (s, 3H), 7.19 (d, 1H), 7.27-7.57(m, 7H)





25


embedded image


m.p.: 147-149


















TABLE 68





Example
Structural formula
Physical property







26


embedded image


m.p.: 69-73





27


embedded image


amorphous 1H-NMR (CDCl3) 1.28 (m, 4H), 1.43 (t, 6H), 2.34 (m, 1H), 3.20 (q, 4H), 3.89 (s, 3H), 7.07 (d, 1H), 7.57 (d, 1H)





28


embedded image


amorphous 1H-NMR (CDCl3) 1.30 (m, 2H), 1.45 (m, 2H), 2.34 (m, 1H), 3.25 (m, 2H), 3.45 (m, 2H), 3.90 (s, 3H), 4.15 (m, 2H), 4.33 (m, 2H), 7.12 (d, 1H), 7.65 (d, 1H)





29


embedded image


amorphous 1H-NMR (CDCl3) 3.22 (m, 2H), 3.44 (m, 2H), 3.52 (s, 3H), 3.90 (s, 3H), 4.14 (m, 2H), 4.32 (m, 2H), 5.74 (s, 2H), 7.05 (d, 1H), 7.25 (s, 1H), 7.47-7.60 (m, 3H), 7.65 (d, 1H), 7.78-7.88 (m, 4H)


















TABLE 69





Example
Structural formula
Physical property







30


embedded image


m.p.: 201-203





31


embedded image


amorphous 1H-NMR (CDCl3) 1.20 (t, 3H), 1.79 (m, 2H), 2.11 (m, 4H), 3.25 (m, 4H), 3.80-3.95 (m, 5H), 5.75 (s, 2H), 7.03 (d, 1H), 7.24 (s, 1H), 7.47-7.63 (m, 4H), 7.79-7.89 (m, 4H)





32


embedded image


amorphous 1H-NMR (CDCl3) 1.59 (m, 1H), 1.75 (m, 1H), 2.10 (m, 6H), 2.41 (t, 2H), 2.77 (t, 2H), 3.22 (m, 4H), 3.88 (s, 3H), 6.84 (d, 1H), 7.58 (d, 1H)





33


embedded image


amorphous 1H-NMR (CDCl3) 1.70 (m, 2H), 2.10 (m, 4H), 3.25 (m, 4H), 3.52 (s, 3H), 3.91 (s, 3H), 5.75 (s, 2H), 7.03 (d, 1H), 7.24 (s, 1H), 7.45-7.65 (m, 4H), 7.80-7.90 (m, 4H)


















TABLE 70







34


embedded image


amorphous 1H-NMR (CDCl3) 1.62 (m, 2H), 1.78-2.17 (m, 12H), 2.43 (t, 2H), 2.73 (t, 2H), 3.13 (m, 2H), 3.32 (m, 2H), 4.82 (m, 1H), 6.79 (d, 1H), 6.84 (d, 1H)





35


embedded image


m.p.: 112-113





36


embedded image


amorphous 1H-NMR (CDCl3): 1.55 (m, 1H), 1.85 (m, 1H), 2.12 (m, 4H), 2.48 (s, 3H), 3.27 (m, 4H), 3.70 (s, 3H), 7.06 (d, 1H), 7.18 (d, 1H), 7.38 (s, 1H)





37


embedded image


amorphous 1H-NMR (CDCl3): 1.27 (m, 2H), 1.43 (m, 2H), 1.54 (m, 1H), 1.83 (m, 1H), 2.15 (m, 4H), 2.38 (m, 1H), 3.08 (m, 2H), 3.43 (m, 2H), 7.03 (d, 1H), 7.21 (t, 1H), 7.49 (d, 1H)





38


embedded image


amorphous 1H-NMR (CDCl3) 1.55 (m, 1H), 1.78 (m, 1H), 2.10 (m, 6H), 2.42 (t, 2H), 2.76 (t, 2H), 3.06 (m, 2H), 3.42 (m, 2H), 6.79 (d, 1H), 7.16 (t, 1H), 7.39 (d, 1H)





39


embedded image


m.p.: 177-179





40


embedded image


amorphous 1H-NMR (CDCl3): 1.57 (m, 1H), 1.80 (m, 1H), 2.11 (m, 4H), 3.08 (m, 2H), 3.43 (m, 2H), 3.51 (s, 3H), 5.73 (s, 2H), 6.97 (d, 1H), 7.19 (t, 1H), 7.31 (s, 1H), 7.44-7.56 (m, 4H), 7.81-7.87 (m, 4H)


















TABLE 71







41


embedded image


m.p.: 178-180





42


embedded image


m.p.: 157-159





43


embedded image


amorphous 1H-NMR (CDCl3): 1.59 (m, 1H), 1.80 (m, 1H), 2.14 (m, 4H), 2.44 (s, 3H), 3.34 (m, 4H), 3.52 (s, 3H), 5.70 (s, 2H), 7.00 (d, 1H), 7.07 (d, 1H), 7.33 (s, 1H), 7.47-7.54 (m, 3H), 7.80-7.86 (m, 4H)





44


embedded image


m.p. 192-196





45


embedded image


amorphous 1H-NMR (CDCl3): 1.65 (m, 1H), 1.78 (m, 1H), 2.19 (m, 4H), 3.35 (m, 4H), 3.52 (s, 3H), 5.74 (s, 2H), 7.03 (d, 1H), 7.25 (s, 1H), 7.48-7.60 (m, 4H), 7.80-7.90 (m, 4H)





46


embedded image


amorphous 1H-NMR (CDCl3): 1.37 (t, 3H), 1.62 (m, 2H), 2.09 (m, 6H), 2.41 (t, 2H), 2.76 (t, 2H), 3.22 (m, 4H), 4.34 (q, 2H), 6.84 (d, 1H), 7.57 (d, 1H)





47


embedded image


m.p. 88-91





48


embedded image


amorphous 1H-NMR (CDCl3): 1.39 (t, 3H), 1.45 (t, 3H), 1.55-1.78 (m, 2H), 2.00-2.25 (m, 4H), 3.10-3.35 (m, 4H), 4.06 (q, 2H), 4.37 (q, 2H), 7.10 (d, 1H), 7.33 (s, 1H), 7.61 (d, 1H)


















TABLE 72







49


embedded image


m.p. 145-148





50


embedded image


viscous oil 1H-NMR (CDCl3): 1.40 (t, 3H), 1.67 (m, 2H), 2.15 (m, 4H), 3.24 (m, 4H), 3.51 (s, 3H), 4.37 (q, 2H), 5.75 (s, 2H), 7.02 (d, 1H), 7.25 (s, 1H), 7.45-7.65 (m, 4H), 7.80-7.89 (m, 4H)





51


embedded image


viscous oil 1H-NMR (CDCl3): 1.20 (t, 3H), 1.40 (t, 3H), 1.55 (m, 2H), 2.15 (m, 4H), 3.25 (m, 4H), 3.89 (q, 2H), 4.37 (q, 2H), 5.75 (s, 2H), 7.03 (d, 1H), 7.26 (s, 1H), 7.47-7.63 (m, 4H), 7.80-7.89 (m, 4H)





52


embedded image


m.p. 78-82


















TABLE 73





Example
Structural formula
Physical property







53


embedded image


1H-NMR (CDCl3) 1.55 (m, 1H), 1.89 (m, 1H), 2.14 (m, 4H), 2.31 (s, 3H), 2.43 (s, 3H), 3.26 (m, 4H), 3.62 (s, 3H), 6.87 (d, 1H), 7.11 (d, 1H)





54


embedded image


1H-NMR (CDCl3) 1.52 (m, 1H), 1.86 (m, 1H), 2.10 (m, 4H), 2.38 (s, 3H), 2.43 (s, 3H), 3.05 (m, 2H), 3.21 (m, 2H), 3.54 (s, 3H), 5.65 (s, 2H), 6.97 (d, 1H), 7.07 (d, 1H), 7.33 (s, 1H), 7.49-7.53 (m, 3H), 7.79-7.86 (m, 4H)





55


embedded image


m.p. 98-105





56


embedded image


m.p. 145-147


















TABLE 74





Example
Structural formula
Physical property







57


embedded image


1H-NMR (CDCl3) 0.63 (m, 2H), 0.78 (m, 2H), 1.65 (m, 3H), 2.09 (m, 4H), 3.15 (m, 2H), 3.31 (m, 2H), 3.39 (s, 3H), 3.86 (s, 3H), 5.26 (s, 2H), 6.79 (d, 1H), 7.03 (d, 1H), 7.41 (dd, 1H), 7.48-7.51 (m, 2H), 7.70-7.84 (m, 4H)





58


embedded image


1H-NMR (CDCl3) 1.39 (d, 6H), 1.68 (m, 2H), 2.12 (m, 4H), 3.25 (m, 4H), 3.69 (s, 3H), 5.24 (m, 1H), 7.08 (d, 1H), 7.32 (s, 1H), 7.58 (d, 1H)





59


embedded image


1H-NMR (CDCl3) 1.38 (d, 6H), 1.45 (t, 3H), 1.67 (m, 2H), 2.14 (m, 4H), 3.25 (m, 4H), 4.05 (q, 2H), 5.23 (m, 1H), 7.09 (d, 1H), 7.33 (s, 1H), 7.58 (d, 1H)


















TABLE 75





Example
Structural formula
Physical property







60


embedded image


1H-NMR (CDCl3) 1.61 (m, 1H), 1.85 (m, 1H), 2.08 (m, 2H), 2.18 (m, 2H), 2.22 (s, 3H), 3.26 (m, 4H), 3.53 (s, 3H), 5.69 (s, 2H), 7.11 (d, 1H), 7.33 (s, 1H), 7.48-7.54 (m, 3H), 7.80-7.86 (m, 4H), 8.36 (d, 1H), 8.74(br, 1H)





61


embedded image


1H-NMR (CDCl3) 1.33 (d, 6H), 1.57 (m, 1H), 1.75 (m, 1H), 1.95-2.10 (m, 2H), 2.09 (m, 4H), 2.41 (t, 2H), 2.76 (t, 2H), 3.25 (m, 4H), 5.21 (m, 1H), 6.84 (d, 1H), 7.55 (d, 1H)





62


embedded image


1H-NMR (CDCl3) 1.60 (m, 1H), 1.86 (m, 1H), 2.08 (m, 2H), 2.23 (m, 2H), 2.24 (s, 3H), 3.28 (m, 4H), 3.74 (s, 3H), 5.94 (br.s, 2H), 7.21 (d, 1H), 7.41 (s, 1H), 8.38 (d, 1H), 8.79 (br.s, 1H)


















TABLE 76





Example
Structural formula
Physical property







63


embedded image


1H-NMR (CDCl3) 1.26 (t, 3H), 1.65 (m, 2H), 1.76 (d, 3H), 2.10 (m, 4H), 3.18 (m, 2H), 3.34 (m, 2H), 3.70 (s, 3H), 3.90 (s, 3H), 4.12 (q, 2H), 6.67 (q, 1H), 6.82 (d, 1H), 7.03 (d, 1H), 7.41 (s, 1H)





64


embedded image


1H-NMR (CDCl3) 1.64 (m, 2H), 2.11 (m, 4H), 2.90 (s, 3H), 3.09 (s, 3H), 3.23 (m, 4H), 3.68 (s, 3H), 7.10 (d, 1H), 7.21 (d, 1H), 7.33 (s, 1H)





65


embedded image


m.p. 152-155





66


embedded image


m.p. 95-97


















TABLE 77





Example
Structural formula
Physical property







67


embedded image


1H-NMR (CDCl3) 1.58 (m, 2H), 2.02 (m, 4H), 3.11 (m, 2H), 3.25 (m, 2H), 3.51 (s, 3H), 5.15 (s, 2H), 5.70 (s, 2H), 6.87 (d, 1H), 6.97 (d, 1H), 7.34-7.43 (m, 4H), 7.49-7.56 (m, 5H), 7.81-7.86 (m, 4H)





68


embedded image


1H-NMR (CDCl3) 1.26 (t, 3H), 1.61 (m, 1H), 1.88 (m, 1H), 2.09 (m, 2H), 2.22 (m, 2H), 2.47 (q, 2H), 3.29 (m, 4H), 3.70 (s, 3H), 7.22 (d, 1H), 7.41 (s, 1H), 8.42 (d, 1H), 8.76 (br, 1H)





69


embedded image


m.p. 158-164





70


embedded image


1H-NMR (CDCl3) 1.53 (m, 1H), 1.81 (m, 1H), 2.12 (m, 4H), 3.24 (m, 4H), 3.65 (s, 3H), 4.00-4.18 (m, 4H), 6.27 (s, 1H), 7.11 (d, 1H), 7.29 (s, 1H), 7.55 (d, 1H)


















TABLE 78





Example
Structural formula
Physical property







71


embedded image


1H-NMR (CDCl3) 1.65 (m, 2H), 1.92 (m, 4H), 1.90-2.10 (m, 4H), 2.79-3.10 (m, 4H), 3.20-3.45 (m, 4H), 3.61 (m, 4H), 3.69 (s, 3H), 7.11 (d, 1H), 7.25 (s, 1H), 7.34 (d, 1H)





72


embedded image


1H-NMR (CDCl3) 1.58 (m, 1H), 1.88 (m, 1H), 2.10-2.25 (m, 4H), 3.29 (m, 4H), 3.70 (s, 3H), 3.80 (s, 3H), 7.23 (d, 1H), 7.42 (s, 1H), 8.18 (d, 1H), 8.30 (br, 1H)





73


embedded image


1H-NMR (CDCl3) 1.50-1.80 (m, 4H), 1.64 (m, 2H), 2.03 (m, 4H), 1.90-2.30 (m, 2H), 3.10-3.45 (m, 4H), 3.22 (m, 4H), 3.51 (br.d, 1H), 3.69 (s, 3H), 3.87 (br.d, 1H), 7.10 (d, 1H), 7.19 (d, 1H), 7.35 (s, 1H)





74


embedded image


m.p. 210-215


















TABLE 79





Example
Structural formula
Physical property







75


embedded image


1H-NMR (CDCl3) 1.65 (m, 2H), 2.05 (m, 6H), 2.44 (t, 2H), 2.72 (t, 2H), 3.15 (m, 2H), 3.29 (m, 2H), 3.93 (s, 3H), 6.88 (d, 1H), 6.92 (d, 1H)





76


embedded image


m.p. 179-181





77


embedded image


m.p. 190-192





78


embedded image


1H-NMR (CDCl3) 1.67 (m, 2H), 2.10 (m, 4H), 3.17 (m, 2H), 3.33 (m, 2H), 3.53 (s, 3H), 3.93 (s, 3H), 5.57 (s, 2H), 6.87 (d, 1H), 7.12 (d, 1H), 7.45-7.52 (m, 3H), 7.54 (s, 1H), 7.75-7.84 (m, 4H)


















TABLE 80





Example
Structural formula
Physical property







79


embedded image


1H-NMR (CDCl3) 1.23 (t, 3H), 1.65 (m, 2H), 10 (m, 4H), 3.17 (m, 2H), 33 (m, 2H), 3.91 (q, 2H), 3.94 (s, 3H), 5.57 (s, 2H), 6.87 (d, 1H), 7.14 (d, 1H), 7.45-7.52 (m, 3H), 7.55 (s, 1H), 7.75-7.87 (m, 4H)





80


embedded image


1H-NMR (CDCl3) 1.64 (m, 2H), 2.09 (m, H), 2.41 (s, 3H), 3.17 (m, 2H), 3.31 (m, 2H), 3.88 (s, 3H), 3.90 (s, 3H), 6.06 (s, 2H), 6.79 (d, 1H), 6.95 (d, 1H), 7.30 (s, 1H), 7.25-7.29 (m, 3H), 7.81 (d, 2H)





81


embedded image


1H-NMR (CDCl3) 1.68 (m, 2H), 2.15 (m, 4H), 3.24 (m, 4H), 3.66 (s, 3H), 3.90 (s, 3H), 7.01 (d, 1H), 7.24 (s, 1H), 7.62 (d, 1H)





82


embedded image


1H-NMR (CDCl3) 1.58 (m, 1H), 1.82 (m, 1H), 2.10 (m, 4H), 2.40 (s, 3H), 3.20 (m, 4H), 3.69 (s, 3H), 3.89 (s, 3H), 7.10 (d, 1H), 7.33 (s, 1H), 7.53 (d, 1H)


















TABLE 81





Example
Structural formula
Physical property







83


embedded image


m.p. 64-68





84


embedded image


1H-NMR(CDCl3) 1.58(m, 1H), 1.72(m, 1H), 2.07(m, 4H), 2.17(br.s, 2H), 3.24(m, 4H), 3.88(s, 3H), 3.95(br.s, 3H), 6.95(d, 1H), 7.16(s, 1H), 7.58(d, 1H)





85


embedded image


1H-NMR(CDCl3) 1.64(m, 2H), 2.05(m, 6H), 2.26(s, 3H), 2.44(t, 2H), 2.74(t, 2H), 3.18(m, 2H), 3.30(m, 2H), 3.85(s, 3H), 6.73(d, 1H), 6.83(d, 1H)





86


embedded image


1H-NMR(CDCl3) 1.66(m, 2H), 2.15(m, 4H), 3.21(m, 2H), 3.36(m, 2H), 3.69(s, 3H), 4.64(d, 2H), 5.32(d, 1H), 5.45(d, 1H), 6.39(d, 1H), 6.83(d, 1H), 7.07(d, 1H), 7.43(s, 1H)





87


embedded image


1H-NMR(CDCl3) 1.66(m, 2H), 2.11(m, 4H), 2.44(s, 3H), 3.19(m, 2H), 3.30(m, 2H), 3.69(s, 3H), 3.89(s, 3H), 6.78(d, 1H), 7.19(d, 1H), 7.45(s, 1H)


















TABLE 82





Example
Structural formula
Physical property







88


embedded image


m.p. 200-202





89


embedded image


1H-NMR(CDCl3) 1.57(s, 9H), 1.61(m, 2H), 2.10(m, 4H), 3.20(m, 2H), 3.33(m, 2H), 3.90(s, 3H), 5.68(s, 2H), 6.82(d, 1H), 7.04(d, 1H), 7.32(s, 1H), 7.48-7.52(m, 2H), 7.65(dd, 1H), 7.84-7.95(m, 4H)





90


embedded image


1H-NMR(CDCl3) 1.26(t, 3H), 1.61(m, 1H), 1.74(m, 1H), 1.79(d, 3H), 2.11(m, 4H), 3.24(m, 4H), 3.69(s, 3H), 3.90(s, 3H), 4.14(q, 2H), 6.70(q, 1H), 7.04(d, 1H), 7.30(s, 1H), 7.59(d, 1H)





91


embedded image


m.p. 145-150


















TABLE 83





Example
Structural formula
Physical property







92


embedded image


m.p. 129-131





93


embedded image


1H-NMR(CDCl3) 1.46(t, 6H), 1.80(s, 3H), 3.24(m, 4H), 3.62(s, 3H), 3.90(s, 3H), 6.84(d, 1H), 6.89(d, 1H)





94


embedded image


1H-NMR(CDCl3) 1.44(t, 6H), 2.03(s, 3H), 3.22(m, 4H), 3.41(s, 3H), 3.86(s, 3H), 5.24(s, 2H), 6.79(d, 1H), 6.98(d, 1H), 7.40(dd, 1H), 7.48-7.53 (m, 2H), 7.70(s, 1H), 7.80-7.84(m, 3H)





95


embedded image


1H-NMR(CDCl3) 1.55(m, 1H), 1.83(m, 1H), 2.13(m, 4H), 3.24(m, 4H), 3.67(s, 3H), 7.10-7.25 (m, 1H), 7.17(t, 1H), 7.30 (s, 1H), 7.60(d, 1H)


















TABLE 84





Example
Structural formula
Physical property







96


embedded image


m.p. 133-137





97


embedded image


1H-NMR(CDCl3) 1.59(m, 2H), 1.77(m, 1H), 2.02(s, 3H), 2.04(m, 2H), 2.18(m, 2H), 3.07(m, 2H), 3.41(m, 2H), 3.62(s, 3H), 3.90(s, 3H), 7.13(dd, 1H), 7.51(s, 1H), 7.72(d, 1H)





98


embedded image


1H-NMR(CDCl3) 1.61(m, 2H), 2.04(m, 4H), 3.13(m, 2H), 3.26(m, 2H), 3.35(s, 3H), 3.92(s, 3H), 5.23(s, 2H), 6.92(d, 1H), 7.25(d, 1H), 7.55(m, 2H), 7.65(d, 2H), 7.82-7.90 (m, 3H), 8.03(s, 1H)





99


embedded image


m.p. 116-118


















TABLE 85





Example
Structural formula
Physical property







100


embedded image


1H-NMR(CDCl3) 1.62(m, 2H), 2.06(m, 4H), 3.18(m, 2H), 3.33(m, 2H), 3.53(s, 3H), 3.78(s, 3H), 3.90(s, 3H), 5.65(s, 2H), 6.69(d, 1H), 7.06(d, 1H), 7.44(s, 1H), 7.48-7.53 (m, 3H), 7.80-7.86(m, 4H)





101


embedded image


1H-NMR(DMSO) 1.57(m, 2H), 1.92(m, 4H), 3.20(m, 4H), 3.79(s, 3H), 6.91(d, 1H), 6.95(d, 1H), 7.59(s, 1H)





102


embedded image


1H-NMR(CDCl3) 0.68-0.77(m, 2H), 0.85-0.93(m, 2H), 1.38-1.50(m, 1H), 1.58(m, 1H), 1.78(m, 1H), 2.04(m, 2H), 2.16(m, 2H), 3.07(m, 2H), 3.43(m, 2H), 3.58(s, 3H), 3.89(s, 3H), 7.29(dd, 1H), 7.66(d, 1H), 7.72(d, 1H)


















TABLE 86





Example
Structural formula
Physical property







103


embedded image


1H-NMR(CDCl3) 1.44(t, 3H), 1.68(m, 2H), 2.11(m, 4H), 3.26(m, 2H), 3.48(m, 2H), 3.81(s, 3H), 3.91(s, 3H), 4.05(q, 2H), 6.74(d, 1H), 7.27(d, 1H), 7.61(s, 1H)





104


embedded image


1H-NMR(CDCl3) 1.65(m, 2H), 2.11(m, 4H), 3.18(m, 2H), 3.33(m, 2H), 3.71(s, 3H), 3.90(s, 3H), 3.95(s, 3H), 6.82(d, 1H), 7.02(d, 1H), 7.59(s, 1H)





105


embedded image


1H-NMR(CDCl3) 1.65(m, 2H), 2.11(m, 4H), 3.18(m, 2H), 3.32(m, 2H), 3.61(s, 3H), 3.90(s, 3H), 4.01(s, 3H), 6.83(d, 1H), 7.05(d, 1H), 8.27(s, 1H)





106


embedded image


1H-NMR(CDCl3) 1.65(m, 2H), 2.10(m, 4H), 2.43(s, 3H), 3.18(m, 2H), 3.32(m, 2H), 3.84(s, 3H), 3.89(s, 3H), 6.75(d, 1H), 6.87(d, 1H), 7.34(d, 2H), 7.54(s, 1H), 7.82(d, 2H)


















TABLE 87





Example
Structural formula
Physical property







107


embedded image


1H-NMR(CDCl3) 1.66(m, 2H), 2.09(m, 4H), 3.19(m, 2H), 3.34(m, 2H), 3.49(s, 3H), 3.91(s, 3H), 5.52(s, 2H), 6.83(d, 1H), 7.01(d, 1H), 7.34-7.41 (m, 6H)





108


embedded image


1H-NMR(CDCl3) 1.56(m, 1H), 1.89(m, 1H), 2.14(m, 4H), 3.25(m, 4H), 3.71(s, 3H), 5.38(dd, 1H), 5.74(dd, 1H), 7.13(d, 1H), 7.29(dd, 1H), 7.41(s, 1H), 7.54(d, 1H)





109


embedded image


m.p. 122-124





110


embedded image


1H-NMR(CDCl3) 1.55(m, 1H), 1.86(m, 1H), 2.07(m, 6H), 2.25(s, 3H), 2.40(s, 3H), 2.42(t, 2H), 2.75(t, 2H), 3.23(m, 4H), 6.76(d, 1H), 7.05(d, 1H)


















TABLE 88





Example
Structural formula
Physical property







111


embedded image


1H-NMR(CDCl3) 1.47(m, 1H), 1.84(m, 1H), 2.04(m, 4H), 2.07(s, 3H), 2.40(s, 3H), 2.42(s, 3H), 2.99(m, 2H), 3.13(m, 2H), 3.46(s, 3H), 5.12(s, 2H), 6.96(d, 1H), 7.08(d, 1H), 7.33(dd, 1H), 7.47-7.53 (m, 2H), 7.63(s, 1H), 7.78-7.84(m, 3H)





112


embedded image


m.p. 107-109





113


embedded image


1H-NMR(CDCl3) 1.66( m, 2H), 2.12(m, 4H), 3.19(m, 2H), 3.30(m, 2H), 3.52(s, 3H), 3.92(s, 3H), 5.60(s, 2H), 6.73(dd, 1H), 7.21(t, 1H), 7.48-7.53 (m, 4H), 7.80-7.86(m, 4H)





114


embedded image


1H-NMR(CDCl3) 1.64(m, 2H), 2.09(m, 4H), 3.17(m, 2H), 3.31(m, 2H), 3.89(s, 6H), 6.13(s, 2H), 6.79(d, 1H), 6.94(d, 1H), 7.30(s, 1H), 8.10(d, 2H), 8.33(d, 2H)


















TABLE 89





Example
Structural formula
Physical property







115


embedded image


m.p. 224-226





116


embedded image


1H-NMR(CDCl3) 1.64(m, 2H), 2.09(m, 4H), 3.17(m, 2H), 3.32(m, 2H), 3.88(s, 3H), 3.90(s, 3H), 6.10(s, 2H), 6.79(d, 1H), 6.96(d, 1H), 7.30(s, 1H), 7.45-7.63(m, 3H), 7.90-7.93(m, 2H)





117


embedded image


1H-NMR(CDCl3) 1.58(m, 1H), 1.88(m, 1H), 2.15(m, 4H), 3.32(m, 4H), 3.70(m, 2H), 4.67(s, 2H), 7.17(d, 1H), 7.35(s, 1H), 7.41(d, 1H)





118


embedded image


1H-NMR(CDCl3) 3.25(s, 3H), 3.63(s, 3H), 3.70(s, 3H), 6.75(d, 1H), 7.10(d, 1H), 7.43(s, 1H), 7.53-7.62(m, 3H), 8.08(dd, 2H)


















TABLE 90





Example
Structural formula
Physical property







119


embedded image


1H-NMR(CDCl3) 2.95(s, 3H), 3.70(s, 3H), 3.92(s, 3H), 4.55(m, 2H), 6.86(d, 1H), 7.15(d, 1H), 7.41(s, 1H), 7.38-7.50(m, 5H)





120


embedded image


1H-NMR(CDCl3) 2.03(m, 2H), 2.43(t, 2H), 2.74(t, 2H), 2.88(s, 3H), 3.88(s, 3H), 4.51(s, 2H), 6.84(d, 1H), 6.91(d, 1H), 7.36-7.48(m, 5H)





121


embedded image


1H-NMR(CDCl3) 2.94(s, 3H), 3.52(s, 3H), 3.91(s, 3H), 4.55(m, 2H), 5.07(s, 2H), 6.84(d, 1H), 7.04(d, 1H), 7.35(s, 1H), 7.38-7.55(m, 7H), 7.80-7.86(m, 5H)





122


embedded image


1H-NMR(CDCl3) 3.24(s, 3H), 3.52(s, 3H), 3.64(s, 3H), 5.70(s, 2H), 6.72(d, 1H), 6.98(d, 1H), 7.3 (s, 1H), 7.49-7.63(m, 6H), 7.81-7.87(m, 4H), 8.08-8.11(m, 2H)


















TABLE 91





Example
Structural formula
Physical property







123


embedded image


m.p. 146-148





124


embedded image


1H-NMR(CDCl3) 1.66(m, 2H), 2.09(m, 4H), 3.19(m, 2H), 3.38(m, 2H), 3.69(s, 3H), 3.90(s, 3H), 5.00(d, 2H), 5.27-5.43 (m, 2H), 5.97-6.06(m, 1H), 6.82(d, 1H), 7.00(d, 1H), 7.35(s, 1H)





125


embedded image


1H-NMR(CDCl3) 1.30(t, 3H), 1.65(m, 2H), 2.11(m, 4H), 3.18(m, 2H), 3.33(m, 2H), 3.72(s, 3H), 3.90(s, 3H), 4.22(q, 2H), 5.23(d, 2H), 6.15(d, 1H), 6.82(d, 1H), 6.98-7.04 (m, 2H), 7.33(s, 1H)





126


embedded image


m.p. 134-136


















TABLE 92





Example
Structural formula
Physical property







127


embedded image


m.p. 153-155





128


embedded image


m.p. 171-173





129


embedded image


1H-NMR(CDCl3) 2.28(m, 4H), 3.24(m, 2H), 3.46(m, 2H), 3.51(s, 3H), 3.91(s, 3H), 5.70(s, 2H), 6.82(d, 1H), 6.99(d, 1H), 7.35(s, 1H), 7.48-7.55 (m, 3H), 7.80-7.86(m, 4H)





130


embedded image


1H-NMR(CDCl3) 1.15(t, 3H), 1.66(m, 2H), 2.10(m, 6H), 3.19(m, 2H), 3.33(m, 2H), 3.66(m, 2H), 3.88(s, 3H), 3.91(s, 3H), 6.83(d, 1H), 7.03(d, 1H), 7.50 (s, 1H)


















TABLE 93





Example
Structural formula
Physical property







131


embedded image


m.p. 121-123





132


embedded image


1H-NMR(CDCl3) 1.59(m, 1H), 1.75(m, 1H), 2.08(m, 4H), 3.11(m, 2H) 3.34(m, 2H), 3.52(s, 3H), 3.84(s, 3H), 5.69(s, 2H), 6.96(dd, 1H), 7.03(t, 1H), 7.35(dd, 1H), 7.39(s, 1H), 7.49-7.54(m, 3H), 7.81-7.86(m, 4H)





133


embedded image


m.p. 72-74





134


embedded image


1H-NMR(CDCl3) 3.30(m, 2H), 3.44(m, 2H), 3.54(s, 3H), 3.77(s, 3H), 3.91(s, 3H), 4.13(m, 4H), 5.64(s, 2H), 6.70(d, 1H), 7.08(d, 1H), 7.43(s, 1H), 7.49-7.53(m, 3H), 7.80-7.86(m, 4H)


















TABLE 94





Example
Structural formula
Physical property







135


embedded image


m.p. 85-87





136


embedded image


1H-NMR(CDCl3) 1.63(m, 2H), 2.04(m, 4H), 2.40(s, 3H), 3.20(m, 2H), 3.31(m, 2H), 3.54(s, 3H), 3.71(s, 3H), 5.67(s, 2H), 6.94(d, 1H), 7.00(d, 1H), 7.42(s, 1H), 7.47-7.54 (m, 3H), 7.81-7.87(m, 4H)





137


embedded image


1H-NMR (CDCl3) 1.24(t, 9H), 1.64(m, 2H), 2.09(m, 4H), 3.06(q, 6H), 3.16(m, 2H), 3.32(m, 2H), 3.46(s, 3H), 3.87(s, 3H), 6.79(d, 1H), 6.97(d, 1H), 7.02(s, 1H)





138


embedded image


1H-NMR(CDCl3) 1.64(m, 2H), 2.08(m, 4H), 3.14(m, 2H), 3.29(m, 2H), 3.67(s, 3H), 3.74(s, 3H), 6.58(d, 1H), 6.93(d, 1H), 7.50(t, 2H), 7.65(m, 1H), 7.80(s, 1H), 8.03(dd, 2H)


















TABLE 95





Example
Structural formula
Physical property







139


embedded image


m.p. 151-154





140


embedded image


m.p. 96-98





141


embedded image


1H-NMR(CDCl3) 1.43(t, 6H), 3.22(m, 4H), 3.53(s, 3H), 3.78(s, 3H), 3.89(s, 3H), 5.66(s, 2H), 6.68(d, 1H), 7.06(d, 1H), 7.43(s, 1H), 7.48-7.54 (m, 3H), 7.80-7.86(m, 4H)





142


embedded image


1H-NMR (CDCl3) 1.68(m, 2H), 1.83(s, 3H), 2.10(m, 4H), 3.20(m, 2H), 3.36(m, 2H), 3.90(s, 3H), 4.79(s, 2H), 6.86(d, 1H), 6.92(d, 1H)


















TABLE 96





Example
Structural formula
Physical property

















143


embedded image


1H-NMR (CDCl3) 1.30 (t, 3H), 1.66 (m, 2H), 1.82 (s, 3H), 2.10 (m, 4H), 3.19 (m, 2H), 3.33 (m, 2H), 3.90 (s, 3H), 4.25 (q, 2H), 4.70 (s, 2H), 6.85 (d, 1H), 6.92 (d, 1H)





144


embedded image


m.p. 97-99





145


embedded image


1H-NMR (CDCl3) 1.08 (t, 6H), 1.98 (m, 4H), 3.18 (m, 4H), 3.69 (s, 3H), 3.91 (s, 3H), 6.84 (d, 1H), 7.12 (d, 1H), 7.42 (s, 1H)





146


embedded image


1H-NMR (CDCl3) 1.07 (t, 6H), 1.96 (m, 4H), 3.18 (m, 4H), 3.51 (s, 3H), 3.90 (s, 3H), 5.70 (s, 2H), 6.81 (d, 1H), 7.01 (d, 1H), 7.33 (s, 1H), 7.48-7.55 (m, 3H), 7.80-7.86 (m, 4H)


















TABLE 97





Example
Structural formula
Physical property

















147


embedded image


1H-NMR (CDCl3) 1.66 (m, 2H), 1.82 (s, 3H), 2.12 (m, 4H), 3.19 (m, 2H), 3.34 (m, 2H), 3.80 (s, 3H), 3.91 (s, 3H) 4.72 (s, 2H), 6.85 (d, 1H), 6.93 (d, 1H)





148


embedded image


1H-NMR (CDCl3) 1.42 (t, 6H), 2.00-2.10 (m, 2H), 2.41 (t, 2H), 2.76 (t, 2H), 3.18 (m, 4H), 3.87 (s, 3H), 6.84 (d, 1H), 7.55 (d, 1H)





149


embedded image


m.p. 150-152





150


embedded image


m.p. 164-166


















TABLE 98





Example
Structural formula
Physical property

















151


embedded image


1H-NMR (CDCl3) 3.21 (s, 6H), 3.51 (s, 3H), 3.91 (s, 3H), 5.69 (s, 2H), 6.83 (d, 1H), 7.06 (d, 1H), 7.34 (s, 1H), 7.48-7.55 (m, 3H), 7,80-7.86 (m, 4H)





152


embedded image


1 H-NMR(CDC13) 1.67 (m, 2H), 2.13 (m, 4H), 2.50 (s, 3H), 3.22 (m,4H), 3.72 (s, 3H), 3.89 (s, 3H), 6.98 (d, 1H), 7.56 (d, 1H), 7.65 (s, 1H)





153


embedded image


1H-NMR (CDCl3) 1.61 (m, 1H), 1.75 (m, 1H), 2.12 (m,4H), 2.55 (s, 3H), 3.24 (m, 4H), 3.60 (s, 3H), 3.89 (s, 3H), 7.01 (d, 1H), 7.58 (d, 1H), 8.35 (s, 1H)





154


embedded image


m.p. 163-165


















TABLE 99





Example
Structural formula
Physical property

















155


embedded image


1H-NMR (CDCl3) 1.64 (m, 2H), 2.10 (m, 4H), 2.54 (s, 3H), 3.17 (m, 2H), 3.32 (m, 2H), 3.61 (s, 3H), 3.89 (s, 3H), 6.83 (d, 1H), 7.07 (d, 1H), 8.36 (s, 1H)





156


embedded image


m.p. 111-113





157


embedded image


1H-NMR (CDCl3) 1.17 (t, 3H), 1.61 (m, 2H), 2.11 (m, 4H), 3.18 (m, 2H), 3.31 (m, 2H), 3.54 (s, 3H), 3.90 (s, 3H), 4.03 (q, 2H), 5.63 (s, 2H), 6.98 (d, 1H), 7.06 (d, 1H), 7.45 (s, 1H), 7.47-7.53 (m, 3H), 7.80-7.86 (m, 4H)





158


embedded image


1H-NMR (CDCl3) 1.42 (t, 6H), 2.06 (m, 2H), 2.24 (s, 3H), 2.37 (s, 3H), 2.42 (t, 2H), 2.74 (t, 2H), 3.03-3.22 (m, 4H), 6.71 (d, 1H), 7.02 (d, 1H)


















TABLE 100





Example
Structural formula
Physical property

















159


embedded image


1H-NMR (CDC13) 2.02 (m, 2H), 2.18 (s, 3H), 2.35 (s, 3H), 2.41 (t 2H), 2.75 (t, 2H), 3,09 (s, 6H), 6.74 (d, 1H), 7.05 (d, 1H)





160


embedded image


m.p. 135-137





161


embedded image


m.p. 115-125





162


embedded image


m.p. 230up


















TABLE 101





Example
Structural formula
Physical property

















163


embedded image


m.p. 124-126





164


embedded image


1H-NMR (CDCl3) 1.17 (t 3H), 1.24 (t, 3H), 1.61 (m, 2H), 2.06 (m, 4H), 3.18 (m, 2H), 3.31 (m, 2H), 3.90 (s, 3H), 3.91 (q, 2H), 4.03 (q, 2H), 5.63 (s, 2H), 6.68 (d, 1H), 7.08 (d, 1H), 7.47 (s, 1H), 7.48-7.54 (m, 3H), 7.80-7.86 (m, 4H)





165


embedded image


1H-NMR (CDCl3) 1.20-1.34 (m, 2H), 1.35-1.50 (m, 2H), 1.62 (m, 1H), 1.74 (m, 1H), 2.13 (m, 4H), 2.30-2.40 (m, 1H), 3.21 (m, 4H), 3.90 (s, 3H), 7.09 (d, 1H), 7.61 (d, 1H)





166


embedded image


1H-NMR (CDCl3) 1.58 (m, 1H), 1.80 (m, 1H), 2.15 (m, 4H), 3.33 (m, 4H), 3.64 (s, 1H), 3.69 (s, 3H), 7.04 (d, 1H), 7.35 (s, 1H), 7.45 (d, 1H)


















TABLE 102





Example
Structural formula
Physical property

















167


embedded image


m.p. 126-128





168


embedded image


m.p. 133-135





169


embedded image


m.p. 155-157





170


embedded image


m.p. 162-164





171


embedded image


1H-NMR (CDCl3) 1.60 (m, 1H), 1.75 (m, 1H), 2.09 (m, 4H), 3.11 (m, 2H), 3.35 (m, 2H), 3.52 (s, 3H), 5.64 (s, 2H), 7.05-7.14 (m, 2H), 7.39-7.54 (m, 5H), 7.82-7.87 (m, 4H)


















TABLE 103





Example
Structural formula
Physical property

















172


embedded image


1H-NMR (CDCl3) 1.58 (m, 1H), 1.74 (m, 1H), 2.09 (m, 6H), 2.46 (t, 2H), 2.74 (t, 2H), 3.10 (m, 2H), 3.36 (m, 2H), 6.99-7.08 (m, 2H), 7.37 (td, 1H)





173


embedded image


1H-NMR (CDCl3) 1.55 (m,1H), 1.76 (m, 1H), 2.04 (t, 2H), 2.11 (m, 4H), 2.41 (t, 2H), 2.75 (t, 2H), 3.28 (m, 4H), 3.30(s, 1H), 6.79 (d, 1H), 7.41 (d, 1H)





174


embedded image


1H-NMR (CDCl3) 1.52 (m, 1H), 1.80 (m, 1H), 2.04 (s, 3H), 2.14 (m, 4H), 3.25 (m, 2H), 3.40 (m, 2H), 3.49 (s, 3H), 5.76 (s, 2H), 6.98 (d, 1H), 7.20 (s, 1H), 7.48-7.56 (m, 3H), 7.62 (d, 1H), 7.79-7.87 (m, 4H)





175


embedded image


m.p. 109-111


















TABLE 104





Example
Structural formula
Physical property

















176


embedded image


1H-NMR (CDCl3) 1.49 (t, 3H), 1.63 (m, 2H), 2.08 (m, 4H), 3.16 (m, 2H), 3.34 (m, 2H), 3.53 (s, 3H), 3.79 (s, 3H), 4.12 (q, 2H), 5.64 (s, 2H), 6.67 (d, 1H), 7.03 (d, 1H), 7.44 (s, 1H), 7.48-7.54 (m, 3H), 7.80-7.86 (m, 4H)





177


embedded image


1H-NMR (CDCl3) 1.48 (t, 3H), 1.64 (m, 2H), 2.09 (m, 4H), 2.44 (s, 3H), 3.17 (m, 2H), 3.34 (m, 2H), 3.72 (s, 3H), 3.75 (s, 3H), 4.10 (q, 2H), 6.66 (d, 1H), 7.05 (d, 1H), 7.69 (s, 1H)





178


embedded image


1H-NMR (CDCl3) 1.48 (t, 3H), 1.67 (m, 2H), 2.11 (m, 4H), 2.55 (s, 3H), 3.09 (m, 2H), 3.56 (m, 2H), 3.59 (s, 3H), 3.68 (s, 3H), 4.12 (q, 2H), 6.69 (d, 1H), 7.16 (d, 1H), 8.40 (s, 1H)





179


embedded image


m.p. 125-127


















TABLE 105





Example
Structural formula
Physical property

















180


embedded image


m.p. 134-137





181


embedded image


m.p. 158-161





182


embedded image


1H-NMR (CDCl3) 1.67 (m, 2H), 2.14 (m, 4H), 3.22 (m, 2H), 3.34 (m, 2H), 3.52 (s, 3H), 5.73 (s, 2H), 6.59 (t, 1H), 6.99 (d, 1H), 7.16 (d, 1H), 7.31 (s, 1H), 7.48-7.55 (m, 3H), 7.81-7.87 (m, 4H)





183


embedded image


1H-NMR (CDCl3) 1.64 (m, 2H), 2.09 (m, 4H), 2.44 (s, 3H), 3.20 (m, 2H), 3.33 (m, 2H), 3.74 (s, 3H), 3.77 (s, 3H), 3.89 (s, 3H), 6.68 (d, 1H), 7.08 (d, 1H), 7.69 (s, 1H)


















TABLE 106





Example
Structural formula
Physical property

















184


embedded image


1H-NMR (CDCl3) 1.58 (m, 2H), 2.04 (m, 4H), 2.55 (s, 3H), 3.12 (m, 2H), 3.49 (m, 2H), 3.59 (s, 3H), 3.68 (s, 3H), 3.89 (s, 3H), 6.72 (d, 1H), 7.18 (d, 1H), 8.40 (s, 1H)





185


embedded image


1H-NMR (CDCl3) 1.68 (m, 2H), 2.14 (m, 4H), 2.43 (s, 3H), 3.21 (m, 2H), 3.34 (m, 2H), 3.72 (s, 3H), 6.60 (t, 1H), 6.95 (d, 1H), 7.14 (d, 1H), 7.73 (s, 1H)





186


embedded image


m.p. 124-126





187


embedded image


m.p. 159-161


















TABLE 107





Example
Structural formula
Physical property

















188


embedded image


1H-NMR (CDCl3) 1.24 (t, 3H), 1.53 (m, 1H), 1.85 (m, 1H), 2.11 (m, 4H), 2.91 (q, 2H), 3.27 (m, 4H), 3.69 (s, 3H), 7.10 (d, 1H), 7.21 (d, 1H), 7.84 (s, 1H)





189


embedded image


m.p. 135-139





190


embedded image


1H-NMR (CDCl3) 1.59 (m, 1H), 1.77 (m, 1H), 2.03 (m, 6H), 2.20 (s, 3H), 2.43 (t, 2H), 2.76 (t, 2H), 3.11 (m, 2H), 3.48 (m, 2H), 6.71 (d, 1H), 7.08 (t, 1H), 7.29 (d, 1H)





191


embedded image


m.p. 166-168


















TABLE 108





Example
Structural formula
Physical property

















192


embedded image


m.p. 90-92





193


embedded image


m.p. 149-151





194


embedded image


m.p. 159-162





195


embedded image


1H-NMR (CDCl3) 2.43 (s, 3H), 3.35 (s, 3H), 3.74 (s, 3H), 3.77 (s, 3H), 6.77 (d, 1H), 7.02 (d, 1H), 7.12 (dd, 1H), 7.65 (dd, 1H), 7.66 (s, 1H), 7.72 (dd, 1H)


















TABLE 109





Example
Structural formula
Physical property

















196


embedded image


m.p. 177-179





197


embedded image


1H-NMR (CDCl3) 1.56 (m, 1H), 1.83 (m, 1H), 2.02 (m, 2H), 2.21 (m, 2H), 2.41 (s, 3H), 3.06 (m, 2H), 3.45 (m, 2H), 3.72 (s, 3H), 6.87 (d, 1H), 7.20 (t, 1H), 7.42 (d, 1H), 7.68 (s, 1H)





198


embedded image


m.p. 151-153





199


embedded image


m.p. 99-101





















Example
Structural formula
Physical property

















200


embedded image


m.p. 159-161





201


embedded image


1H-NMR (CDCl3) 1.39 (d, 6H), 1.62 (m, 1H), 1.73 (m, 1H), 2.07 (m, 2H), 2.19 (m, 2H), 3.15 (m, 2H), 3.27 (m, 2H), 3.45-3.65 (m, 1H), 3.72 (s, 3H), 3.89 (s, 3H), 6.99 (d, 1H), 7.57 (d, 1H), 7.65 (s, 1H)





202


embedded image


1H-NMR (CDCl3) 1.02 (t, 3H), 1.67 (m, 2H), 1.65-1.80 (m, 2H),2.10 (m, 2H), 2.20 (m, 2H), 2.90 (t, 2H), 3.15 (m, 2H), 3.27 (m, 2H), 3.72 (s, 3H), 3.89 (s, 3H), 6.99 (d, 1H), 7.57 (d, 1H), 7.63 (s, 1H)


















TABLE 111





Example
Structural formula
Physical property







203


embedded image


1H-NMR (CDCl3) 1.50 (s, 9H), 1.61 (m, 1H), l.71 (m, 1H), 2.09 (m, 2H), 2.20 (m, 2H), 3.15 (m, 2H), 3.27 (ddd, 2H), 3.71 (s, 3H), 3.89 (s, 3H), 6.98 (d, 1H), 7.56 (d, 1H), 7.67 (s, 1H)





204


embedded image


1H-NMR (CDCl3) 1.52 (m, 1H), 1.77 (m, 1H), 2.11 (m, 4H), 2.17 (s, 3H), 3.19 (m, 4H), 3.69 (s, 3H), 5.08 (s, 1H), 5.18-5.20 (m, 1H), 7.07 (d, 1H), 7.17 (d, 1H), 7.41 (s, 1H)





205


embedded image


m.p. 169-171





206


embedded image


1H-NMR (CDCl3) 1.64 (m, 2H), 2.09 (m, 4H), 2.43 (s, 3H), 2.55 (t, 1H), 3.20 (m, 2H), 3.37 (m, 2H), 3.73 (s, 3H), 4.77 (d, 2H), 6.98 (m, 2H), 7.67 (s, 1H)


















TABLE 112





Example
Structural formula
Physical property







207


embedded image


1H-NMR (CDCl3) 1.52 (m, 1H), 1.76 (m, 1H), 2.07 (m, 4H), 2.16 (dd, 3H), 2.41 (s, 3H), 3.17 (m, 4H), 3.73 (s, 3H), 5.00-5.07 (m, 1H), 5.15-5.20 (m, 1H), 6.96 (d, 1H), 7.13 (d, 1H), 7.70 (s, 1H)





208


embedded image


m.p. 102-104





209


embedded image


1H-NMR (CDCl3) 1.20 (d, 6H), 1.50 (m, 1H), 1.80 (m, 1H), 1.95-2.10 (m, 2H), 2.10 (m, 4H), 2.42 (t, 2H), 2.75 (t, 2H), 3.23 (m, 4H), 3.65-3.80 (m, 1H), 6.88 (d, 1H), 7.21 (d, 1H)





210


embedded image


m.p. 167-169


















TABLE 113





Example
Structural formula
Physical property










211


embedded image


1H-NMR (CDCl3) 1.55 (d, 6H), 2.43 (s, 3H), 2.97 (s, 3H), 3.39 (m, 1H), 3.73 (s, 3H), 3.91 (s, 3H), 6.82 (d, 1H), 7.01 (d, 1H), 7,64 (s, 1H)





212


embedded image


m.p. 153-155





213


embedded image


1H-NMR (CDCl3) 1.66 (m, 2H), 2.10 (m, 4H), 2.43 (s, 3H), 3.22 (m, 2H), 3.40 (m, 2H), 3.43 (s, 3H), 3.73 (s, 3H), 3.86 (m, 2H), 4.18 (m, 2H), 6.80 (d, 1H), 6.95 (d, H), 7.64 (s, 1H)





214


embedded image


m.p. 158-164





215


embedded image


m.p. 188-190


















TABLE 114





Example
Structural formula
Physical property







216


embedded image


1H-NMR (CDCl3) 0.38 (m, 2H), 0.65 (m, 2H), 1.38 (m, 1H), 1.66 (m, 2H), 2.11 (m, 4H), 3.28 (m, 2H), 3.43 (m, 2H), 3.51 (s, 3H), 3.88 (d, 2H), 5.69 (s, 2H), 6.96 (d, 1H), 7.07 (d, 1H), 7.35 (s, 1H), 7.48-7.55 (m, 3H), 7.80-7.86 (m, 4H)





217


embedded image


1H-NMR(CDC13) 1.64 (m, 2H), 2.06 (m, 6H), 2.43 (t, 2H), 2.74 (t, 2H), 3.17 (m, 2H), 3.34 (m, 2H), 3.88 (s, 3H), 6.79 (d, 1H), 6.87 (d, 1H)





218


embedded image


m.p. 84-86 diastereomer mixutre 1.9:1


















TABLE 115





Example
Structural formula
Physical property










219


embedded image


1H-NMR (CDCl3) 1.44 (d, 1.1/3H, l.58 (d, 1.9/3H), 1.85 (m, 2H), 2.11 (m, 4H), 3.25 (m, 4H), 3.51 (s, 3H), 3.93 (s, 3H), 5.70(s, 2H), 6.82 (d, 1H), 6.94-7.00 (m, 1H), 7.36 (s, 1H), 7.49-7.55 (m, 3H), 7.80-7.86 (m, 4H) diastereomer mixutre 1.9:1





220


embedded image


1H-NMR(CDCl3) 1.61 (m, 1H), 1.73 (m, 1H), 2.13 (m, 4H), 3.16 (m, 2H), 3.28 (m, 2H), 3.76 (s, 3H), 3.90 (s, 3H), 5.77 (s, 2H), 7.01 (d, 1H), 7.29 (s, 1H), 7.59 (d, 1H)





221


embedded image


m.p. 93-95





222


embedded image


1H-NMR (CDCl3) 1.65 (m, 2H), 2.11 (m, 4H), 3.20 (m, 2H), 3.38 (m, 2H), 3.51 (s, 3H), 3.55 (s, 3H), 5.23 (s, 2H), 5.71 (s, 2H), 6.96 (d, 1H), 7.07 (d, 1H), 7.35 (s, 1H), 7.49-7.55 (m, 3H), 7.81- 7.86 (m, 4H)


















TABLE 116





Example
Structural formula
Physical property







223


embedded image


m.p. 144-146





224


embedded image


1H-NMR (CDCl3) 1.66 (m, 2H), 2.09 (m, 4H), 3.20 (m, 2H), 3.35 (m, 2H), 3.51 (s, 3H), 3.89 (s, 3H), 5.71 (s, 2H), 6.85 (d, 1H), 6.96 (d, 1H), 7.32 (s, 1H), 7.48- 7.55 (m, 3H), 7.81-7.86 (m, 4H)





225


embedded image


1H-NMR (CDCl3) 1.44 (t, 3H), 1.66 (m, 2H), 2.13 (m, 4H), 3.21 (m, 2H), 3.36 (m, 2H), 3.90 (s, 3H), 4.05 (q, 2H), 6.87 (d, 1H), 7.07 (d, 1H), 7.40 (s, 1H)





226


embedded image


1H-NMR (CDCl3) 1.21 (t, 3H), 1.66 (m, 2H), 2.12 (m, 4H), 3.20 (m, 2H), 3.37 (m, 2H), 3.89 (q, 2H), 3.90 (s, 3H), 5.72 (s, 2H), 6.86 (d, 1H), 6.97 (d, 1H), 7.34 (s, 1H), 7.48-7.57 (m, 3H), 7.80-7.87 (m, 4H)


















TABLE 117





Example
Structural formula
Physical property







227


embedded image


1H-NMR (CDCl3) 1.33 (d, 6H), 1.64 (m, 2H), 2.11 (m, 4H), 2.82 (m, 1H), 3.17 (m, 2H), 3.33 (m, 2H), 3.68 (s, 3H), 3.89 (s, 3H), 6.81 (d, 1H), 7.00 (d, 1H), 7.61 (s, 1H)





228


embedded image


m.p. 97-103





229


embedded image


1H-NMR (CDCl3) 1.58 (m, 1H), 1.75 (m, 1H), 2.08 (m, 2H), 2.17 (m, 2H), 3.23 (m, 4H), 3.29 (s, 3H), 3.45 (s, 3H), 3.87 (s, 3H), 5.15 (s, 2H), 6.98 (d, 1H), 7.54 (d, 1H), 7.82 (s, 1H)





230


embedded image


1H-NMR (CDC13) 1.33 (d, 6H), 1.67 (m, 2H), 2.07 (m, 2H), 2.20 (m, 2H), 3.15 (m, 2H), 3.27 (ddd, 2H), 3.68 (s, 3H), 3.89 (s, 3H), 7.00 (d, 1H), 7.55 (d, 1H), 7.59 (s, 1H)


















TABLE 118





Example
Structural formula
Physical property







231


embedded image


1H-NMR (CDCl3) 1.40 (s, 9H), 1.60(m, 1H), 1.75 (m, 1H), 2.07 (m, 2H), 2.20 (m, 2H), 3.14 (m, 2H), 3.27 (ddd, 2H), 3.68 (s, 3H), 3.89 (s, 3H), 7.02 (d, 1H), 7.48 (s, 1H), 7.57 (d, 1H)





232


embedded image


1H-NMR (CDCl3) 1.60 (m, 2H), 2.06 (m, 4H), 3.14 (m, 2H), 3.29 (m, 2H), 3.53 (s, 3H), 3.70 (s, 3H), 3.85 (s, 3H), 5.46 (s, 2H), 6.78 (d, 1H), 6.95 (d, 1H), 7.34 (s, 1H)





233


embedded image


m.p. 165-167





234


embedded image


1H-NMR (CDCl3) 1.66 (m, 2H), 2.11 (m, 4H), 3.19 (m, 2H), 3.34 (m, 2H), 3.73 (s, 3H), 3.91 (s, 3H), 5.07 (td, 2H), 6.83 (d, 1H), 7.01 (d, 1H), 7.35 (s, 1H)


















TABLE 119





Example
Structural formula
Physical property







235


embedded image


m.p. 131-132





236


embedded image


1H-NMR (CDCl3) 1.62 (m, 2H), 2.08 (m, 2H), 2.21 (m, 2H), 3.16 (m, 2H), 3.28 (ddd, 2H), 3.75 (s, 3H), 3.90 (s, 3H), 4.99 (q, 2H), 7.01 (d, 1H), 7.26 (s, 1H), 7.61 (d, 1H)





237


embedded image


1H-NMR (CDCl3) 1.39 (s, 9H), 1.64 (m, 2H), 2.10 (m, 4H), 3.17 (m, 2H), 3.32 (m, 2H), 3.68 (s, 3H), 3.89 (s, 3H), 6.81 (d, 1H), 7.01 (d, 1H), 7.56 (s, 1H)





238


embedded image


m.p. 112-114


















TABLE 120





Example
Structural formula
Physical property







239


embedded image


1H-NMR (CDCl3) 1.64 (m, 2H), 2.10 (m, 4H), 2.33 (s, 3H), 3.22 (m, 2H), 3.40 (m, 2H), 3.51 (s, 3H), 5.23 (s, 2H), 5.70 (s, 2H), 6.90 (d, 1H), 6.99 (d, 1H), 7.35 (s, 1H), 7.49-7.55 (m, 3H), 7.80-7.87 (m, 4H)





240


embedded image


1H-NMR (CDCl3) 1.63 (m, 1H), 1.73 (m, 1H), 2.10 (m, 2H), 2.19 (m, 2H), 3.16 (m, 2H), 3.27 (ddd, 2H), 3.59 (s, 3H), 3.75 (s, 3H), 3.90 (s, 3H), 5.55 (s, 2H), 7.01 (d, 1H), 7.29 (s, 1H), 7.59 (d, 1H)





241


embedded image


m.p. 104-106





242


embedded image


m.p. 106-108


















TABLE 121





Example
Structural formula
Physical property







243


embedded image


1H-NMR (CDCl3) 1.65 (m, 2H), 2.11 (m, 4H), 3.20 (m, 2H), 3.33 (m, 2H), 3.52 (s, 3H), 4.54 (td, 2H), 5.71 (s, 2H), 6.94 (d, 1H), 6.99 (d, 1H), 7.30 (s, 1H), 7.49-7.55 (m, 3H), 7.80-7.87 (m, 4H)





244


embedded image


1H-NMR (CDCl3) 0.99 (t, 3H), 1.51 (m, 2H), 1.99 (m, 2H), 3.09 (s, 3H), 3.29 (m, 2H), 3.69 (s, 3H), 3.92 (s, 3H), 6.86 (d, 1H), 7.15 (d, 1H), 7.43 (s, 1H)





245


embedded image


m.p. 95-97





246


embedded image


m.p. 129-131


















TABLE 122





Example
Structural formula
Physical property







247


embedded image


m.p.: 165-168





248


embedded image


amorphous 1H-NMR (CDCl3) 1.47 (t, 6H), 3.25 (m, 4H), 3.51 (s, 3H), 3.90 (s, 3H), 5.70 (s, 2H), 6.81 (d, 1H), 7.01 (d, 1H), 7.34 (s, 1H), 7.48- 7.55 (m, 3H), 7.80-7.86 (m, 4H)





249


embedded image


m.p.: 88-91





250


embedded image


m.p.: 138-140


















TABLE 123





Example
Structural formula
Physical property







251


embedded image


m.p.: 152-154





252


embedded image


amorphous 1H-NMR (CDCl3) 3.30 (s, 3H), 3.50 (s, 3H), 5.72 (s, 2H), 6.89 (d, 1H), 7.06 (t, 1H), 7.23 (s, 1H), 7.30 (d, 1H), 7.48-7.65 (m, 6H), 7.8l-8.06 (m, 6H)





253


embedded image


amorphous 1H-NMR (CDCl3) 1.66 (m, 2H), 2.08 (m, 4H), 3.17 (m, 3.87 (s, 3H), 5.23 (s, 2H), 6.80 (d, 1H), 7.13 (d, 1H), 7.38-7.52 (m, 3H), 7.68-7.83 (m, 4H)


















TABLE 124





Example
Structural formula
Physical property










254


embedded image


m.p.: 85-87





255


embedded image


m.p.: 100-104





256


embedded image


amorphous 1H-NMR (CDCl3) 1.56 (m, 1H), 1.79 (m, 1H), 2.09 (m, 4H), 2.31 (s, 3H), 2.42 (s, 3H), 3.18 (m, 4H), 3.73 (s, 3H), 3.89 (s, 3H), 6.98 (d, 1H), 7.49 (d, 1H), 7.59 (s, 1H)





257


embedded image


amorphous 1H-NMR (CDCl3) 1.51 (s, 9H), 1.60 (m, 1H), 1.80 (m, 1H), 2.09 (m, 4H), 2.31 (s, 3H), 3.18 (m, 4H), 3.72 (s, 3H), 3.88 (s, 3H), 6.98 (d, 1H), 7.50 (d, 1H), 7.58 (s, 1H)


















TABLE 125





Example
Structural formula
Physical property







258


embedded image


viscous oil 1H-NMR (CDCl3) 0.97 (t, 3H), 1.38 (s, 6H), 1.40-1.50 (m, 2H), 1.62 (m, 1H), 1.71 (m, 1H), 1.68-1.80 (m, 2H), 2.09 (m, 2H), 2.20 (m, 2H), 3.14 (m, 2H), 3.26 (m, 2H), 3.68 (s, 3H), 3.89 (s, 3H), 7.02 (d, 1H), 7.44 (s, 1H), 7.57 (d, 1H)





259


embedded image


m.p.: 77-79





260


embedded image


amorphous 1H-NMR (CDCl3) 1.65 (m, 2H), 2.10 (m, 4H), 3.19 (m, 2H), 3.35 (m, 2H), 3.38 (s, 3H), 3.51 (s, 3H), 3.58 (m, 2H), 3.90 (m, 2H), 5.33 (s, 2H), 5.71 (s, 2H), 6.96 (d, 1H), 7.11 (d, 1H), 7.34 (8, 1H), 7.49- 7.55 (m, 3H), 7.81-7.87 (m, 4H)









In addition, the compound of Example 36 was synthesized by the following method.




embedded image


0.18 g of 4-bromo-2-chloro-1-{[1-methyl-5-(2-naphthyl methoxy)pyrazole-4-yl]carbonyl}-3-(1-oxothianylidene amino)benzene was added with 10 ml of dioxane, and replaced with nitrogen gas after deaerating under reduced pressure. The resulting solution was added with 0.17 g of potassium carbonate and 0.25 g of tetrakistriphenyl phosphine palladium under nitrogen stream, followed by performing further sufficient nitrogen gas replacement. The resulting reaction solution was added with 0.08 g of trimethyl boroxin and heated under reflux for a whole day and night. Nex, the reaction solution was cooled to room temperature, and added with 200 ml of ethyl acetate and 100 ml of water to filter insoluble matter using Celite. Celite was washed with 300 ml of ethyl acetate and 300 ml of water, and extracted the solution. The organic layer was washed with brine, dried with magnesium sulfate, filtered, concentrated. The residue was purified by silica gel column chromatography (eluent: chloroform/methanol=19/1) to obtain 0.04 g (yield: 34%) of 2-chloro-1-[(5-hydroxy-1-methylpyrazole-4-yl)carbonyl]-4-methyl-3-(1-oxothianylidene amino)benzene which is yellow-colored and amorphous.


(3) Formulation Example

Next, some formulation examples for the herbicide of the present invention will be described. However, the active ingredients of the compounds, the additives and addition ratios are not limited to those indicated in the examples and can be varied over a wide range. In addition, the term “pails” in the formulation examples indicates parts by weight.












(Formulation example 1) Wettable Powder


















Compound of the present invention
20 parts



White carbon
20 parts



Diatomite
52 parts



Sodium alkyl sulfate
 8 parts










The above components are uniformly mixed and finely crushed to obtain a wettable powder containing 20% of the active ingredient.












(Formulation example 2) Emulsion


















Compound of the present invention
20 parts



Xylene
55 parts



Dimethyl formamide
15 parts



Polyoxyethylene phenyl ether
10 parts










The above components are mixed and dissolved to obtain an emulsion containing 20% of the active ingredient.












(Formulation example 3) Granules


















Compound of the present invention
 5 parts



Talc
40 parts



Clay
38 parts



Bentonite
10 parts



Sodium alkyl sulfate
 7 parts










The above components are uniformly mixed and finely crushed to granulate particles having a diameter of 0.5 to 1.0 min and obtain granules containing 5% of the active ingredient.


(4) Test Example

Next, Test examples demonstrating the effects of the herbicide of the present invention will be described.


Test Example 1

Plastic pots having an area of 100 cm2 and a depth of 10 cm were filled with paddy soil which is puddled by adding water, and seeds of Echinochloa crus-galli and Scirpus juncoides were planted in the pots. After seeding, rice plants at the 2.5-leaf stage were transplanted and the pots were filled with water. The rice plants were grown in a greenhouse. When Echinochloa crus-galli had grown to the 1.5-leaf stage, test solution was applied to the pots at an application dosage of 63 g per hectare. The herbicidal effects and harmful effects on the rice plants were examined after 3 weeks. The results are shown in the following table.


Herbicidal effects were examined according to the examination criteria described below and were represented by the herbicidal index.


Examination Criteria












TABLE 11







Herbicidal rate
Herbicidal index



















 0%
0



20-29%
2



40-49%
4



60-69%
6



80-89%
8



100%
10










Numbers 1, 3, 5, 7, 9 represent values intermediate between 0 and 2, 2 and 4, 4 and 6, 6 and 8, 8 and 10.










Herbicidal





rate






(
%
)


=







{

(

Fresh





weight





of





shoots





in





a





non


-


treated





plot

)

}

-






{

(

Fresh





weight





of





shoots





in





a





treated





plot

)

}





(

Fresh





weight





of





shoots





in





a





non


-


treated





plot

)


×
100





[

Equation





1

]
















TABLE 12









Screening (63 g/ha)










Compound
Rice

Echinochloa crus-galli


Scripus juncoides














Example 1
0
10
8


Example 2
0
8
8


Example 3
0
8
8


Example 4
0
10
10


Example 5
0
10
10


Example 6
0
10
10


Example 7
0
5
8


Example 8
0
10
9


Example 9
0
10
7


Example 10
0
7
7


Example 11
2
10
8


Example 12
0
10
9


Example 13
0
7
8


Example 14
1
7
8


Example 15
2
10
8


Example 16
3
10
10


Example 17
0
7
8


Example 18
0
7
8


Example 20
0
0
4


Example 21
0
10
9


Example 22
0
0
5


Example 23
0
7
8


Example 24
0
7
8


Example 25
0
10
9


Example 26
0
7
8


Example 27
0
8
7


Example 29
0
10
8


Example 30
0
10
8


Example 31
0
10
8


Example 33
0
7
6


Example 34
0
6
5


Example 36
0
10
9


Example 37
2
7
8


Example 38
3
8
8


Example 39
0
9
8


Example 40
0
7
8


Example 41
0
4
6


Example 42
0
3
6


Example 43
0
2
5


Example 44
0
6
7


Example 45
0
10
5


Example 48
0
7
8


Example 50
0
5
8


Example 51
0
5
8


Example 52
0
10
9


Example 53
0
10
9


Example 54
0
10
8


Example 55
0
6
8


Example 56
0
7
9


Example 57
0
10
7


Example 58
0
6
8


Example 59
2
6
8


Example 61
3
8
8


Example 63
0
7
8


Example 65
0
10
5


Example 69
1
10
9


Example 70
0
7
8


Example 72
0
10
5


Example 74
2
10
9


Example 75
0
6
6


Example 76
0
7
7


Example 80
0
9
8


Example 82
0
5
8


Example 83
0
7
8


Example 84
0
6
8


Example 85
0
6
6


Example 86
0
8
8


Example 87
0
9
8


Example 88
0
8
8


Example 89
0
6
7


Example 90
0
9
8


Example 93
0
7
8


Example 95
0
10
8


Example 96
0
7
7


Example 97
0
7
7


Example 99
0
9
8


Example 100
0
7
6


Example 102
0
6
6


Example 104
0
10
9


Example 105
0
10
8


Example 106
0
10
8


Example 107
0
7
7


Example 108
0
10
8


Example 109
0
7
8


Example 110
0
10
8


Example 111
0
6
8


Example 112
0
8
8


Example 113
0
7
6


Example 114
0
10
8


Example 115
0
10
8


Example 116
0
7
8


Example 117
0
5
8


Example 118
0
7
8


Example 119
0
10
8


Example 120
0
8
5


Example 121
0
7
7


Example 122
0
10
6


Example 123
0
7
5


Example 126
0
10
8


Example 127
0
8
8


Example 128
0
10
8


Example 129
0
7
8


Example 130
0
10
8


Example 131
0
6
8


Example 132
0
6
8


Example 133
0
6
7


Example 134
0
5
8


Example 135
0
5
7


Example 136
0
7
8


Example 137
0
10
8


Example 138
0
10
8


Example 139
0
10
8


Example 145
0
10
8


Example 146
0
5
6


Example 148
0
6
8


Example 149
0
5
6


Example 150
0
5
8


Example 151
0
6
5


Example 152
0
10
8


Example 153
0
7
8


Example 154
0
10
8


Example 155
0
8
8


Example 158
0
5
5


Example 161
0
9
8


Example 165
0
5
8


Example 166
0
6
8


Example 173
0
5
7


Example 177
0
5
7


Example 179
1
7
7


Example 181
0
10
9


Example 182
0
10
7


Example 183
0
7
6


Example 185
0
10
7


Example 187
0
10
5


Example 188
1
10
7


Example 191
0
6
7


Example 193
0
6
7


Example 196
0
6
8


Example 197
0
7
7


Example 198
0
5
7


Example 201
0
5
7


Example 202
0
7
7


Example 203
0
10
7


Example 204
0
5
7


Example 207
0
6
7


Example 208
0
8
7


Example 209
0
7
6


Example 210
0
6
9


Example 211
0
6
8


Example 218
0
6
7


Example 247
0
10
9


Example 248
0
5
8


Example 250
0
7
8


Example 253
0
6
8









INDUSTRIAL APPLICABILITY

The composition of the present invention including as an active ingredient one or two or more types of benzoyl derivative having sulfoxyimino group, or salt thereof may be used as a herbicide which is reliably effective when used in a low dose and are highly safe.

Claims
  • 1. A benzoyl derivative represented by formula (I)
  • 2. The benzoyl derivative or salt thereof according to claim 1, wherein the benzoyl derivative is represented by formula (1-b):
  • 3. The benzoyl derivative or salt thereof according to claim 1, wherein in the formulas, R1 represents a halogen atom, an alkyl group or —N═S(═O)R2R3 (in the formula, R2 and R3 are as defined above).
  • 4. The benzoyl derivative or salt thereof according to claim 1, wherein in the formulas, E represents an alkoxy group or an alkoxycarbonyl group.
  • 5. The benzoyl derivative or salt thereof according to claim 3, wherein in the formulas, E represents an alkoxy group or an alkoxycarbonyl group.
  • 6. A herbicide comprising at least one type of benzoyl derivative or salt thereof according to claim 1 as an active ingredient.
  • 7. A herbicide comprising at least one type of benzoyl derivative or salt thereof according to claim 3 as an active ingredient.
  • 8. A herbicide comprising at least one type of benzoyl derivative or salt thereof according to claim 4 as an active ingredient.
  • 9. A herbicide comprising at least one type of benzoyl derivative or salt thereof according to claim 5 as an active ingredient.
  • 10. The benzoyl derivative or salt thereof according to claim 2, wherein in the formulas, R1 represents a halogen atom, an alkyl group or —N═S(═O)R2R3 (in the formula, R2 and R3 are as defined above).
  • 11. The benzoyl derivative or salt thereof according to claim 2, wherein in the formulas, E represents an alkoxy group or an alkoxycarbonyl group.
  • 12. The benzoyl derivative or salt thereof according to claim 10, wherein in the formulas, E represents an alkoxy group or an alkoxycarbonyl group.
  • 13. A herbicide comprising at least one type of benzoyl derivative or salt thereof according to claim 2 as an active ingredient.
  • 14. A herbicide comprising at least one type of benzoyl derivative or salt thereof according to claim 10 as an active ingredient.
  • 15. A herbicide comprising at least one type of benzoyl derivative or salt thereof according to claim 11 as an active ingredient.
  • 16. A herbicide comprising at least one type of benzoyl derivative or salt thereof according to claim 12 as an active ingredient.
Priority Claims (1)
Number Date Country Kind
2008-202445 Aug 2008 JP national
PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/JP2009/003696 8/3/2009 WO 00 2/4/2011